Bruce N. Alpert
Form N-PX is to be used by a registered management investment company, other than a small business investment company registered on Form N-5 (§§ 239.24 and 274.5 of this chapter), to file reports with the Commission, not later than August 31 of each year, containing the registrant's proxy voting record for the most recent twelve-month period ended June 30, pursuant to section 30 of the Investment Company Act of 1940 and rule 30b1-4 thereunder (17 CFR 270.30b1-4). The Commission may use the information provided on Form N-PX in its regulatory, disclosure review, inspection, and policymaking roles.
A registrant is required to disclose the information specified by Form N-PX, and the Commission will make this information public. A registrant is not required to respond to the collection of information contained in Form N-PX unless the Form displays a currently valid Office of Management and Budget ("OMB") control number. Please direct comments concerning the accuracy of the information collection burden estimate and any suggestions for reducing the burden to the Secretary, Securities and Exchange Commission, 450 Fifth Street, NW, Washington, DC 20549-0609. The OMB has reviewed this collection of information under the clearance requirements of 44 U.S.C. § 3507.
Investment Company Report |
|
| ITO EN,LTD. | | |
| Security | J25027103 | | | | Meeting Type | Annual General Meeting |
| Ticker Symbol | | | | | Meeting Date | 28-Jul-2020 | |
| ISIN | JP3143000002 | | | | Agenda | 712915430 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| | Please reference meeting materials. | Non-Voting | | | | | | |
| 1 | Approve Appropriation of Surplus | Management | | For | | For | | |
| 2.1 | Appoint a Director Honjo, Hachiro | Management | | Against | | Against | | |
| 2.2 | Appoint a Director Honjo, Daisuke | Management | | For | | For | | |
| 2.3 | Appoint a Director Honjo, Shusuke | Management | | For | | For | | |
| 2.4 | Appoint a Director Hashimoto, Shunji | Management | | For | | For | | |
| 2.5 | Appoint a Director Watanabe, Minoru | Management | | For | | For | | |
| 2.6 | Appoint a Director Yashiro, Mitsuo | Management | | For | | For | | |
| 2.7 | Appoint a Director Nakano, Yoshihisa | Management | | For | | For | | |
| 2.8 | Appoint a Director Kamiya, Shigeru | Management | | For | | For | | |
| 2.9 | Appoint a Director Yosuke Jay Oceanbright Honjo | Management | | For | | For | | |
| 2.10 | Appoint a Director Hirata, Atsushi | Management | | For | | For | | |
| 2.11 | Appoint a Director Taguchi, Morikazu | Management | | For | | For | | |
| 2.12 | Appoint a Director Usui, Yuichi | Management | | For | | For | | |
| 2.13 | Appoint a Director Tanaka, Yutaka | Management | | For | | For | | |
| 2.14 | Appoint a Director Takano, Hideo | Management | | For | | For | | |
| 3 | Appoint a Corporate Auditor Takasawa, Yoshiaki | Management | | For | | For | | |
| MCKESSON CORPORATION | | |
| Security | 58155Q103 | | | | Meeting Type | Annual |
| Ticker Symbol | MCK | | | | Meeting Date | 29-Jul-2020 | |
| ISIN | US58155Q1031 | | | | Agenda | 935239182 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1A. | Election of Director for a one-year term: Dominic J. Caruso | Management | | For | | For | | |
| 1B. | Election of Director for a one-year term: N. Anthony Coles, M.D. | Management | | For | | For | | |
| 1C. | Election of Director for a one-year term: M. Christine Jacobs | Management | | For | | For | | |
| 1D. | Election of Director for a one-year term: Donald R. Knauss | Management | | For | | For | | |
| 1E. | Election of Director for a one-year term: Marie L. Knowles | Management | | For | | For | | |
| 1F. | Election of Director for a one-year term: Bradley E. Lerman | Management | | For | | For | | |
| 1G. | Election of Director for a one-year term: Maria Martinez | Management | | For | | For | | |
| 1H. | Election of Director for a one-year term: Edward A. Mueller | Management | | For | | For | | |
| 1I. | Election of Director for a one-year term: Susan R. Salka | Management | | For | | For | | |
| 1J. | Election of Director for a one-year term: Brian S. Tyler | Management | | For | | For | | |
| 1K. | Election of Director for a one-year term: Kenneth E. Washington, Ph.D. | Management | | For | | For | | |
| 2. | Ratification of the appointment of Deloitte & Touche LLP as the company's independent registered public accounting firm for the fiscal year ending March 31, 2021. | Management | | For | | For | | |
| 3. | Advisory vote on executive compensation. | Management | | For | | For | | |
| 4. | Shareholder proposal on action by written consent of shareholders. | Shareholder | | Against | | For | | |
| 5. | Shareholder proposal on disclosure of lobbying activities and expenditures. | Shareholder | | Abstain | | Against | | |
| 6. | Shareholder proposal on statement of purpose of a corporation. | Shareholder | | Abstain | | Against | | |
| VITASOY INTERNATIONAL HOLDINGS LTD | | |
| Security | Y93794108 | | | | Meeting Type | Annual General Meeting |
| Ticker Symbol | | | | | Meeting Date | 18-Aug-2020 | |
| ISIN | HK0345001611 | | | | Agenda | 712957248 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| CMMT | PLEASE NOTE THAT THE COMPANY NOTICE AND PROXY FORM ARE AVAILABLE BY CLICKING-ON THE URL LINKS:- https://www1.hkexnews.hk/listedco/listconews/sehk/2020/ 0716/2020071600526.pdf-AND- https://www1.hkexnews.hk/listedco/listconews/sehk/2020/ 0716/2020071600542.pdf | Non-Voting | | | | | | |
| CMMT | PLEASE NOTE IN THE HONG KONG MARKET THAT A VOTE OF 'ABSTAIN' WILL BE TREATED-THE SAME AS A 'TAKE NO ACTION' VOTE | Non-Voting | | | | | | |
| 1 | TO RECEIVE AND ADOPT THE AUDITED FINANCIAL STATEMENTS AND THE REPORTS OF THE DIRECTORS AND AUDITORS FOR THE YEAR ENDED 31ST MARCH, 2020 | Management | | For | | For | | |
| 2 | TO DECLARE A FINAL DIVIDEND: HK28.4 CENTS PER ORDINARY SHARE | Management | | For | | For | | |
| 3.A.I | TO RE-ELECT DR. ROY CHI-PING CHUNG AS AN INDEPENDENT NONEXECUTIVE DIRECTOR | Management | | For | | For | | |
| 3.AII | TO RE-ELECT MS. YVONNE MO-LING LO AS A NON- EXECUTIVE DIRECTOR | Management | | Against | | Against | | |
| 3AIII | TO RE-ELECT MR. PETER TAK-SHING LO AS A NON- EXECUTIVE DIRECTOR | Management | | For | | For | | |
| 3.AIV | TO RE-ELECT MS. MAY LO AS A NON-EXECUTIVE DIRECTOR | Management | | For | | For | | |
| 3.A.V | TO RE-ELECT MR. EUGENE LYE AS AN EXECUTIVE DIRECTOR | Management | | For | | For | | |
| 3.B | TO DETERMINE THE REMUNERATION OF THE DIRECTORS | Management | | For | | For | | |
| 4 | TO APPOINT AUDITORS AND AUTHORISE THE DIRECTORS TO FIX THEIR REMUNERATION: KPMG | Management | | For | | For | | |
| 5.A | TO GRANT A GENERAL MANDATE TO THE DIRECTORS TO ISSUE, ALLOT AND DEAL WITH ADDITIONAL SHARES OF THE COMPANY, NOT EXCEEDING 10% OF THE NUMBER OF ISSUED SHARES OF THE COMPANY AS AT THE DATE OF THIS RESOLUTION | Management | | Against | | Against | | |
| 5.B | TO GRANT A GENERAL MANDATE TO THE DIRECTORS TO BUY-BACK SHARES OF THE COMPANY, NOT EXCEEDING 10% OF THE NUMBER OF ISSUED SHARES OF THE COMPANY AS AT THE DATE OF THIS RESOLUTION | Management | | For | | For | | |
| 5.C | TO ADD THE NUMBER OF SHARES BOUGHT-BACK PURSUANT TO RESOLUTION 5B TO THE NUMBER OF SHARES AVAILABLE PURSUANT TO RESOLUTION 5A | Management | | Against | | Against | | |
| THE J. M. SMUCKER COMPANY | | |
| Security | 832696405 | | | | Meeting Type | Annual |
| Ticker Symbol | SJM | | | | Meeting Date | 19-Aug-2020 | |
| ISIN | US8326964058 | | | | Agenda | 935244599 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1A. | Election of Director whose term of office will expire in 2021: Susan E. Chapman-Hughes | Management | | For | | For | | |
| 1B. | Election of Director whose term of office will expire in 2021: Paul J. Dolan | Management | | For | | For | | |
| 1C. | Election of Director whose term of office will expire in 2021: Jay L. Henderson | Management | | For | | For | | |
| 1D. | Election of Director whose term of office will expire in 2021: Kirk L. Perry | Management | | For | | For | | |
| 1E. | Election of Director whose term of office will expire in 2021: Sandra Pianalto | Management | | For | | For | | |
| 1F. | Election of Director whose term of office will expire in 2021: Nancy Lopez Russell | Management | | For | | For | | |
| 1G. | Election of Director whose term of office will expire in 2021: Alex Shumate | Management | | For | | For | | |
| 1H. | Election of Director whose term of office will expire in 2021: Mark T. Smucker | Management | | For | | For | | |
| 1I. | Election of Director whose term of office will expire in 2021: Richard K. Smucker | Management | | For | | For | | |
| 1J. | Election of Director whose term of office will expire in 2021: Timothy P. Smucker | Management | | For | | For | | |
| 1K. | Election of Director whose term of office will expire in 2021: Jodi L. Taylor | Management | | For | | For | | |
| 1L. | Election of Director whose term of office will expire in 2021: Dawn C. Willoughby | Management | | For | | For | | |
| 2. | Ratification of appointment of Ernst & Young LLP as the Company's Independent Registered Public Accounting Firm for the 2021 fiscal year. | Management | | For | | For | | |
| 3. | Advisory approval of the Company's executive compensation. | Management | | For | | For | | |
| 4. | Approval of The J. M. Smucker Company 2020 Equity and Incentive Compensation Plan. | Management | | For | | For | | |
| INTERNATIONAL FLAVORS & FRAGRANCES INC. | | |
| Security | 459506101 | | | | Meeting Type | Special |
| Ticker Symbol | IFF | | | | Meeting Date | 27-Aug-2020 | |
| ISIN | US4595061015 | | | | Agenda | 935255566 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1. | To approve the issuance of shares of IFF common stock to the stockholders of Nutrition and Biosciences, Inc. in the Merger pursuant to the terms of the Merger Agreement (the "Share Issuance"). | Management | | For | | For | | |
| 2. | To approve the adjournment of the Special Meeting, if necessary or appropriate, to solicit additional proxies if there are not sufficient votes at the time of the Special Meeting to approve the Share Issuance. | Management | | For | | For | | |
| NUVASIVE, INC. | | |
| Security | 670704105 | | | | Meeting Type | Special |
| Ticker Symbol | NUVA | | | | Meeting Date | 10-Sep-2020 | |
| ISIN | US6707041058 | | | | Agenda | 935253966 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1. | To approve an amendment to the Company's Restated Certificate of Incorporation to increase the number of shares of our common stock authorized for issuance from 120,000,000 shares to 150,000,000 shares | Management | | For | | For | | |
| 2. | To approve the adjournment of the Special Meeting to a later date or dates, if necessary or appropriate, to solicit additional proxies if there are insufficient votes to adopt Proposal 1. | Management | | For | | For | | |
| PATTERSON COMPANIES, INC. | | |
| Security | 703395103 | | | | Meeting Type | Annual |
| Ticker Symbol | PDCO | | | | Meeting Date | 14-Sep-2020 | |
| ISIN | US7033951036 | | | | Agenda | 935253384 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1A. | Election of Director: John D. Buck | Management | | For | | For | | |
| 1B. | Election of Director: Alex N. Blanco | Management | | For | | For | | |
| 1C. | Election of Director: Jody H. Feragen | Management | | For | | For | | |
| 1D. | Election of Director: Robert C. Frenzel | Management | | For | | For | | |
| 1E. | Election of Director: Francis J. Malecha | Management | | For | | For | | |
| 1F. | Election of Director: Ellen A. Rudnick | Management | | For | | For | | |
| 1G. | Election of Director: Neil A. Schrimsher | Management | | For | | For | | |
| 1H. | Election of Director: Mark S. Walchirk | Management | | For | | For | | |
| 2. | Advisory approval of executive compensation. | Management | | For | | For | | |
| 3. | To ratify the selection of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending April 24, 2021. | Management | | For | | For | | |
| COMPUTER TASK GROUP, INCORPORATED | | |
| Security | 205477102 | | | | Meeting Type | Annual |
| Ticker Symbol | CTG | | | | Meeting Date | 17-Sep-2020 | |
| ISIN | US2054771025 | | | | Agenda | 935261216 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1. | DIRECTOR | Management | | | | | | |
| | | 1 | James R. Helvey III | | | | For | | For | | |
| | | 2 | Owen J. Sullivan | | | | For | | For | | |
| 2. | To approve, in an advisory and non-binding vote, the compensation of the Company's named executive officers. | Management | | For | | For | | |
| 3. | To ratify the appointment of Grant Thornton LLP as the Company's independent registered accounting firm for the 2020 fiscal year. | Management | | For | | For | | |
| 4. | To approve and ratify the Company's 2020 Equity Award Plan. | Management | | Against | | Against | | |
| GENERAL MILLS, INC. | | |
| Security | 370334104 | | | | Meeting Type | Annual |
| Ticker Symbol | GIS | | | | Meeting Date | 22-Sep-2020 | |
| ISIN | US3703341046 | | | | Agenda | 935257976 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1A. | Election of Director: R. Kerry Clark | Management | | For | | For | | |
| 1B. | Election of Director: David M. Cordani | Management | | For | | For | | |
| 1C. | Election of Director: Roger W. Ferguson Jr. | Management | | For | | For | | |
| 1D. | Election of Director: Jeffrey L. Harmening | Management | | For | | For | | |
| 1E. | Election of Director: Maria G. Henry | Management | | For | | For | | |
| 1F. | Election of Director: Jo Ann Jenkins | Management | | For | | For | | |
| 1G. | Election of Director: Elizabeth C. Lempres | Management | | For | | For | | |
| 1H. | Election of Director: Diane L. Neal | Management | | For | | For | | |
| 1I. | Election of Director: Steve Odland | Management | | For | | For | | |
| 1J. | Election of Director: Maria A. Sastre | Management | | For | | For | | |
| 1K. | Election of Director: Eric D. Sprunk | Management | | For | | For | | |
| 1L. | Election of Director: Jorge A. Uribe | Management | | For | | For | | |
| 2. | Advisory Vote on Executive Compensation. | Management | | For | | For | | |
| 3. | Ratify Appointment of the Independent Registered Public Accounting Firm. | Management | | For | | For | | |
| CONAGRA BRANDS, INC. | | |
| Security | 205887102 | | | | Meeting Type | Annual |
| Ticker Symbol | CAG | | | | Meeting Date | 23-Sep-2020 | |
| ISIN | US2058871029 | | | | Agenda | 935259374 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1A. | Election of Director: Anil Arora | Management | | For | | For | | |
| 1B. | Election of Director: Thomas K. Brown | Management | | For | | For | | |
| 1C. | Election of Director: Sean M. Connolly | Management | | For | | For | | |
| 1D. | Election of Director: Joie A. Gregor | Management | | For | | For | | |
| 1E. | Election of Director: Rajive Johri | Management | | For | | For | | |
| 1F. | Election of Director: Richard H. Lenny | Management | | For | | For | | |
| 1G. | Election of Director: Melissa Lora | Management | | For | | For | | |
| 1H. | Election of Director: Ruth Ann Marshall | Management | | For | | For | | |
| 1I. | Election of Director: Craig P. Omtvedt | Management | | For | | For | | |
| 1J. | Election of Director: Scott Ostfeld | Management | | For | | For | | |
| 2. | Ratification of the appointment of KPMG LLP as our independent auditor for fiscal 2021. | Management | | For | | For | | |
| 3. | Advisory approval of our named executive officer compensation. | Management | | For | | For | | |
| INVITAE CORPORATION | | |
| Security | 46185L103 | | | | Meeting Type | Special |
| Ticker Symbol | NVTA | | | | Meeting Date | 01-Oct-2020 | |
| ISIN | US46185L1035 | | | | Agenda | 935268335 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1. | To vote on a proposal to adopt the Agreement and Plan of Merger and Plan of Reorganization, dated as of June 21, 2020, by and among Invitae Corporation, Apollo Merger Sub A Inc., Apollo Merger Sub B LLC, ArcherDX, Inc. and Kyle Lefkoff, solely in his capacity as holders' representative, and approve the merger contemplated thereby. | Management | | For | | For | | |
| 2. | To vote on a proposal to approve, for the purpose of complying with the applicable provisions of NYSE Listing Rule 312.03, the issuance of up to an aggregate of approximately 16.3 million shares of Invitae common stock in a private placement and the issuance of warrants to purchase 1.0 million shares of Invitae common stock in connection with a senior secured term loan facility. | Management | | For | | For | | |
| 3. | To vote on a proposal to approve the adjournment of the special meeting to a later date or dates, if necessary or appropriate, to solicit additional proxies in the event there are not sufficient votes at the time of the special meeting to approve the merger proposal. | Management | | For | | For | | |
| UNILEVER PLC | | |
| Security | 904767704 | | | | Meeting Type | Annual |
| Ticker Symbol | UL | | | | Meeting Date | 12-Oct-2020 | |
| ISIN | US9047677045 | | | | Agenda | 935265125 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| C1. | To approve the Cross-Border Merger: Please refer to the notice of Court Meeting contained in Schedule 1 of the Circular for further details. | Management | | For | | | | |
| G1. | To vote For or Against the Special Resolution: The Special Resolution is to approve: (i) Unification, including all such steps as are necessary to be taken for the purpose of effecting Unification; and (ii) the related amendments to the Company's articles of association. The Special Resolution is set out in full in the notice of General Meeting contained in Schedule 2 of the Circular. | Management | | For | | | | |
| THE PROCTER & GAMBLE COMPANY | | |
| Security | 742718109 | | | | Meeting Type | Annual |
| Ticker Symbol | PG | | | | Meeting Date | 13-Oct-2020 | |
| ISIN | US7427181091 | | | | Agenda | 935264969 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1A. | ELECTION OF DIRECTOR: Francis S. Blake | Management | | For | | For | | |
| 1B. | ELECTION OF DIRECTOR: Angela F. Braly | Management | | For | | For | | |
| 1C. | ELECTION OF DIRECTOR: Amy L. Chang | Management | | For | | For | | |
| 1D. | ELECTION OF DIRECTOR: Joseph Jimenez | Management | | For | | For | | |
| 1E. | ELECTION OF DIRECTOR: Debra L. Lee | Management | | For | | For | | |
| 1F. | ELECTION OF DIRECTOR: Terry J. Lundgren | Management | | For | | For | | |
| 1G. | ELECTION OF DIRECTOR: Christine M. McCarthy | Management | | For | | For | | |
| 1H. | ELECTION OF DIRECTOR: W. James McNerney, Jr. | Management | | For | | For | | |
| 1I. | ELECTION OF DIRECTOR: Nelson Peltz | Management | | For | | For | | |
| 1J. | ELECTION OF DIRECTOR: David S. Taylor | Management | | For | | For | | |
| 1K. | ELECTION OF DIRECTOR: Margaret C. Whitman | Management | | For | | For | | |
| 1L. | ELECTION OF DIRECTOR: Patricia A. Woertz | Management | | For | | For | | |
| 2. | Ratify Appointment of the Independent Registered Public Accounting Firm. | Management | | For | | For | | |
| 3. | Advisory Vote to Approve the Company's Executive Compensation (the "Say on Pay" vote). | Management | | For | | For | | |
| 4. | Approval of The Procter & Gamble Company International Stock Ownership Plan, As Amended and Restated. | Management | | For | | For | | |
| 5. | Shareholder Proposal - Report on Efforts to Eliminate Deforestation. | Shareholder | | Abstain | | Against | | |
| 6. | Shareholder Proposal - Annual Report on Diversity. | Shareholder | | Abstain | | Against | | |
| LIFEWAY FOODS, INC. | | |
| Security | 531914109 | | | | Meeting Type | Annual |
| Ticker Symbol | LWAY | | | | Meeting Date | 16-Oct-2020 | |
| ISIN | US5319141090 | | | | Agenda | 935266230 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1. | DIRECTOR | Management | | | | | | |
| | | 1 | Ludmila Smolyansky | | | | For | | For | | |
| | | 2 | Julie Smolyansky | | | | For | | For | | |
| | | 3 | Edward Smolyansky | | | | For | | For | | |
| | | 4 | Renzo Bernardi | | | | For | | For | | |
| | | 5 | Jody Levy | | | | For | | For | | |
| | | 6 | Jason Scher | | | | For | | For | | |
| | | 7 | Pol Sikar | | | | For | | For | | |
| | | 8 | Dorri McWhorter | | | | For | | For | | |
| 2. | To ratify the appointment of Mayer Hoffman McCann P.C. as our independent registered public accounting firm for the fiscal year ending December 31, 2020. | Management | | For | | For | | |
| SEMLER SCIENTIFIC, INC. | | |
| Security | 81684M104 | | | | Meeting Type | Annual |
| Ticker Symbol | SMLR | | | | Meeting Date | 22-Oct-2020 | |
| ISIN | US81684M1045 | | | | Agenda | 935272752 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1. | DIRECTOR | Management | | | | | | |
| | | 1 | Arthur Leibowitz, M.D. | | | | For | | For | | |
| 2. | Approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the proxy statement. | Management | | For | | For | | |
| 3. | Approve, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of the Company's named executive officers. | Management | | 1 Year | | For | | |
| 4. | To ratify the selection by the Audit Committee of the board of directors of BDO USA, LLP as the independent registered public accounting firm of the Company for its year ending December 31, 2020. | Management | | For | | For | | |
| TELADOC HEALTH, INC. | | |
| Security | 87918A105 | | | | Meeting Type | Special |
| Ticker Symbol | TDOC | | | | Meeting Date | 29-Oct-2020 | |
| ISIN | US87918A1051 | | | | Agenda | 935274794 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1. | Approval of Share Issuance. To approve the issuance of shares of Teladoc Health, Inc. ("Teladoc") common stock to the shareholders of Livongo Health, Inc. ("Livongo") pursuant to the Agreement and Plan of Merger, dated as of August 5, 2020, by and among Teladoc, Livongo, and Tempranillo Merger Sub, Inc., a wholly-owned subsidiary of Teladoc (the "Teladoc share issuance proposal"). | Management | | For | | For | | |
| 2. | Adoption of Charter Amendment. To adopt an amendment to the certificate of incorporation of Teladoc (the "Teladoc charter amendment proposal") | Management | | For | | For | | |
| 3. | Adjournment of Teladoc Shareholder Meeting. To approve the adjournment of the Teladoc shareholder meeting to solicit additional proxies if there are not sufficient votes at the time of the Teladoc shareholder meeting to approve the Teladoc share issuance proposal and the Teladoc charter amendment proposal or to ensure that any supplement or amendment to the accompanying joint proxy statement/prospectus is timely provided to Teladoc shareholders. | Management | | For | | For | | |
| CARDIOVASCULAR SYSTEMS, INC. | | |
| Security | 141619106 | | | | Meeting Type | Annual |
| Ticker Symbol | CSII | | | | Meeting Date | 11-Nov-2020 | |
| ISIN | US1416191062 | | | | Agenda | 935276128 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1A. | Election of Director: Martha Goldberg Aronson | Management | | For | | For | | |
| 1B. | Election of Director: William Cohn, M.D. | Management | | For | | For | | |
| 1C. | Election of Director: Stephen Stenbeck | Management | | For | | For | | |
| 2. | To ratify the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for its fiscal year ending June 30, 2021. | Management | | For | | For | | |
| 3. | To approve, on an advisory basis, the compensation paid to our named executive officers as disclosed in the proxy statement. | Management | | For | | For | | |
| JDE PEET'S B.V. | | |
| Security | N44664105 | | | | Meeting Type | ExtraOrdinary General Meeting |
| Ticker Symbol | | | | | Meeting Date | 18-Nov-2020 | |
| ISIN | NL0014332678 | | | | Agenda | 713168599 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| CMMT | PLEASE NOTE THAT BENEFICIAL OWNER DETAILS IS REQUIRED FOR THIS MEETING. IF NO- BENEFICIAL OWNER DETAILS IS PROVIDED, YOUR INSTRUCTION MAY BE REJECTED. THANK-YOU. | Non-Voting | | | | | | |
| CMMT | PLEASE NOTE THAT SHAREHOLDER DETAILS ARE REQUIRED TO VOTE AT THIS MEETING. IF-NO SHAREHOLDER DETAILS ARE PROVIDED, YOUR INSTRUCTION MAY CARRY A HEIGHTENED-RISK OF BEING REJECTED. THANK YOU | Non-Voting | | | | | | |
| 1 | OPENING AND ANNOUNCEMENTS | Non-Voting | | | | | | |
| 2. | PROPOSAL TO APPOINT MR. FABIEN SIMON AS EXECUTIVE MEMBER OF THE BOARD | Management | | No Action | | | | |
| 3. | PROPOSAL TO MAKE A TECHNICAL AMENDMENT TO JDE PEET'S' DIRECTORS' REMUNERATION POLICY | Management | | No Action | | | | |
| 4. | PROPOSAL TO APPOINT MR. FRANK ENGELEN AS NON-EXECUTIVE MEMBER OF THE BOARD | Management | | No Action | | | | |
| 5 | CLOSING OF THE MEETING | Non-Voting | | | | | | |
| CMMT | 22 OCT 2020: PLEASE NOTE THAT THIS IS A REVISION DUE TO DUE CHANGE IN-NUMBERING OF RESOLUTIONS 2., 3., 4. IF YOU HAVE ALREADY SENT IN YOUR VOTES,-PLEASE DO NOT VOTE AGAIN UNLESS YOU DECIDE TO AMEND YOUR ORIGINAL-INSTRUCTIONS. THANK YOU. | Non-Voting | | | | | | |
| CAMPBELL SOUP COMPANY | | |
| Security | 134429109 | | | | Meeting Type | Annual |
| Ticker Symbol | CPB | | | | Meeting Date | 18-Nov-2020 | |
| ISIN | US1344291091 | | | | Agenda | 935279528 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 01 | Election of Director: Fabiola R. Arredondo | Management | | For | | For | | |
| 02 | Election of Director: Howard M. Averill | Management | | For | | For | | |
| 03 | Election of Director: John P. (JP) Bilbrey | Management | | For | | For | | |
| 04 | Election of Director: Mark A. Clouse | Management | | For | | For | | |
| 05 | Election of Director: Bennett Dorrance | Management | | For | | For | | |
| 06 | Election of Director: Maria Teresa (Tessa) Hilado | Management | | For | | For | | |
| 07 | Election of Director: Sarah Hofstetter | Management | | For | | For | | |
| 08 | Election of Director: Marc B. Lautenbach | Management | | For | | For | | |
| 09 | Election of Director: Mary Alice D. Malone | Management | | For | | For | | |
| 10 | Election of Director: Keith R. McLoughlin | Management | | For | | For | | |
| 11 | Election of Director: Kurt T. Schmidt | Management | | For | | For | | |
| 12 | Election of Director: Archbold D. van Beuren | Management | | For | | For | | |
| 2. | To ratify the appointment of PricewaterhouseCoopers LLP as our Independent registered public accounting firm for fiscal 2021. | Management | | For | | For | | |
| 3. | To vote on an advisory resolution to approve the fiscal 2020 compensation of our named executive officers, commonly referred to as "say on pay" vote. | Management | | For | | For | | |
| THE HAIN CELESTIAL GROUP, INC. | | |
| Security | 405217100 | | | | Meeting Type | Annual |
| Ticker Symbol | HAIN | | | | Meeting Date | 24-Nov-2020 | |
| ISIN | US4052171000 | | | | Agenda | 935283630 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1a. | Election of Director: Richard A. Beck | Management | | For | | For | | |
| 1b. | Election of Director: Celeste A. Clark | Management | | For | | For | | |
| 1c. | Election of Director: Dean Hollis | Management | | For | | For | | |
| 1d. | Election of Director: Shervin J. Korangy | Management | | For | | For | | |
| 1e. | Election of Director: Mark L. Schiller | Management | | For | | For | | |
| 1f. | Election of Director: Michael B. Sims | Management | | For | | For | | |
| 1g. | Election of Director: Glenn W. Welling | Management | | For | | For | | |
| 1h. | Election of Director: Dawn M. Zier | Management | | For | | For | | |
| 2. | To approve, on an advisory basis, named executive officer compensation. | Management | | For | | For | | |
| 3. | To ratify the appointment of Ernst & Young LLP to act as registered independent accountants of the Company for the fiscal year ending June 30, 2021. | Management | | For | | For | | |
| CHR. HANSEN HOLDING A/S | | |
| Security | K1830B107 | | | | Meeting Type | Annual General Meeting |
| Ticker Symbol | | | | | Meeting Date | 25-Nov-2020 | |
| ISIN | DK0060227585 | | | | Agenda | 713299635 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| CMMT | IN THE MAJORITY OF MEETINGS THE VOTES ARE CAST WITH THE REGISTRAR WHO WILL-FOLLOW CLIENT INSTRUCTIONS. IN A SMALL PERCENTAGE OF MEETINGS THERE IS NO-REGISTRAR AND CLIENTS VOTES MAY BE CAST BY THE CHAIRMAN OF THE BOARD OR A-BOARD MEMBER AS PROXY. CLIENTS CAN ONLY EXPECT THEM TO ACCEPT PRO-MANAGEMENT-VOTES. THE ONLY WAY TO GUARANTEE THAT ABSTAIN AND/OR AGAINST VOTES ARE-REPRESENTED AT THE MEETING IS TO SEND YOUR OWN REPRESENTATIVE OR ATTEND THE-MEETING IN PERSON. THE SUB CUSTODIAN BANKS OFFER REPRESENTATION SERVICES FOR- AN ADDED FEE IF REQUESTED. THANK YOU | Non-Voting | | | | | | |
| CMMT | PLEASE BE ADVISED THAT SPLIT AND PARTIAL VOTING IS NOT AUTHORISED FOR A-BENEFICIAL OWNER IN THE DANISH MARKET. PLEASE CONTACT YOUR GLOBAL CUSTODIAN-FOR FURTHER INFORMATION. | Non-Voting | | | | | | |
| CMMT | IMPORTANT MARKET PROCESSING REQUIREMENT: A BENEFICIAL OWNER SIGNED POWER OF- ATTORNEY (POA) IS REQUIRED IN ORDER TO LODGE AND EXECUTE YOUR VOTING- INSTRUCTIONS IN THIS MARKET. ABSENCE OF A POA, MAY CAUSE YOUR INSTRUCTIONS TO-BE REJECTED. IF YOU HAVE ANY QUESTIONS, PLEASE CONTACT YOUR CLIENT SERVICE- REPRESENTATIVE | Non-Voting | | | | | | |
| CMMT | PLEASE NOTE THAT SHAREHOLDER DETAILS ARE REQUIRED TO VOTE AT THIS MEETING. IF-NO SHAREHOLDER DETAILS ARE PROVIDED, YOUR INSTRUCTION MAY CARRY A HEIGHTENED-RISK OF BEING REJECTED. THANK YOU | Non-Voting | | | | | | |
| CMMT | PLEASE NOTE THAT SHAREHOLDERS ARE ALLOWED TO VOTE 'IN FAVOR' OR 'ABSTAIN'-ONLY FOR RESOLUTION NUMBERS 7.A.A, 7.B.A TO 7.B.G AND 8.A. THANK YOU. | Non-Voting | | | | | | |
| 1 | REPORT ON THE COMPANY'S ACTIVITIES (NOT TO BE PUT TO A VOTE) | Non-Voting | | | | | | |
| 2 | APPROVAL OF THE 2019/20 ANNUAL REPORT | Management | | No Action | | | | |
| 3 | RESOLUTION ON THE APPROPRIATION OF PROFIT | Management | | No Action | | | | |
| 4 | PRESENTATION OF THE COMPANY'S 2019/20 REMUNERATION REPORT FOR AN ADVISORY VOTE | Management | | No Action | | | | |
| 5 | RESOLUTION ON REMUNERATION OF MEMBERS OF THE BOARD OF DIRECTORS | Management | | No Action | | | | |
| 6.A | PROPOSALS FROM THE BOARD OF DIRECTORS: PROPOSED AMENDMENT TO ARTICLE 6.9 OF THE COMPANY'S ARTICLES OF ASSOCIATION; STANDARD AGENDA FOR THE ANNUAL GENERAL MEETING | Management | | No Action | | | | |
| 6.B | PROPOSALS FROM THE BOARD OF DIRECTORS: PROPOSED AMENDMENT TO ARTICLE 6.1 OF THE COMPANY'S ARTICLES OF ASSOCIATION; AUTHORISATION TO THE BOARD OF DIRECTORS TO RESOLVE TO HOLD PARTIAL OR FULL ELECTRONIC GENERAL MEETINGS | Management | | No Action | | | | |
| 6.C | PROPOSED AMENDMENT TO ARTICLE 7.3 OF THE COMPANY'S ARTICLES OF ASSOCIATION; SHAREHOLDERS' NOTIFICATION OF ATTENDANCE | Management | | No Action | | | | |
| 7.A.A | ELECTION OF A CHAIR OF THE BOARD OF DIRECTOR: DOMINIQUE REINICHE (RE-ELECTION) | Management | | No Action | | | | |
| 7.B.A | ELECTION OF OTHER MEMBER TO THE BOARD OF DIRECTORS: JESPER BRANDGAARD (RE-ELECTION) | Management | | No Action | | | | |
| 7.B.B | ELECTION OF OTHER MEMBER TO THE BOARD OF DIRECTORS: LUIS CANTARELL (RE-ELECTION) | Management | | No Action | | | | |
| 7.B.C | ELECTION OF OTHER MEMBER TO THE BOARD OF DIRECTORS: HEIDI KLEINBACH-SAUTER (RE- ELECTION) | Management | | No Action | | | | |
| 7.B.D | ELECTION OF OTHER MEMBER TO THE BOARD OF DIRECTORS: MARK WILSON (RE-ELECTION) | Management | | No Action | | | | |
| 7.B.E | ELECTION OF OTHER MEMBER TO THE BOARD OF DIRECTORS: LISE KAAE (ELECTION) | Management | | No Action | | | | |
| 7.B.F | ELECTION OF OTHER MEMBER TO THE BOARD OF DIRECTORS: KEVIN LANE (ELECTION) | Management | | No Action | | | | |
| 7.B.G | ELECTION OF OTHER MEMBER TO THE BOARD OF DIRECTORS: LILLIE LI VALEUR (ELECTION) | Management | | No Action | | | | |
| 8.A | ELECTION OF A COMPANY AUDITOR: RE-ELECTION OF PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONS PARTNERSELSKAB | Management | | No Action | | | | |
| 9.A | PLEASE NOTE THAT THIS RESOLUTION IS A SHAREHOLDER PROPOSAL: PROPOSALS FROM AKADEMIKER PENSION: GOING FORWARD AND STARTING FROM THE 2020/21 FINANCIAL YEAR, THE COMPANY MUST APPLY THE RECOMMENDATIONS OF THE TASK FORCE ON CLIMATE-RELATED FINANCIAL DISCLOSURES (TCFD) AS THE FRAMEWORK FOR CLIMATE-RELATED DISCLOSURE IN THE COMPANY'S ANNUAL REPORT | Shareholder | | No Action | | | | |
| 9.B | PLEASE NOTE THAT THIS RESOLUTION IS A SHAREHOLDER PROPOSAL: PROPOSALS FROM AKADEMIKER PENSION: THE BOARD OF DIRECTORS MUST COMPLETE AN ASSESSMENT OF THE ABILITY OF THE COMPANY TO PUBLISH COUNTRY-BY-COUNTRY TAX REPORTING IN LINE WITH THE GLOBAL REPORTING INITIATIVE'S STANDARD (GRI 207: TAX 2019) STARTING FROM THE FINANCIAL YEAR 2021/22. THE FINDINGS OF THE ASSESSMENT SHOULD BE MADE PUBLIC BEFORE THE AGM IN 2021 | Shareholder | | No Action | | | | |
| 10 | AUTHORIZATION OF THE CHAIRMAN OF THE ANNUAL GENERAL MEETING | Management | | No Action | | | | |
| MEDTRONIC PLC | | |
| Security | G5960L103 | | | | Meeting Type | Annual |
| Ticker Symbol | MDT | | | | Meeting Date | 11-Dec-2020 | |
| ISIN | IE00BTN1Y115 | | | | Agenda | 935288286 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1A. | Election of Director: Richard H. Anderson | Management | | For | | For | | |
| 1B. | Election of Director: Craig Arnold | Management | | For | | For | | |
| 1C. | Election of Director: Scott C. Donnelly | Management | | For | | For | | |
| 1D. | Election of Director: Andrea J. Goldsmith, Ph.D. | Management | | For | | For | | |
| 1E. | Election of Director: Randall J. Hogan, III | Management | | For | | For | | |
| 1F. | Election of Director: Michael O. Leavitt | Management | | For | | For | | |
| 1G. | Election of Director: James T. Lenehan | Management | | For | | For | | |
| 1H. | Election of Director: Kevin E. Lofton | Management | | For | | For | | |
| 1I. | Election of Director: Geoffrey S. Martha | Management | | For | | For | | |
| 1J. | Election of Director: Elizabeth G. Nabel, M.D. | Management | | For | | For | | |
| 1K. | Election of Director: Denise M. O'Leary | Management | | For | | For | | |
| 1L. | Election of Director: Kendall J. Powell | Management | | For | | For | | |
| 2. | To ratify, in a non-binding vote, the appointment of PricewaterhouseCoopers LLP as the Company's independent auditor for fiscal year 2021 and to authorize, in a binding vote, the Board of Directors, acting through the Audit Committee, to set the auditor's remuneration. | Management | | For | | For | | |
| 3. | To approve, in a non-binding advisory vote, named executive officer compensation (a "Say-on-Pay" vote). | Management | | For | | For | | |
| 4. | To renew the Board's authority to issue shares. | Management | | For | | For | | |
| 5. | To renew the Board's authority to opt out of pre-emption rights. | Management | | Against | | Against | | |
| 6. | Authorizing the Company and any subsidiary of the Company to make overseas market purchases of Medtronic ordinary shares. | Management | | For | | For | | |
| LIGAND PHARMACEUTICALS INCORPORATED | | |
| Security | 53220K504 | | | | Meeting Type | Special |
| Ticker Symbol | LGND | | | | Meeting Date | 15-Dec-2020 | |
| ISIN | US53220K5048 | | | | Agenda | 935302101 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1. | Amendment and Restatement of the Ligand Pharmaceuticals Incorporated 2002 Stock Incentive Plan. | Management | | Against | | Against | | |
| 2. | Adjournment of Special Meeting, if necessary, to solicit additional proxies if there are not sufficient votes to approve Proposal 1. | Management | | Abstain | | Against | | |
| UNITED NATURAL FOODS, INC. | | |
| Security | 911163103 | | | | Meeting Type | Annual |
| Ticker Symbol | UNFI | | | | Meeting Date | 12-Jan-2021 | |
| ISIN | US9111631035 | | | | Agenda | 935308951 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1a. | Election of Director: Eric F. Artz | Management | | For | | For | | |
| 1b. | Election of Director: Ann Torre Bates | Management | | For | | For | | |
| 1c. | Election of Director: Denise M. Clark | Management | | For | | For | | |
| 1d. | Election of Director: Daphne J. Dufresne | Management | | For | | For | | |
| 1e. | Election of Director: Michael S. Funk | Management | | For | | For | | |
| 1f. | Election of Director: James L. Muehlbauer | Management | | For | | For | | |
| 1g. | Election of Director: Peter A. Roy | Management | | For | | For | | |
| 1h. | Election of Director: Steven L. Spinner | Management | | For | | For | | |
| 1i. | Election of Director: Jack Stahl | Management | | For | | For | | |
| 2. | Ratification of the selection of KPMG LLP as our independent registered public accounting firm for the fiscal year ending July 31, 2021. | Management | | For | | For | | |
| 3. | Approval, on an advisory basis, of our executive compensation. | Management | | For | | For | | |
| 4. | Approval of an Amendment to the United Natural Foods, Inc. 2020 Equity Incentive Plan. | Management | | Against | | Against | | |
| BECTON, DICKINSON AND COMPANY | | |
| Security | 075887109 | | | | Meeting Type | Annual |
| Ticker Symbol | BDX | | | | Meeting Date | 26-Jan-2021 | |
| ISIN | US0758871091 | | | | Agenda | 935316845 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1A. | Election of Director: Catherine M. Burzik | Management | | For | | For | | |
| 1B. | Election of Director: R. Andrew Eckert | Management | | For | | For | | |
| 1C. | Election of Director: Vincent A. Forlenza | Management | | For | | For | | |
| 1D. | Election of Director: Claire M. Fraser | Management | | For | | For | | |
| 1E. | Election of Director: Jeffrey W. Henderson | Management | | For | | For | | |
| 1F. | Election of Director: Christopher Jones | Management | | For | | For | | |
| 1G. | Election of Director: Marshall O. Larsen | Management | | For | | For | | |
| 1H. | Election of Director: David F. Melcher | Management | | For | | For | | |
| 1I. | Election of Director: Thomas E. Polen | Management | | For | | For | | |
| 1J. | Election of Director: Claire Pomeroy | Management | | For | | For | | |
| 1K. | Election of Director: Rebecca W. Rimel | Management | | For | | For | | |
| 1L. | Election of Director: Timothy M. Ring | Management | | For | | For | | |
| 1M. | Election of Director: Bertram L. Scott | Management | | For | | For | | |
| 2. | Ratification of the selection of the independent registered public accounting firm. | Management | | For | | For | | |
| 3. | Advisory vote to approve named executive officer compensation. | Management | | For | | For | | |
| 4. | Shareholder proposal seeking to lower the ownership threshold required to call a special shareholders meeting, if properly presented at the meeting. | Shareholder | | Against | | For | | |
| KERRY GROUP PLC | | |
| Security | G52416107 | | | | Meeting Type | ExtraOrdinary General Meeting |
| Ticker Symbol | | | | | Meeting Date | 28-Jan-2021 | |
| ISIN | IE0004906560 | | | | Agenda | 713484082 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| CMMT | PLEASE NOTE THAT SHAREHOLDER DETAILS ARE REQUIRED TO VOTE AT THIS MEETING. IF-NO SHAREHOLDER DETAILS ARE PROVIDED, YOUR INSTRUCTION MAY CARRY A HEIGHTENED-RISK OF BEING REJECTED. THANK YOU | Non-Voting | | | | | | |
| 1 | CONSENT TO THE MIGRATION FROM CREST TO EUROCLEAR BANK'S CENTRAL SECURITIES DEPOSITORY | Management | | No Action | | | | |
| 2 | AMENDMENT OF THE ARTICLES OF ASSOCIATION OF THE COMPANY | Management | | No Action | | | | |
| 3 | AUTHORISATION TO THE COMPANY TO TAKE ALL NECESSARY STEPS TO EFFECT THE MIGRATION | Management | | No Action | | | | |
| POST HOLDINGS, INC. | | |
| Security | 737446104 | | | | Meeting Type | Annual |
| Ticker Symbol | POST | | | | Meeting Date | 28-Jan-2021 | |
| ISIN | US7374461041 | | | | Agenda | 935310261 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1. | DIRECTOR | Management | | | | | | |
| | | 1 | Edwin H. Callison | | | | For | | For | | |
| | | 2 | William P. Stiritz | | | | For | | For | | |
| 2. | Ratification of PricewaterhouseCoopers LLP as the Company's Independent Registered Public Accounting Firm for the fiscal year ending September 30, 2021. | Management | | For | | For | | |
| 3. | Advisory approval of the Company's executive compensation. | Management | | For | | For | | |
| ENERGIZER HOLDINGS, INC. | | |
| Security | 29272W109 | | | | Meeting Type | Annual |
| Ticker Symbol | ENR | | | | Meeting Date | 01-Feb-2021 | |
| ISIN | US29272W1099 | | | | Agenda | 935317568 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1A. | Election of Director: Carlos Abrams-Rivera | Management | | For | | For | | |
| 1B. | Election of Director: Bill G. Armstrong | Management | | For | | For | | |
| 1C. | Election of Director: Cynthia J. Brinkley | Management | | For | | For | | |
| 1D. | Election of Director: Rebecca Frankiewicz | Management | | For | | For | | |
| 1E. | Election of Director: Alan R. Hoskins | Management | | For | | For | | |
| 1F. | Election of Director: Kevin J. Hunt | Management | | For | | For | | |
| 1G. | Election of Director: James C. Johnson | Management | | For | | For | | |
| 1H. | Election of Director: Mark S. LaVigne | Management | | For | | For | | |
| 1I. | Election of Director: Patrick J. Moore | Management | | For | | For | | |
| 1J. | Election of Director: Nneka L. Rimmer | Management | | For | | For | | |
| 1K. | Election of Director: Robert V. Vitale | Management | | For | | For | | |
| 2. | To ratify the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for fiscal 2021. | Management | | For | | For | | |
| 3. | Advisory, non-binding vote on executive compensation. | Management | | For | | For | | |
| EDGEWELL PERSONAL CARE COMPANY | | |
| Security | 28035Q102 | | | | Meeting Type | Annual |
| Ticker Symbol | EPC | | | | Meeting Date | 04-Feb-2021 | |
| ISIN | US28035Q1022 | | | | Agenda | 935313813 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1A. | Election of Director: Robert W. Black | Management | | For | | For | | |
| 1B. | Election of Director: George R. Corbin | Management | | For | | For | | |
| 1C. | Election of Director: Daniel J. Heinrich | Management | | For | | For | | |
| 1D. | Election of Director: Carla C. Hendra | Management | | For | | For | | |
| 1E. | Election of Director: John C. Hunter, III | Management | | For | | For | | |
| 1F. | Election of Director: James C. Johnson | Management | | For | | For | | |
| 1G. | Election of Director: Rod R. Little | Management | | For | | For | | |
| 1H. | Election of Director: Joseph D. O'Leary | Management | | For | | For | | |
| 1I. | Election of Director: Rakesh Sachdev | Management | | For | | For | | |
| 1J. | Election of Director: Swan Sit | Management | | For | | For | | |
| 1K. | Election of Director: Gary K. Waring | Management | | For | | For | | |
| 2. | To ratify the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for fiscal 2021. | Management | | For | | For | | |
| 3. | To cast a non-binding advisory vote on executive compensation. | Management | | For | | For | | |
| INGLES MARKETS, INCORPORATED | | |
| Security | 457030104 | | | | Meeting Type | Annual |
| Ticker Symbol | IMKTA | | | | Meeting Date | 09-Feb-2021 | |
| ISIN | US4570301048 | | | | Agenda | 935320096 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1. | DIRECTOR | Management | | | | | | |
| | | 1 | Ernest E. Ferguson | | | | For | | For | | |
| | | 2 | John R. Lowden | | | | For | | For | | |
| 2. | To approve, by non-binding vote, executive compensation, as disclosed in the Proxy Statement. | Management | | For | | For | | |
| 3. | To recommend, by non-binding vote, the frequency of executive compensation votes. | Management | | 1 Year | | For | | |
| 4. | Stockholder proposal concerning equal voting rights for each share. | Shareholder | | Against | | For | | |
| SURMODICS, INC. | | |
| Security | 868873100 | | | | Meeting Type | Annual |
| Ticker Symbol | SRDX | | | | Meeting Date | 11-Feb-2021 | |
| ISIN | US8688731004 | | | | Agenda | 935318508 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1. | DIRECTOR | Management | | | | | | |
| | | 1 | David R. Dantzker, M.D. | | | | For | | For | | |
| | | 2 | Lisa W. Heine | | | | For | | For | | |
| | | 3 | Gary R. Maharaj | | | | For | | For | | |
| 2. | Set the number of directors at six (6). | Management | | For | | For | | |
| 3. | Ratify the appointment of Deloitte & Touche LLP as Surmodics' independent registered public accounting firm for fiscal year 2021. | Management | | For | | For | | |
| 4. | Approve, in a non-binding advisory vote, the Company's executive compensation. | Management | | For | | For | | |
| BELLRING BRANDS, INC. | | |
| Security | 079823100 | | | | Meeting Type | Annual |
| Ticker Symbol | BRBR | | | | Meeting Date | 03-Mar-2021 | |
| ISIN | US0798231009 | | | | Agenda | 935325488 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1. | DIRECTOR | Management | | | | | | |
| | | 1 | Jennifer Kuperman | | | | For | | For | �� | |
| | | 2 | Thomas P. Erickson | | | | For | | For | | |
| 2. | Ratification of PricewaterhouseCoopers LLP as the Company's independent Registered Public Accounting Firm for the fiscal year ending September 30, 2021. | Management | | For | | For | | |
| REALPAGE, INC. | | |
| Security | 75606N109 | | | | Meeting Type | Special |
| Ticker Symbol | RP | | | | Meeting Date | 08-Mar-2021 | |
| ISIN | US75606N1090 | | | | Agenda | 935334261 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1. | To approve the adoption of the Agreement and Plan of Merger (the "Merger Agreement"), dated as of December 20, 2020, by and among Mirasol Parent, LLC, Mirasol Merger Sub, Inc., and RealPage, Inc. ("RealPage"). | Management | | For | | For | | |
| 2. | To approve, on an advisory (non-binding) basis, the compensation that may be paid or become payable to RealPage's named executive officers that is based on or otherwise relates to the Merger Agreement and the transactions contemplated by the Merger Agreement. | Management | | For | | For | | |
| 3. | To adjourn the special meeting to a later date or dates if necessary or appropriate to solicit additional proxies if there are insufficient votes to approve Proposal 1 at the time of the special meeting. | Management | | For | | For | | |
| AMERISOURCEBERGEN CORPORATION | | |
| Security | 03073E105 | | | | Meeting Type | Annual |
| Ticker Symbol | ABC | | | | Meeting Date | 11-Mar-2021 | |
| ISIN | US03073E1055 | | | | Agenda | 935328939 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1A. | Election of Director: Ornella Barra | Management | | For | | For | | |
| 1B. | Election of Director: Steven H. Collis | Management | | For | | For | | |
| 1C. | Election of Director: D. Mark Durcan | Management | | For | | For | | |
| 1D. | Election of Director: Richard W. Gochnauer | Management | | For | | For | | |
| 1E. | Election of Director: Lon R. Greenberg | Management | | For | | For | | |
| 1F. | Election of Director: Jane E. Henney, M.D. | Management | | For | | For | | |
| 1G. | Election of Director: Kathleen W. Hyle | Management | | For | | For | | |
| 1H. | Election of Director: Michael J. Long | Management | | For | | For | | |
| 1I. | Election of Director: Henry W. McGee | Management | | For | | For | | |
| 1J. | Election of Director: Dennis M. Nally | Management | | For | | For | | |
| 2. | Ratification of Ernst & Young LLP as the Company's independent registered public accounting firm for fiscal year 2021. | Management | | For | | For | | |
| 3. | Advisory vote to approve the compensation of named executive officers. | Management | | For | | For | | |
| 4. | Stockholder proposal, if properly presented, to adopt a policy that the Chair of the Board be an Independent Director. | Shareholder | | Against | | For | | |
| THE COOPER COMPANIES, INC. | | |
| Security | 216648402 | | | | Meeting Type | Annual |
| Ticker Symbol | COO | | | | Meeting Date | 17-Mar-2021 | |
| ISIN | US2166484020 | | | | Agenda | 935329715 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1A. | Election of Director: Colleen E. Jay | Management | | For | | For | | |
| 1B. | Election of Director: William A. Kozy | Management | | For | | For | | |
| 1C. | Election of Director: Jody S. Lindell | Management | | For | | For | | |
| 1D. | Election of Director: Teresa S. Madden | Management | | For | | For | | |
| 1E. | Election of Director: Gary S. Petersmeyer | Management | | For | | For | | |
| 1F. | Election of Director: Robert S. Weiss | Management | | For | | For | | |
| 1G. | Election of Director: Albert G. White III | Management | | For | | For | | |
| 2. | Ratification of the appointment of KPMG LLP as the independent registered public accounting firm for The Cooper Companies, Inc. for the fiscal year ending October 31, 2021. | Management | | For | | For | | |
| 3. | An advisory vote on the compensation of our named executive officers as presented in the Proxy Statement. | Management | | For | | For | | |
| DLH HOLDINGS CORP. | | |
| Security | 23335Q100 | | | | Meeting Type | Annual |
| Ticker Symbol | DLHC | | | | Meeting Date | 18-Mar-2021 | |
| ISIN | US23335Q1004 | | | | Agenda | 935330770 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1. | DIRECTOR | Management | | | | | | |
| | | 1 | James P. Allen | | | | For | | For | | |
| | | 2 | Martin J. Delaney | | | | For | | For | | |
| | | 3 | Dr. Elder Granger | | | | For | | For | | |
| | | 4 | Dr. Frances M. Murphy | | | | For | | For | | |
| | | 5 | Zachary C. Parker | | | | For | | For | | |
| | | 6 | Frederick G. Wasserman | | | | For | | For | | |
| | | 7 | Austin J. Yerks III | | | | For | | For | | |
| | | 8 | Stephen J. Zelkowicz | | | | For | | For | | |
| 2. | An Advisory Vote regarding the approval of compensation paid to our named Executive Officers. | Management | | For | | For | | |
| 3. | Approval of an Amendment to the 2016 Omnibus Equity Incentive Plan. | Management | | Against | | Against | | |
| 4. | Ratification of Independent Registered Public Accounting Firm. | Management | | For | | For | | |
| SUNTORY BEVERAGE & FOOD LIMITED | | |
| Security | J78186103 | | | | Meeting Type | Annual General Meeting |
| Ticker Symbol | | | | | Meeting Date | 26-Mar-2021 | |
| ISIN | JP3336560002 | | | | Agenda | 713633558 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| | Please reference meeting materials. | Non-Voting | | | | | | |
| 1 | Approve Appropriation of Surplus | Management | | For | | For | | |
| 2 | Amend Articles to: Allow the Board of Directors to Authorize Appropriation of Surplus and Purchase Own Shares | Management | | For | | For | | |
| 3.1 | Appoint a Director who is not Audit and Supervisory Committee Member Saito, Kazuhiro | Management | | For | | For | | |
| 3.2 | Appoint a Director who is not Audit and Supervisory Committee Member Kimura, Josuke | Management | | For | | For | | |
| 3.3 | Appoint a Director who is not Audit and Supervisory Committee Member Shekhar Mundlay | Management | | For | | For | | |
| 3.4 | Appoint a Director who is not Audit and Supervisory Committee Member Peter Harding | Management | | For | | For | | |
| 3.5 | Appoint a Director who is not Audit and Supervisory Committee Member Aritake, Kazutomo | Management | | For | | For | | |
| 3.6 | Appoint a Director who is not Audit and Supervisory Committee Member Inoue, Yukari | Management | | For | | For | | |
| 4.1 | Appoint a Director who is Audit and Supervisory Committee Member Yamazaki, Yuji | Management | | Against | | Against | | |
| 4.2 | Appoint a Director who is Audit and Supervisory Committee Member Uchida, Harumichi | Management | | For | | For | | |
| 4.3 | Appoint a Director who is Audit and Supervisory Committee Member Masuyama, Mika | Management | | For | | For | | |
| 5 | Appoint a Substitute Director who is Audit and Supervisory Committee Member Amitani, Mitsuhiro | Management | | For | | For | | |
| SMITH & NEPHEW PLC | | |
| Security | 83175M205 | | | | Meeting Type | Annual |
| Ticker Symbol | SNN | | | | Meeting Date | 14-Apr-2021 | |
| ISIN | US83175M2052 | | | | Agenda | 935341139 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1. | To receive the audited accounts. | Management | | For | | For | | |
| 2. | To approve the Directors' Remuneration Report (excluding policy). | Management | | For | | For | | |
| 3. | To declare a final dividend. | Management | | For | | For | | |
| 4. | ELECTION/RE-ELECTION OF DIRECTOR: Roland Diggelmann | Management | | For | | For | | |
| 5. | ELECTION/RE-ELECTION OF DIRECTOR: Erik Engstrom | Management | | For | | For | | |
| 6. | ELECTION/RE-ELECTION OF DIRECTOR: Robin Freestone | Management | | For | | For | | |
| 7. | ELECTION/RE-ELECTION OF DIRECTOR: John Ma | Management | | For | | For | | |
| 8. | ELECTION/RE-ELECTION OF DIRECTOR: Katarzyna Mazur-Hofsaess | Management | | For | | For | | |
| 9. | ELECTION/RE-ELECTION OF DIRECTOR: Rick Medlock | Management | | For | | For | | |
| 10. | ELECTION/RE-ELECTION OF DIRECTOR: Anne- Françoise Nesmes | Management | | For | | For | | |
| 11. | ELECTION/RE-ELECTION OF DIRECTOR: Marc Owen | Management | | For | | For | | |
| 12. | ELECTION/RE-ELECTION OF DIRECTOR: Roberto Quarta | Management | | For | | For | | |
| 13. | ELECTION/RE-ELECTION OF DIRECTOR: Angie Risley | Management | | For | | For | | |
| 14. | ELECTION/RE-ELECTION OF DIRECTOR: Bob White | Management | | For | | For | | |
| 15. | To re-appoint the Auditor. | Management | | For | | For | | |
| 16. | To authorise Directors' to determine the remuneration of the Auditor. | Management | | For | | For | | |
| 17. | To renew the Directors' authority to allot shares. | Management | | For | | For | | |
| 18. | To renew the Directors' authority for the disapplication of the pre-emption rights. | Management | | For | | For | | |
| 19. | To authorise the Directors to disapply pre-emption rights for the purposes of acquisitions or other capital investments. | Management | | For | | For | | |
| 20. | To renew the Directors' limited authority to make market purchases of the Company's own shares. | Management | | For | | For | | |
| 21. | To authorise general meetings to be held on 14 clear days' notice. | Management | | For | | For | | |
| 22. | To approve the new Articles of Association. | Management | | For | | For | | |
| NESTLE S.A. | | |
| Security | H57312649 | | | | Meeting Type | Annual General Meeting |
| Ticker Symbol | | | | | Meeting Date | 15-Apr-2021 | |
| ISIN | CH0038863350 | | | | Agenda | 713713469 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| CMMT | PLEASE NOTE THAT THIS IS AN AMENDMENT TO MEETING ID 508495 DUE TO RECEIPT OF-CHANGE IN VOTING STAUS FOR RESOLUTON 8. ALL VOTES RECEIVED ON THE PREVIOUS-MEETING WILL BE DISREGARDED IF VOTE DEADLINE EXTENSIONS ARE GRANTED.-THEREFORE PLEASE REINSTRUCT ON THIS MEETING NOTICE ON THE NEW JOB. IF HOWEVER-VOTE DEADLINE EXTENSIONS ARE NOT GRANTED IN THE MARKET, THIS MEETING WILL BE- CLOSED AND YOUR VOTE INTENTIONS ON THE ORIGINAL MEETING WILL BE APPLICABLE.-PLEASE ENSURE VOTING IS SUBMITTED PRIOR TO CUTOFF ON THE ORIGINAL MEETING,-AND AS SOON AS POSSIBLE ON THIS NEW AMENDED MEETING. THANK YOU | Non-Voting | | | | | | |
| CMMT | PLEASE NOTE THAT BENEFICIAL OWNER DETAILS ARE REQUIRED FOR THIS MEETING. IF-NO BENEFICIAL OWNER DETAILS ARE PROVIDED, YOUR INSTRUCTION MAY BE REJECTED.-THANK YOU. | Non-Voting | | | | | | |
| CMMT | PART 2 OF THIS MEETING IS FOR VOTING ON AGENDA AND MEETING ATTENDANCE-REQUESTS ONLY. PLEASE ENSURE THAT YOU HAVE FIRST VOTED IN FAVOUR OF THE-REGISTRATION OF SHARES IN PART 1 OF THE MEETING. IT IS A MARKET REQUIREMENT-FOR MEETINGS OF THIS TYPE THAT THE SHARES ARE REGISTERED AND MOVED TO A-REGISTERED LOCATION AT THE CSD, AND SPECIFIC POLICIES AT THE INDIVIDUAL-SUB- CUSTODIANS MAY VARY. UPON RECEIPT OF THE VOTE INSTRUCTION, IT IS POSSIBLE-THAT A MARKER MAY BE PLACED ON YOUR SHARES TO ALLOW FOR RECONCILIATION AND-RE- REGISTRATION FOLLOWING A TRADE. THEREFORE WHILST THIS DOES NOT PREVENT THE-TRADING OF SHARES, ANY THAT ARE REGISTERED MUST BE FIRST DEREGISTERED IF-REQUIRED FOR SETTLEMENT. DEREGISTRATION CAN AFFECT THE VOTING RIGHTS OF THOSE-SHARES. IF YOU HAVE CONCERNS REGARDING YOUR ACCOUNTS, PLEASE CONTACT YOUR-CLIENT REPRESENTATIVE | Non-Voting | | | | | | |
| 1.1 | APPROVAL OF THE ANNUAL REVIEW, THE FINANCIAL STATEMENTS OF NESTLE S.A. AND THE CONSOLIDATED FINANCIAL STATEMENTS OF THE NESTLE GROUP FOR 2020 | Management | | No Action | | | | |
| 1.2 | ACCEPTANCE OF THE COMPENSATION REPORT 2020 (ADVISORY VOTE) | Management | | No Action | | | | |
| 2 | DISCHARGE TO THE MEMBERS OF THE BOARD OF DIRECTORS AND OF THE MANAGEMENT | Management | | No Action | | | | |
| 3 | APPROPRIATION OF PROFIT RESULTING FROM THE BALANCE SHEET OF NESTLE S.A. (PROPOSED DIVIDEND) FOR THE FINANCIAL YEAR 2020 | Management | | No Action | | | | |
| 4.1.1 | RE-ELECTION AS MEMBER AND CHAIRMAN OF THE BOARD OF DIRECTORS: PAUL BULCKE | Management | | No Action | | | | |
| 4.1.2 | RE-ELECTION AS MEMBER OF THE BOARD OF DIRECTORS: ULF MARK SCHNEIDER | Management | | No Action | | | | |
| 4.1.3 | RE-ELECTION AS MEMBER OF THE BOARD OF DIRECTORS: HENRI DE CASTRIES | Management | | No Action | | | | |
| 4.1.4 | RE-ELECTION AS MEMBER OF THE BOARD OF DIRECTORS: RENATO FASSBIND | Management | | No Action | | | | |
| 4.1.5 | RE-ELECTION AS MEMBER OF THE BOARD OF DIRECTORS: PABLO ISLA | Management | | No Action | | | | |
| 4.1.6 | RE-ELECTION AS MEMBER OF THE BOARD OF DIRECTORS: ANN M. VENEMAN | Management | | No Action | | | | |
| 4.1.7 | RE-ELECTION AS MEMBER OF THE BOARD OF DIRECTORS: EVA CHENG | Management | | No Action | | | | |
| 4.1.8 | RE-ELECTION AS MEMBER OF THE BOARD OF DIRECTORS: PATRICK AEBISCHER | Management | | No Action | | | | |
| 4.1.9 | RE-ELECTION AS MEMBER OF THE BOARD OF DIRECTORS: KASPER RORSTED | Management | | No Action | | | | |
| 4.110 | RE-ELECTION AS MEMBER OF THE BOARD OF DIRECTORS: KIMBERLY A. ROSS | Management | | No Action | | | | |
| 4.111 | RE-ELECTION AS MEMBER OF THE BOARD OF DIRECTORS: DICK BOER | Management | | No Action | | | | |
| 4.112 | RE-ELECTION AS MEMBER OF THE BOARD OF DIRECTORS: DINESH PALIWAL | Management | | No Action | | | | |
| 4.113 | RE-ELECTION AS MEMBER OF THE BOARD OF DIRECTORS: HANNE JIMENEZ DE MORA | Management | | No Action | | | | |
| 4.2 | ELECTION TO THE BOARD OF DIRECTORS: LINDIWE MAJELE SIBANDA | Management | | No Action | | | | |
| 4.3.1 | ELECTION AS MEMBER OF THE COMPENSATION COMMITTEE: PABLO ISLA | Management | | No Action | | | | |
| 4.3.2 | ELECTION AS MEMBER OF THE COMPENSATION COMMITTEE: PATRICK AEBISCHER | Management | | No Action | | | | |
| 4.3.3 | ELECTION AS MEMBER OF THE COMPENSATION COMMITTEE: DICK BOER | Management | | No Action | | | | |
| 4.3.4 | ELECTION AS MEMBER OF THE COMPENSATION COMMITTEE: KASPER RORSTED | Management | | No Action | | | | |
| 4.4 | ELECTION OF THE STATUTORY AUDITORS: ERNST AND YOUNG LTD, LAUSANNE BRANCH | Management | | No Action | | | | |
| 4.5 | ELECTION OF THE INDEPENDENT REPRESENTATIVE: HARTMANN DREYER, ATTORNEYS-AT-LAW | Management | | No Action | | | | |
| 5.1 | APPROVAL OF THE COMPENSATION OF THE BOARD OF DIRECTORS | Management | | No Action | | | | |
| 5.2 | APPROVAL OF THE COMPENSATION OF THE EXECUTIVE BOARD | Management | | No Action | | | | |
| 6 | CAPITAL REDUCTION (BY CANCELLATION OF SHARES) | Management | | No Action | | | | |
| 7 | SUPPORT OF NESTLE'S CLIMATE ROADMAP (ADVISORY VOTE) | Management | | No Action | | | | |
| 8 | IN THE EVENT OF ANY YET UNKNOWN NEW OR MODIFIED PROPOSAL BY A SHAREHOLDER DURING THE GENERAL MEETING, I INSTRUCT THE INDEPENDENT REPRESENTATIVE TO VOTE AS FOLLOWS: (YES = VOTE IN FAVOR OF ANY SUCH YET UNKNOWN PROPOSAL, NO = VOTE AGAINST ANY SUCH YET UNKNOWN PROPOSAL, ABSTAIN = ABSTAIN FROM VOTING) - THE BOARD OF DIRECTORS RECOMMENDS TO VOTE NO ON ANY SUCH YET UNKNOWN PROPOSAL | Shareholder | | No Action | | | | |
| CALAVO GROWERS, INC. | | |
| Security | 128246105 | | | | Meeting Type | Annual |
| Ticker Symbol | CVGW | | | | Meeting Date | 21-Apr-2021 | |
| ISIN | US1282461052 | | | | Agenda | 935341432 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1. | DIRECTOR | Management | | | | | | |
| | | 1 | Farha Aslam | | | | For | | For | | |
| | | 2 | Marc L. Brown | | | | For | | For | | |
| | | 3 | Michael A. DiGregorio | | | | For | | For | | |
| | | 4 | Harold Edwards | | | | For | | For | | |
| | | 5 | James D. Helin | | | | For | | For | | |
| | | 6 | Steven Hollister | | | | For | | For | | |
| | | 7 | Kathleen M. Holmgren | | | | For | | For | | |
| | | 8 | John M. Hunt | | | | For | | For | | |
| | | 9 | J. Link Leavens | | | | For | | For | | |
| | | 10 | Donald M. Sanders | | | | For | | For | | |
| | | 11 | Scott Van Der Kar | | | | For | | For | | |
| 2. | RATIFICATION OF APPOINTMENT OF DELOITTE & TOUCHE LLP AS INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF CALAVO GROWERS, INC. FOR THE YEAR ENDING OCTOBER 31, 2021. | Management | | For | | For | | |
| 3. | ADVISORY VOTE APPROVING THE EXECUTIVE COMPENSATION DISCLOSED IN THE ACCOMPANYING PROXY STATEMENT. | Management | | For | | For | | |
| 4. | APPROVAL OF THE CALAVO GROWERS, INC. 2020 EQUITY INCENTIVE PLAN. | Management | | For | | For | | |
| PFIZER INC. | | |
| Security | 717081103 | | | | Meeting Type | Annual |
| Ticker Symbol | PFE | | | | Meeting Date | 22-Apr-2021 | |
| ISIN | US7170811035 | | | | Agenda | 935344503 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1A. | Election of Director: Ronald E. Blaylock | Management | | For | | For | | |
| 1B. | Election of Director: Albert Bourla | Management | | For | | For | | |
| 1C. | Election of Director: Susan Desmond-Hellmann | Management | | For | | For | | |
| 1D. | Election of Director: Joseph J. Echevarria | Management | | For | | For | | |
| 1E. | Election of Director: Scott Gottlieb | Management | | For | | For | | |
| 1F. | Election of Director: Helen H. Hobbs | Management | | For | | For | | |
| 1G. | Election of Director: Susan Hockfield | Management | | For | | For | | |
| 1H. | Election of Director: Dan R. Littman | Management | | For | | For | | |
| 1I. | Election of Director: Shantanu Narayen | Management | | For | | For | | |
| 1J. | Election of Director: Suzanne Nora Johnson | Management | | For | | For | | |
| 1K. | Election of Director: James Quincey | Management | | For | | For | | |
| 1L. | Election of Director: James C. Smith | Management | | For | | For | | |
| 2. | Ratify the selection of KPMG LLP as independent registered public accounting firm for 2021. | Management | | For | | For | | |
| 3. | 2021 advisory approval of executive compensation. | Management | | For | | For | | |
| 4. | Shareholder proposal regarding independent chair policy. | Shareholder | | Against | | For | | |
| 5. | Shareholder proposal regarding political spending report. | Shareholder | | Abstain | | Against | | |
| 6. | Shareholder proposal regarding access to COVID-19 products. | Shareholder | | Abstain | | Against | | |
| JOHNSON & JOHNSON | | |
| Security | 478160104 | | | | Meeting Type | Annual |
| Ticker Symbol | JNJ | | | | Meeting Date | 22-Apr-2021 | |
| ISIN | US4781601046 | | | | Agenda | 935345214 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1A. | Election of Director: Mary C. Beckerle | Management | | For | | For | | |
| 1B. | Election of Director: D. Scott Davis | Management | | For | | For | | |
| 1C. | Election of Director: Ian E. L. Davis | Management | | For | | For | | |
| 1D. | Election of Director: Jennifer A. Doudna | Management | | For | | For | | |
| 1E. | Election of Director: Alex Gorsky | Management | | For | | For | | |
| 1F. | Election of Director: Marillyn A. Hewson | Management | | For | | For | | |
| 1G. | Election of Director: Hubert Joly | Management | | For | | For | | |
| 1H. | Election of Director: Mark B. McClellan | Management | | For | | For | | |
| 1I. | Election of Director: Anne M. Mulcahy | Management | | For | | For | | |
| 1J. | Election of Director: Charles Prince | Management | | For | | For | | |
| 1K. | Election of Director: A. Eugene Washington | Management | | For | | For | | |
| 1L. | Election of Director: Mark A. Weinberger | Management | | For | | For | | |
| 1M. | Election of Director: Nadja Y. West | Management | | For | | For | | |
| 1N. | Election of Director: Ronald A. Williams | Management | | For | | For | | |
| 2. | Advisory Vote to Approve Named Executive Officer Compensation. | Management | | For | | For | | |
| 3. | Ratification of Appointment of PricewaterhouseCoopers LLP as the Independent Registered Public Accounting Firm for 2021. | Management | | For | | For | | |
| 4. | Report on Government Financial Support and Access to COVID-19 Vaccines and Therapeutics. | Shareholder | | Abstain | | Against | | |
| 5. | Independent Board Chair. | Shareholder | | Against | | For | | |
| 6. | Civil Rights Audit. | Shareholder | | Abstain | | Against | | |
| 7. | Executive Compensation Bonus Deferral. | Shareholder | | Abstain | | Against | | |
| PPD, INC. | | |
| Security | 69355F102 | | | | Meeting Type | Annual |
| Ticker Symbol | PPD | | | | Meeting Date | 23-Apr-2021 | |
| ISIN | US69355F1021 | | | | Agenda | 935341569 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1. | DIRECTOR | Management | | | | | | |
| | | 1 | Stephen Ensley | | | | For | | For | | |
| | | 2 | Maria Teresa Hilado | | | | For | | For | | |
| | | 3 | David Simmons | | | | For | | For | | |
| 2. | To approve, on an advisory basis, the compensation of our named executive officers. | Management | | For | | For | | |
| 3. | To approve, on an advisory basis, the frequency of future stockholder advisory votes on the compensation of our named executive officers. | Management | | 1 Year | | For | | |
| 4. | To ratify the appointment of Deloitte & Touche LLP. | Management | | For | | For | | |
| ABBOTT LABORATORIES | | |
| Security | 002824100 | | | | Meeting Type | Annual |
| Ticker Symbol | ABT | | | | Meeting Date | 23-Apr-2021 | |
| ISIN | US0028241000 | | | | Agenda | 935345125 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1. | DIRECTOR | Management | | | | | | |
| | | 1 | R.J. Alpern | | | | For | | For | | |
| | | 2 | R.S. Austin | | | | For | | For | | |
| | | 3 | S.E. Blount | | | | For | | For | | |
| | | 4 | R.B. Ford | | | | For | | For | | |
| | | 5 | M.A. Kumbier | | | | For | | For | | |
| | | 6 | D.W. McDew | | | | For | | For | | |
| | | 7 | N. McKinstry | | | | For | | For | | |
| | | 8 | W.A. Osborn | | | | For | | For | | |
| | | 9 | M.F. Roman | | | | For | | For | | |
| | | 10 | D.J. Starks | | | | For | | For | | |
| | | 11 | J.G. Stratton | | | | For | | For | | |
| | | 12 | G.F. Tilton | | | | For | | For | | |
| | | 13 | M.D. White | | | | For | | For | | |
| 2. | Ratification of Ernst & Young LLP as Auditors. | Management | | For | | For | | |
| 3. | Say on Pay - An Advisory Vote to Approve Executive Compensation. | Management | | For | | For | | |
| 4A. | Amendments to the Articles of Incorporation to Eliminate Statutory Supermajority Voting Standards for: Amendments to the Articles of Incorporation. | Management | | For | | For | | |
| 4B. | Amendments to the Articles of Incorporation to Eliminate Statutory Supermajority Voting Standards for: Approval of Certain Extraordinary Transactions. | Management | | For | | For | | |
| 5. | Shareholder Proposal - Lobbying Disclosure. | Shareholder | | Abstain | | Against | | |
| 6. | Shareholder Proposal - Report on Racial Justice. | Shareholder | | Abstain | | Against | | |
| 7. | Shareholder Proposal - Independent Board Chairman. | Shareholder | | Against | | For | | |
| BAUSCH HEALTH COMPANIES, INC. | | |
| Security | 071734107 | | | | Meeting Type | Annual |
| Ticker Symbol | BHC | | | | Meeting Date | 27-Apr-2021 | |
| ISIN | CA0717341071 | | | | Agenda | 935352726 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1A. | Election of Director: Richard U. De Schutter | Management | | For | | For | | |
| 1B. | Election of Director: D. Robert Hale | Management | | For | | For | | |
| 1C. | Election of Director: Brett Icahn | Management | | For | | For | | |
| 1D. | Election of Director: Dr. Argeris (Jerry) N. Karabelas | Management | | For | | For | | |
| 1E. | Election of Director: Sarah B. Kavanagh | Management | | For | | For | | |
| 1F. | Election of Director: Steven D. Miller | Management | | For | | For | | |
| 1G. | Election of Director: Joseph C. Papa | Management | | For | | For | | |
| 1H. | Election of Director: John A. Paulson | Management | | For | | For | | |
| 1I. | Election of Director: Robert N. Power | Management | | For | | For | | |
| 1J. | Election of Director: Russel C. Robertson | Management | | For | | For | | |
| 1K. | Election of Director: Thomas W. Ross, Sr. | Management | | For | | For | | |
| 1L. | Election of Director: Andrew C. von Eschenbach, M.D. | Management | | For | | For | | |
| 1M. | Election of Director: Amy B. Wechsler, M.D. | Management | | For | | For | | |
| 2. | The approval, in an advisory vote, of the compensation of our Named Executive Officers. | Management | | For | | For | | |
| 3. | To appoint PricewaterhouseCoopers LLP as the auditor for the Company to hold office until the close of the 2022 Annual Meeting of Shareholders and to authorize the Company's Board of Directors to fix the auditor's remuneration. | Management | | For | | For | | |
| BIO-RAD LABORATORIES, INC. | | |
| Security | 090572207 | | | | Meeting Type | Annual |
| Ticker Symbol | BIO | | | | Meeting Date | 27-Apr-2021 | |
| ISIN | US0905722072 | | | | Agenda | 935380686 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1.1 | Election of Nominee: Melinda Litherland | Management | | For | | For | | |
| 1.2 | Election of Nominee: Arnold A. Pinkston | Management | | For | | For | | |
| 2. | PROPOSAL to ratify the selection of KPMG LLP to serve as the Company's independent auditors. | Management | | For | | For | | |
| MODERNA, INC. | | |
| Security | 60770K107 | | | | Meeting Type | Annual |
| Ticker Symbol | MRNA | | | | Meeting Date | 28-Apr-2021 | |
| ISIN | US60770K1079 | | | | Agenda | 935347206 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1 | DIRECTOR | Management | | | | | | |
| | | 1 | Robert Langer, Sc.D. | | | | For | | For | | |
| | | 2 | Elizabeth Nabel, M.D. | | | | For | | For | | |
| | | 3 | Elizabeth Tallett | | | | For | | For | | |
| 2. | To cast a non-binding, advisory vote to approve the compensation of our named executive officers. | Management | | For | | For | | |
| 3. | To ratify the appointment of Ernst & Young LLP as our registered independent public accounting firm for the year ending December 31, 2021. | Management | | For | | For | | |
| CIGNA CORPORATION | | |
| Security | 125523100 | | | | Meeting Type | Annual |
| Ticker Symbol | CI | | | | Meeting Date | 28-Apr-2021 | |
| ISIN | US1255231003 | | | | Agenda | 935350772 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1A. | Election of Director: David M. Cordani | Management | | For | | For | | |
| 1B. | Election of Director: William J. DeLaney | Management | | For | | For | | |
| 1C. | Election of Director: Eric J. Foss | Management | | For | | For | | |
| 1D. | Election of Director: Elder Granger, MD, MG, USA (Retired) | Management | | For | | For | | |
| 1E. | Election of Director: Isaiah Harris, Jr. | Management | | For | | For | | |
| 1F. | Election of Director: George Kurian | Management | | For | | For | | |
| 1G. | Election of Director: Kathleen M. Mazzarella | Management | | For | | For | | |
| 1H. | Election of Director: Mark B. McClellan, MD, PhD | Management | | For | | For | | |
| 1I. | Election of Director: John M. Partridge | Management | | For | | For | | |
| 1J. | Election of Director: Kimberly A. Ross | Management | | For | | For | | |
| 1K. | Election of Director: Eric C. Wiseman | Management | | For | | For | | |
| 1L. | Election of Director: Donna F. Zarcone | Management | | For | | For | | |
| 2. | Advisory approval of Cigna's executive compensation. | Management | | For | | For | | |
| 3. | Approval of the Amended and Restated Cigna Long- Term Incentive Plan. | Management | | Against | | Against | | |
| 4. | Ratification of the appointment of PricewaterhouseCoopers LLP as Cigna's independent registered public accounting firm for 2021. | Management | | For | | For | | |
| 5. | Shareholder proposal - Shareholder right to act by written consent. | Shareholder | | Against | | For | | |
| 6. | Shareholder proposal - Gender pay gap report. | Shareholder | | Abstain | | Against | | |
| 7. | Shareholder proposal - Board ideology disclosure policy. | Shareholder | | Against | | For | | |
| HCA HEALTHCARE, INC. | | |
| Security | 40412C101 | | | | Meeting Type | Annual |
| Ticker Symbol | HCA | | | | Meeting Date | 28-Apr-2021 | |
| ISIN | US40412C1018 | | | | Agenda | 935354237 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1A. | Election of Director: Thomas F. Frist III | Management | | For | | For | | |
| 1B. | Election of Director: Samuel N. Hazen | Management | | For | | For | | |
| 1C. | Election of Director: Meg G. Crofton | Management | | For | | For | | |
| 1D. | Election of Director: Robert J. Dennis | Management | | For | | For | | |
| 1E. | Election of Director: Nancy-Ann DeParle | Management | | For | | For | | |
| 1F. | Election of Director: William R. Frist | Management | | For | | For | | |
| 1G. | Election of Director: Charles O. Holliday, Jr | Management | | For | | For | | |
| 1H. | Election of Director: Michael W. Michelson | Management | | For | | For | | |
| 1I. | Election of Director: Wayne J. Riley, M.D. | Management | | For | | For | | |
| 2. | To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2021. | Management | | For | | For | | |
| 3. | Advisory vote to approve named executive officer compensation. | Management | | For | | For | | |
| 4. | Stockholder proposal, if properly presented at the meeting, requesting that the Board of Directors take the steps necessary to allow stockholders to act by written consent. | Shareholder | | Against | | For | | |
| 5. | Stockholder proposal, if properly presented at the meeting, requesting a report on the feasibility of increasing the impact of quality metrics on executive compensation. | Shareholder | | Abstain | | Against | | |
| GALAPAGOS N V | | |
| Security | 36315X101 | | | | Meeting Type | Annual |
| Ticker Symbol | GLPG | | | | Meeting Date | 28-Apr-2021 | |
| ISIN | US36315X1019 | | | | Agenda | 935371500 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 2. | Acknowledgement and approval of the non-consolidated annual accounts of the Company for the financial year ended on 31 December 2020 and approval of the allocation of the annual result as proposed by the supervisory board. | Management | | For | | For | | |
| 5. | Acknowledgement and approval of the remuneration report. | Management | | Abstain | | Against | | |
| 6. | Release from liability to be granted to the members of the supervisory board, the members of the former board of directors and the statutory auditor for the performance of their duties in the course of the financial year ended on 31 December 2020. | Management | | Abstain | | Against | | |
| 8.1 | Re-appointment of Katrine Bosley as member of the supervisory board of the Company. | Management | | For | | For | | |
| 8.2 | Re-appointment of Raj Parekh as member of the supervisory board of the Company. | Management | | For | | For | | |
| GALAPAGOS N V | | |
| Security | 36315X101 | | | | Meeting Type | Annual |
| Ticker Symbol | GLPG | | | | Meeting Date | 28-Apr-2021 | |
| ISIN | US36315X1019 | | | | Agenda | 935407874 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 2. | Acknowledgement and approval of the non-consolidated annual accounts of the Company for the financial year ended on 31 December 2020 and approval of the allocation of the annual result as proposed by the supervisory board. | Management | | For | | For | | |
| 5. | Acknowledgement and approval of the remuneration report. | Management | | Abstain | | Against | | |
| 6. | Release from liability to be granted to the members of the supervisory board, the members of the former board of directors and the statutory auditor for the performance of their duties in the course of the financial year ended on 31 December 2020. | Management | | Abstain | | Against | | |
| 8.1 | Re-appointment of Katrine Bosley as member of the supervisory board of the Company. | Management | | For | | For | | |
| 8.2 | Re-appointment of Raj Parekh as member of the supervisory board of the Company. | Management | | For | | For | | |
| KERRY GROUP PLC | | |
| Security | G52416107 | | | | Meeting Type | Annual General Meeting |
| Ticker Symbol | | | | | Meeting Date | 29-Apr-2021 | |
| ISIN | IE0004906560 | | | | Agenda | 713732065 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| CMMT | PLEASE NOTE THAT SHAREHOLDER DETAILS ARE REQUIRED TO VOTE AT THIS MEETING. IF-NO SHAREHOLDER DETAILS ARE PROVIDED, YOUR INSTRUCTION MAY CARRY A HEIGHTENED-RISK OF BEING REJECTED. THANK YOU | Non-Voting | | | | | | |
| 01 | TO RECEIVE AND CONSIDER THE FINANCIAL STATEMENTS AND THE DIRECTORS AND AUDITORS REPORTS THEREON | Management | | No Action | | | | |
| 02 | TO DECLARE A FINAL DIVIDEND | Management | | No Action | | | | |
| 03A | TO ELECT MS EMER GILVARRY | Management | | No Action | | | | |
| 03B | TO ELECT MR JINLONG WANG | Management | | No Action | | | | |
| 04A | TO RE-ELECT MR GERRY BEHAN | Management | | No Action | | | | |
| 04B | TO RE-ELECT DR HUGH BRADY | Management | | No Action | | | | |
| 04C | TO RE-ELECT MR GERARD CULLIGAN | Management | | No Action | | | | |
| 04D | TO RE-ELECT DR KARIN DORREPAAL | Management | | No Action | | | | |
| 04E | TO RE-ELECT MS MARGUERITE LARKIN | Management | | No Action | | | | |
| 04F | TO RE-ELECT MR TOM MORAN | Management | | No Action | | | | |
| 04G | TO RE-ELECT MR CON MURPHY | Management | | No Action | | | | |
| 04H | TO RE-ELECT MR CHRISTOPHER ROGERS | Management | | No Action | | | | |
| 04I | TO RE-ELECT MR EDMOND SCANLON | Management | | No Action | | | | |
| 04J | TO RE-ELECT MR PHILIP TOOMEY | Management | | No Action | | | | |
| 05 | AUTHORITY TO DETERMINE THE AUDITORS REMUNERATION | Management | | No Action | | | | |
| 06 | CONSIDERATION OF DIRECTORS' REMUNERATION REPORT (EXCLUDING SECTION C) | Management | | No Action | | | | |
| 07 | CONSIDERATION OF DIRECTORS' REMUNERATION POLICY | Management | | No Action | | | | |
| 08 | AUTHORITY TO ISSUE ORDINARY SHARES | Management | | No Action | | | | |
| 09 | AUTHORITY TO DISAPPLY PRE-EMPTION RIGHTS | Management | | No Action | | | | |
| 10 | AUTHORITY TO DISAPPLY PRE-EMPTION RIGHTS FOR AN ADDITIONAL 5 PER CENT FOR SPECIFIED TRANSACTIONS | Management | | No Action | | | | |
| 11 | AUTHORITY TO MAKE MARKET PURCHASES OF THE COMPANY'S OWN SHARES | Management | | No Action | | | | |
| 12 | APPROVE KERRY GROUP PLC 2021 LONG-TERM INCENTIVE PLAN | Management | | No Action | | | | |
| CMMT | INTERMEDIARY CLIENTS ONLY - PLEASE NOTE THAT IF YOU ARE CLASSIFIED AS AN- INTERMEDIARY CLIENT UNDER THE SHAREHOLDER RIGHTS DIRECTIVE II, YOU SHOULD BE-PROVIDING THE UNDERLYING SHAREHOLDER INFORMATION AT THE VOTE INSTRUCTION-LEVEL. IF YOU ARE UNSURE ON HOW TO PROVIDE THIS LEVEL OF DATA TO BROADRIDGE-OUTSIDE OF PROXYEDGE, PLEASE SPEAK TO YOUR DEDICATED CLIENT SERVICE-REPRESENTATIVE FOR ASSISTANCE. | Non-Voting | | | | | | |
| DANONE SA | | |
| Security | F12033134 | | | | Meeting Type | MIX |
| Ticker Symbol | | | | | Meeting Date | 29-Apr-2021 | |
| ISIN | FR0000120644 | | | | Agenda | 713755657 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| CMMT | THE FOLLOWING APPLIES TO SHAREHOLDERS THAT DO NOT HOLD SHARES DIRECTLY WITH A- FRENCH CUSTODIAN: PROXY CARDS: VOTING INSTRUCTIONS WILL BE FORWARDED TO THE- GLOBAL CUSTODIANS ON THE VOTE DEADLINE DATE. IN CAPACITY AS REGISTERED- INTERMEDIARY, THE GLOBAL CUSTODIANS WILL SIGN THE PROXY CARDS AND FORWARD-THEM TO THE LOCAL CUSTODIAN. IF YOU REQUEST MORE INFORMATION, PLEASE CONTACT-YOUR CLIENT REPRESENTATIVE. | Non-Voting | | | | | | |
| CMMT | FOLLOWING CHANGES IN THE FORMAT OF PROXY CARDS FOR FRENCH MEETINGS, ABSTAIN-IS NOW A VALID VOTING OPTION. FOR ANY ADDITIONAL ITEMS RAISED AT THE MEETING-THE VOTING OPTION WILL DEFAULT TO 'AGAINST', OR FOR POSITIONS WHERE THE PROXY-CARD IS NOT COMPLETED BY BROADRIDGE, TO THE PREFERENCE OF YOUR CUSTODIAN. | Non-Voting | | | | | | |
| CMMT | PLEASE NOTE THAT SHAREHOLDER DETAILS ARE REQUIRED TO VOTE AT THIS MEETING. IF-NO SHAREHOLDER DETAILS ARE PROVIDED, YOUR INSTRUCTION MAY CARRY A HEIGHTENED-RISK OF BEING REJECTED. THANK YOU | Non-Voting | | | | | | |
| CMMT | PLEASE NOTE THAT DUE TO THE CURRENT COVID19 CRISIS AND IN ACCORDANCE WITH THE- PROVISIONS ADOPTED BY THE FRENCH GOVERNMENT UNDER LAW NO. 2020-1379 OF- NOVEMBER 14, 2020, EXTENDED AND MODIFIED BY LAW NO 2020-1614 OF DECEMBER 18,-2020 THE GENERAL MEETING WILL TAKE PLACE BEHIND CLOSED DOORS WITHOUT THE-PHYSICAL PRESENCE OF THE SHAREHOLDERS. TO COMPLY WITH THESE LAWS, PLEASE DO-NOT SUBMIT ANY REQUESTS TO ATTEND THE MEETING IN PERSON. SHOULD THIS-SITUATION CHANGE, THE COMPANY ENCOURAGES ALL SHAREHOLDERS TO REGULARLY-CONSULT THE COMPANY WEBSITE | Non-Voting | | | | | | |
| CMMT | 14 APR 2021: PLEASE NOTE THAT IMPORTANT ADDITIONAL MEETING INFORMATION IS-AVAILABLE BY CLICKING ON THE MATERIAL URL LINK:- https://www.journal- officiel.gouv.fr/balo/document/202104142100917-45 AND-PLEASE NOTE THAT THIS IS A REVISION DUE TO MODIFICATION OF COMMENT AND CHANGE-IN | Non-Voting | | | | | | |
| | NUMBERING OF ALL RESOLUTIONS AND CHANGE IN TEXT OF COMMENT AND RECEIPT OF-UPDATED BALO. IF YOU HAVE ALREADY SENT IN YOUR VOTES TO MID 541236, PLEASE DO-NOT VOTE AGAIN UNLESS YOU DECIDE TO AMEND YOUR ORIGINAL INSTRUCTIONS | | | | | | | | | |
| CMMT | PLEASE NOTE THAT IF YOU HOLD CREST DEPOSITORY INTERESTS (CDIS) AND-PARTICIPATE AT THIS MEETING, YOU (OR YOUR CREST SPONSORED MEMBER/CUSTODIAN)-WILL BE REQUIRED TO INSTRUCT A TRANSFER OF THE RELEVANT CDIS TO THE ESCROW-ACCOUNT SPECIFIED IN THE ASSOCIATED CORPORATE EVENT IN THE CREST SYSTEM. THIS-TRANSFER WILL NEED TO BE COMPLETED BY THE SPECIFIED CREST SYSTEM DEADLINE.-ONCE THIS TRANSFER HAS SETTLED, THE CDIS WILL BE BLOCKED IN THE CREST SYSTEM.-THE CDIS WILL BE RELEASED FROM ESCROW AS SOON AS PRACTICABLE ON THE BUSINESS-DAY PRIOR TO MEETING DATE UNLESS OTHERWISE SPECIFIED. IN ORDER FOR A VOTE TO- BE ACCEPTED, THE VOTED POSITION MUST BE BLOCKED IN THE REQUIRED ESCROW-ACCOUNT IN THE CREST SYSTEM. BY VOTING ON THIS MEETING, YOUR CREST SPONSORED-MEMBER/CUSTODIAN MAY USE YOUR VOTE INSTRUCTION AS THE AUTHORIZATION TO TAKE-THE NECESSARY ACTION WHICH WILL INCLUDE TRANSFERRING YOUR INSTRUCTED POSITION-TO ESCROW. PLEASE CONTACT YOUR CREST SPONSORED MEMBER/CUSTODIAN DIRECTLY FOR-FURTHER INFORMATION ON THE CUSTODY PROCESS AND WHETHER OR NOT THEY REQUIRE-SEPARATE INSTRUCTIONS FROM YOU AND PLEASE NOTE THAT SHAREHOLDER DETAILS ARE-REQUIRED TO VOTE AT THIS MEETING. IF NO SHAREHOLDER DETAILS ARE PROVIDED,-YOUR INSTRUCTION MAY CARRY A HEIGHTENED RISK OF BEING REJECTED. THANK YOU | Non-Voting | | | | | | |
| CMMT | 07 APR 2021: PLEASE NOTE THAT THIS IS AN AMENDMENT TO MEETING ID 535348 DUE-TO RECEIPT OF ADDITIONAL RESOLUTIONS 27 AND 28. ALL VOTES RECEIVED ON THE-PREVIOUS MEETING WILL BE DISREGARDED IF VOTE DEADLINE EXTENSIONS ARE GRANTED.-THEREFORE PLEASE REINSTRUCT ON THIS MEETING NOTICE ON THE NEW JOB. IF HOWEVER-VOTE DEADLINE EXTENSIONS ARE NOT GRANTED IN THE MARKET, THIS MEETING WILL BE-CLOSED AND YOUR VOTE INTENTIONS ON THE ORIGINAL MEETING WILL BE APPLICABLE.-PLEASE ENSURE VOTING IS SUBMITTED PRIOR TO CUTOFF ON THE ORIGINAL MEETING,-AND AS SOON AS POSSIBLE ON THIS NEW AMENDED MEETING. THANK YOU. | Non-Voting | | | | | | |
| 1 | APPROVAL OF THE CORPORATE FINANCIAL STATEMENTS FOR THE FINANCIAL YEAR ENDED 31 DECEMBER 2020 | Management | | No Action | | | | |
| 2 | APPROVAL OF THE CONSOLIDATED FINANCIAL STATEMENTS FOR THE FINANCIAL YEAR ENDED 31 DECEMBER 2020 | Management | | No Action | | | | |
| 3 | ALLOCATION OF INCOME FOR THE FINANCIAL YEAR ENDED 31 DECEMBER 2020 AND SETTING OF THE DIVIDEND AT 1.94 EUROS PER SHARE | Management | | No Action | | | | |
| 4 | RENEWAL OF THE TERM OF OFFICE OF MR. GUIDO BARILLA AS DIRECTOR | Management | | No Action | | | | |
| 5 | RENEWAL OF THE TERM OF OFFICE OF MRS. CECILE CABANIS AS DIRECTOR | Management | | No Action | | | | |
| 6 | RENEWAL OF THE TERM OF OFFICE OF MR. MICHEL LANDEL AS DIRECTOR PURSUANT TO PARAGRAPH 2 OF ARTICLE 15-II OF THE BY-LAWS | Management | | No Action | | | | |
| 7 | RENEWAL OF THE TERM OF OFFICE OF MRS. SERPIL TIMURAY AS DIRECTOR | Management | | No Action | | | | |
| 8 | RATIFICATION OF THE CO-OPTATION OF MR. GILLES SCHNEPP AS DIRECTOR, AS A REPLACEMENT FOR MR. GREGG L. ENGLES, WHO RESIGNED | Management | | No Action | | | | |
| 9 | APPROVAL OF THE AGREEMENTS SUBJECT TO THE PROVISIONS OF ARTICLES L.225-38 AND FOLLOWING OF THE FRENCH COMMERCIAL CODE CONCLUDED BY THE COMPANY WITH THE SICAV DANONE COMMUNITIES | Management | | No Action | | | | |
| 10 | APPROVAL OF THE INFORMATION RELATING TO THE REMUNERATION OF CORPORATE OFFICERS MENTIONED IN SECTION I OF ARTICLE L.22-10-9 OF THE FRENCH COMMERCIAL CODE FOR THE FINANCIAL YEAR 2020 | Management | | No Action | | | | |
| 11 | APPROVAL OF THE COMPENSATION ELEMENTS PAID DURING OR AWARDED IN RESPECT OF THE FINANCIAL YEAR ENDED 31 DECEMBER 2020 TO MR. EMMANUEL FABER, CHAIRMAN AND CHIEF EXECUTIVE OFFICER | Management | | No Action | | | | |
| 12 | APPROVAL OF THE REMUNERATION POLICY FOR EXECUTIVE CORPORATE OFFICERS FOR THE FINANCIAL YEAR 2021 | Management | | No Action | | | | |
| 13 | SETTING OF THE OVERALL ANNUAL REMUNERATION AMOUNT OF DIRECTORS | Management | | No Action | | | | |
| 14 | APPROVAL OF THE REMUNERATION POLICY FOR THE DIRECTORS FOR THE FINANCIAL YEAR 2021 | Management | | No Action | | | | |
| 15 | AUTHORIZATION TO BE GRANTED TO THE BOARD OF DIRECTORS IN ORDER TO PURCHASE, RETAIN OR TRANSFER SHARES OF THE COMPANY | Management | | No Action | | | | |
| 16 | DELEGATION OF AUTHORITY TO THE BOARD OF DIRECTORS IN ORDER TO ISSUE COMMON SHARES AND TRANSFERABLE SECURITIES, WITH RETENTION OF THE SHAREHOLDERS' PRE-EMPTIVE SUBSCRIPTION RIGHT | Management | | No Action | | | | |
| 17 | DELEGATION OF AUTHORITY TO THE BOARD OF DIRECTORS IN ORDER TO ISSUE COMMON SHARES AND TRANSFERABLE SECURITIES, WITH CANCELLATION OF THE SHAREHOLDERS' PRE- EMPTIVE SUBSCRIPTION RIGHT, BUT WITH THE OBLIGATION TO GRANT A PRIORITY RIGHT | Management | | No Action | | | | |
| 18 | DELEGATION OF AUTHORITY TO THE BOARD OF DIRECTORS IN CASE OF A CAPITAL INCREASE WITH CANCELLATION OF THE SHAREHOLDERS' PRE- EMPTIVE SUBSCRIPTION RIGHT, IN ORDER TO INCREASE THE NUMBER OF SECURITIES TO BE ISSUED | Management | | No Action | | | | |
| 19 | DELEGATION OF AUTHORITY TO THE BOARD OF DIRECTORS IN ORDER TO ISSUE COMMON SHARES AND TRANSFERABLE SECURITIES, WITHOUT THE SHAREHOLDERS' PRE-EMPTIVE SUBSCRIPTION RIGHT, IN THE EVENT OF A PUBLIC EXCHANGE OFFER INITIATED BY THE COMPANY | Management | | No Action | | | | |
| 20 | DELEGATION OF POWERS TO THE BOARD OF DIRECTORS IN ORDER TO ISSUE COMMON SHARES AND TRANSFERABLE SECURITIES, WITHOUT THE SHAREHOLDERS' PRE-EMPTIVE SUBSCRIPTION RIGHT, TO REMUNERATE CONTRIBUTIONS IN KIND GRANTED TO THE COMPANY AND CONSTITUTED OF EQUITY SECURITIES OR TRANSFERABLE SECURITIES GRANTING ACCESS TO THE CAPITAL | Management | | No Action | | | | |
| 21 | DELEGATION OF AUTHORITY TO THE BOARD OF DIRECTORS IN ORDER TO INCREASE THE COMPANY'S CAPITAL BY INCORPORATION OF RESERVES, PROFITS, PREMIUMS OR OTHER AMOUNTS WHOSE CAPITALISATION WOULD BE ALLOWED | Management | | No Action | | | | |
| 22 | DELEGATION OF AUTHORITY TO THE BOARD OF DIRECTORS IN ORDER TO ISSUE COMMON SHARES AND TRANSFERABLE SECURITIES RESERVED FOR EMPLOYEES WHO ARE MEMBERS OF A COMPANY SAVINGS PLAN AND/OR FOR TRANSFERS OF RESERVED SECURITIES, WITHOUT THE SHAREHOLDERS' PRE-EMPTIVE SUBSCRIPTION RIGHT | Management | | No Action | | | | |
| 23 | DELEGATION OF AUTHORITY TO THE BOARD OF DIRECTORS IN ORDER TO ISSUE COMMON SHARES AND TRANSFERABLE SECURITIES, WITH CANCELLATION OF THE PRE-EMPTIVE SUBSCRIPTION RIGHT, RESERVED FOR CATEGORIES OF BENEFICIARIES CONSISTING OF EMPLOYEES WORKING IN FOREIGN COMPANIES OF THE DANONE GROUP, OR IN A SITUATION OF INTERNATIONAL MOBILITY, IN THE CONTEXT OF EMPLOYEE SHAREHOLDING OPERATIONS | Management | | No Action | | | | |
| 24 | AUTHORIZATION GRANTED TO THE BOARD OF DIRECTORS TO PROCEED WITH ALLOCATIONS OF EXISTING SHARES OR SHARES TO BE ISSUED OF THE COMPANY, WITHOUT THE SHAREHOLDERS' PRE-EMPTIVE SUBSCRIPTION RIGHT | Management | | No Action | | | | |
| 25 | AUTHORIZATION GRANTED TO THE BOARD OF DIRECTORS IN ORDER TO REDUCE THE CAPITAL BY CANCELLING SHARES | Management | | No Action | | | | |
| 26 | POWERS TO CARRY OUT FORMALITIES | Management | | No Action | | | | |
| 27 | APPROVAL OF THE COMPENSATION POLICY FOR EXECUTIVE CORPORATE OFFICERS ON AN INTERIM BASIS FOR THE FINANCIAL YEAR 2021 | Management | | No Action | | | | |
| 28 | APPROVAL OF THE ELEMENTS OF COMPENSATION PAID DURING OR AWARDED IN RESPECT OF THE FINANCIAL YEAR 2021 TO MR. EMMANUEL FABER, CHAIRMAN AND CHIEF EXECUTIVE OFFICER, UNTIL HIS DEPARTURE | Management | | No Action | | | | |
| OWENS & MINOR, INC. | | |
| Security | 690732102 | | | | Meeting Type | Annual |
| Ticker Symbol | OMI | | | | Meeting Date | 29-Apr-2021 | |
| ISIN | US6907321029 | | | | Agenda | 935348309 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1.1 | Election of Director for the term of one-year: Aster Angagaw | Management | | For | | For | | |
| 1.2 | Election of Director for the term of one-year: Mark A. Beck | Management | | For | | For | | |
| 1.3 | Election of Director for the term of one-year: Gwendolyn M. Bingham | Management | | For | | For | | |
| 1.4 | Election of Director for the term of one-year: Robert J. Henkel | Management | | For | | For | | |
| 1.5 | Election of Director for the term of one-year: Stephen W. Klemash | Management | | For | | For | | |
| 1.6 | Election of Director for the term of one-year: Mark F. McGettrick | Management | | For | | For | | |
| 1.7 | Election of Director for the term of one-year: Edward A. Pesicka | Management | | For | | For | | |
| 1.8 | Election of Director for the term of one-year: Michael C. Riordan | Management | | For | | For | | |
| 2. | Ratification of the appointment of KPMG LLP as the Company's independent public accounting firm for the year ending December 31, 2021. | Management | | For | | For | | |
| 3. | Advisory vote to approve the compensation of the Company's named executive officers. | Management | | For | | For | | |
| CHURCH & DWIGHT CO., INC. | | |
| Security | 171340102 | | | | Meeting Type | Annual |
| Ticker Symbol | CHD | | | | Meeting Date | 29-Apr-2021 | |
| ISIN | US1713401024 | | | | Agenda | 935348753 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1A. | Election of Director for a term of one year: James R. Craigie | Management | | For | | For | | |
| 1B. | Election of Director for a term of one year: Matthew T. Farrell | Management | | For | | For | | |
| 1C. | Election of Director for a term of one year: Bradley C. Irwin | Management | | For | | For | | |
| 1D. | Election of Director for a term of one year: Penry W. Price | Management | | For | | For | | |
| 1E. | Election of Director for a term of one year: Susan G. Saideman | Management | | For | | For | | |
| 1F. | Election of Director for a term of one year: Ravichandra K. Saligram | Management | | For | | For | | |
| 1G. | Election of Director for a term of one year: Robert K. Shearer | Management | | For | | For | | |
| 1H. | Election of Director for a term of one year: Janet S. Vergis | Management | | For | | For | | |
| 1I. | Election of Director for a term of one year: Arthur B. Winkleblack | Management | | For | | For | | |
| 1J. | Election of Director for a term of one year: Laurie J. Yoler | Management | | For | | For | | |
| 2. | An advisory vote to approve compensation of our named executive officers. | Management | | For | | For | | |
| 3. | Proposal to amend the Company's Amended and Restated Certificate of Incorporation to remove the requirement for holders of two- thirds of our outstanding stock to fill vacancies on the Board of Directors. | Management | | For | | For | | |
| 4. | Proposal to amend the Company's Amended and Restated Certificate of Incorporation to remove the requirement to have holders of two-thirds of our outstanding stock approve certain mergers, consolidations or dispositions of substantial assets. | Management | | For | | For | | |
| 5. | Proposal to amend the Company's Amended and Restated Certificate of Incorporation to remove certain procedural provisions that will no longer be required once the Board is fully declassified. | Management | | For | | For | | |
| 6. | Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for 2021. | Management | | For | | For | | |
| KELLOGG COMPANY | | |
| Security | 487836108 | | | | Meeting Type | Annual |
| Ticker Symbol | K | | | | Meeting Date | 30-Apr-2021 | |
| ISIN | US4878361082 | | | | Agenda | 935348359 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1A. | Election of Director (term expires 2024): Carter Cast | Management | | For | | For | | |
| 1B. | Election of Director (term expires 2024): Zack Gund | Management | | For | | For | | |
| 1C. | Election of Director (term expires 2024): Don Knauss | Management | | For | | For | | |
| 1D. | Election of Director (term expires 2024): Mike Schlotman | Management | | For | | For | | |
| 2. | Advisory resolution to approve executive compensation. | Management | | For | | For | | |
| 3. | Ratification of the appointment of PricewaterhouseCoopers LLP as Kellogg's independent registered public accounting firm for fiscal year 2021. | Management | | For | | For | | |
| 4. | Management proposal to reduce supermajority vote requirements. | Management | | For | | For | | |
| 5. | Shareowner proposal, if properly presented at the meeting, to adopt shareowner right to call a special meeting. | Shareholder | | For | | | | |
| BAXTER INTERNATIONAL INC. | | |
| Security | 071813109 | | | | Meeting Type | Annual |
| Ticker Symbol | BAX | | | | Meeting Date | 04-May-2021 | |
| ISIN | US0718131099 | | | | Agenda | 935352459 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1A. | Election of Director: José (Joe) Almeida | Management | | For | | For | | |
| 1B. | Election of Director: Thomas F. Chen | Management | | For | | For | | |
| 1C. | Election of Director: John D. Forsyth | Management | | For | | For | | |
| 1D. | Election of Director: Peter S. Hellman | Management | | For | | For | | |
| 1E. | Election of Director: Michael F. Mahoney | Management | | For | | For | | |
| 1F. | Election of Director: Patricia B. Morrison | Management | | For | | For | | |
| 1G. | Election of Director: Stephen N. Oesterle | Management | | For | | For | | |
| 1H. | Election of Director: Cathy R. Smith | Management | | For | | For | | |
| 1I. | Election of Director: Thomas T. Stallkamp | Management | | For | | For | | |
| 1J. | Election of Director: Albert P.L. Stroucken | Management | | For | | For | | |
| 1K. | Election of Director: Amy A. Wendell | Management | | For | | For | | |
| 1L. | Election of Director: David S. Wilkes | Management | | For | | For | | |
| 2. | Advisory Vote to Approve Named Executive Officer Compensation. | Management | | For | | For | | |
| 3. | Ratification of Appointment of Independent Registered Public Accounting Firm. | Management | | For | | For | | |
| 4. | Vote to Approve the Omnibus Plan. | Management | | Abstain | | Against | | |
| 5. | Vote to Approve the ESPP Amendment. | Management | | For | | For | | |
| 6. | Stockholder Proposal - Right to Act by Written Consent. | Shareholder | | Against | | For | | |
| 7. | Stockholder Proposal - Independent Board Chairman. | Shareholder | | Against | | For | | |
| INTRICON CORPORATION | | |
| Security | 46121H109 | | | | Meeting Type | Annual |
| Ticker Symbol | IIN | | | | Meeting Date | 04-May-2021 | |
| ISIN | US46121H1095 | | | | Agenda | 935359287 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1. | DIRECTOR | Management | | | | | | |
| | | 1 | Nicholas A. Giordano | | | | For | | For | | |
| | | 2 | Raymond Huggenberger | | | | For | | For | | |
| 2. | An advisory vote to approve executive compensation, as described in the Proxy Statement, referred to as "say-on- pay." | Management | | For | | For | | |
| 3. | To approve an amendment to Intricon Corporation's Amended and Restated 2015 Equity Incentive Plan to, among other matters, increase the number of shares of common stock authorized for issuance under that plan by 500,000 shares, as more fully described in the Proxy Statement. | Management | | Against | | Against | | |
| 4. | To ratify the appointment of Deloitte & Touche LLP as Intricon Corporation's independent registered public accounting firm for fiscal year 2021. | Management | | For | | For | | |
| BRISTOL-MYERS SQUIBB COMPANY | | |
| Security | 110122108 | | | | Meeting Type | Annual |
| Ticker Symbol | BMY | | | | Meeting Date | 04-May-2021 | |
| ISIN | US1101221083 | | | | Agenda | 935359643 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1A) | Election of Director: Peter J. Arduini | Management | | For | | For | | |
| 1B) | Election of Director: Michael W. Bonney | Management | | For | | For | | |
| 1C) | Election of Director: Giovanni Caforio, M.D. | Management | | For | | For | | |
| 1D) | Election of Director: Julia A. Haller, M.D. | Management | | For | | For | | |
| 1E) | Election of Director: Paula A. Price | Management | | For | | For | | |
| 1F) | Election of Director: Derica W. Rice | Management | | For | | For | | |
| 1G) | Election of Director: Theodore R. Samuels | Management | | For | | For | | |
| 1H) | Election of Director: Gerald L. Storch | Management | | For | | For | | |
| 1I) | Election of Director: Karen Vousden, Ph.D. | Management | | For | | For | | |
| 1J) | Election of Director: Phyllis R. Yale | Management | | For | | For | | |
| 2. | Advisory Vote to Approve the Compensation of our Named Executive Officers. | Management | | For | | For | | |
| 3. | Approval of the Company's 2021 Stock Award and Incentive Plan. | Management | | For | | For | | |
| 4. | Ratification of the Appointment of an Independent Registered Public Accounting Firm. | Management | | For | | For | | |
| 5. | Approval of an Amendment to the Certificate of Incorporation to Lower the Ownership Threshold for Special Shareholder Meetings to 15%. | Management | | For | | For | | |
| 6. | Shareholder Proposal on Adoption of a Board Policy that the Chairperson of the Board be an Independent Director. | Shareholder | | Against | | For | | |
| 7. | Shareholder Proposal on Shareholder Right to Act by Written Consent. | Shareholder | | Against | | For | | |
| 8. | Shareholder Proposal to Lower the Ownership Threshold for Special Shareholder Meetings to 10%. | Shareholder | | Against | | For | | |
| MAPLE LEAF FOODS INC | | |
| Security | 564905107 | | | | Meeting Type | Annual General Meeting |
| Ticker Symbol | | | | | Meeting Date | 05-May-2021 | |
| ISIN | CA5649051078 | | | | Agenda | 713740125 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| CMMT | PLEASE NOTE THAT SHAREHOLDERS ARE ALLOWED TO VOTE 'IN FAVOR' OR 'AGAINST'-ONLY FOR RESOLUTIONS 3 AND 4 AND 'IN FAVOR' OR 'ABSTAIN' ONLY FOR RESOLUTION-NUMBERS 1.1 TO 1.10 AND 2. THANK YOU | Non-Voting | | | | | | |
| 1.1 | ELECTION OF DIRECTOR: WILLIAM E. AZIZ | Management | | For | | For | | |
| 1.2 | ELECTION OF DIRECTOR: W. GEOFFREY BEATTIE | Management | | For | | For | | |
| 1.3 | ELECTION OF DIRECTOR: RONALD G. CLOSE | Management | | For | | For | | |
| 1.4 | ELECTION OF DIRECTOR: JEAN M. FRASER | Management | | For | | For | | |
| 1.5 | ELECTION OF DIRECTOR: TIMOTHY D. HOCKEY | Management | | For | | For | | |
| 1.6 | ELECTION OF DIRECTOR: JOHN A. LEDERER | Management | | For | | For | | |
| 1.7 | ELECTION OF DIRECTOR: KATHERINE N. LEMON | Management | | For | | For | | |
| 1.8 | ELECTION OF DIRECTOR: JONATHAN W.F. MCCAIN | Management | | For | | For | | |
| 1.9 | ELECTION OF DIRECTOR: MICHAEL H. MCCAIN | Management | | For | | For | | |
| 1.10 | ELECTION OF DIRECTOR: CAROL M. STEPHENSON | Management | | For | | For | | |
| 2 | APPOINTMENT OF KPMG LLP, AS AUDITORS OF MAPLE LEAF FOODS INC. FOR THE ENSUING YEAR AND AUTHORIZING THE DIRECTORS TO FIX THEIR REMUNERATION | Management | | For | | For | | |
| 3 | TO APPROVE, ON AN ADVISORY AND NON-BINDING BASIS, MAPLE LEAF FOODS INC.'S APPROACH TO EXECUTIVE COMPENSATION | Management | | For | | For | | |
| 4 | TO APPROVE THE AMENDMENT OF THE 2016 SHARE OPTION PLAN TO INCREASE THE NUMBER OF SHARES AVAILABLE FOR ISSUANCE | Management | | For | | For | | |
| PEPSICO, INC. | | |
| Security | 713448108 | | | | Meeting Type | Annual |
| Ticker Symbol | PEP | | | | Meeting Date | 05-May-2021 | |
| ISIN | US7134481081 | | | | Agenda | 935355342 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1A. | Election of Director: Segun Agbaje | Management | | For | | For | | |
| 1B. | Election of Director: Shona L. Brown | Management | | For | | For | | |
| 1C. | Election of Director: Cesar Conde | Management | | For | | For | | |
| 1D. | Election of Director: Ian Cook | Management | | For | | For | | |
| 1E. | Election of Director: Dina Dublon | Management | | For | | For | | |
| 1F. | Election of Director: Michelle Gass | Management | | For | | For | | |
| 1G. | Election of Director: Ramon L. Laguarta | Management | | For | | For | | |
| 1H. | Election of Director: Dave Lewis | Management | | For | | For | | |
| 1I. | Election of Director: David C. Page | Management | | For | | For | | |
| 1J. | Election of Director: Robert C. Pohlad | Management | | For | | For | | |
| 1K. | Election of Director: Daniel Vasella | Management | | For | | For | | |
| 1L. | Election of Director: Darren Walker | Management | | For | | For | | |
| 1M. | Election of Director: Alberto Weisser | Management | | For | | For | | |
| 2. | Ratification of the appointment of KPMG LLP as the Company's independent registered public accounting firm for fiscal year 2021. | Management | | For | | For | | |
| 3. | Advisory approval of the Company's executive compensation. | Management | | For | | For | | |
| 4. | Shareholder Proposal - Special Shareholder Meeting Vote Threshold. | Shareholder | | Against | | For | | |
| 5. | Shareholder Proposal - Report on Sugar and Public Health. | Shareholder | | Against | | For | | |
| 6. | Shareholder Proposal - Report on External Public Health Costs. | Shareholder | | Against | | For | | |
| UNILEVER PLC | | |
| Security | 904767704 | | | | Meeting Type | Annual |
| Ticker Symbol | UL | | | | Meeting Date | 05-May-2021 | |
| ISIN | US9047677045 | | | | Agenda | 935356659 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1. | To receive the Report and Accounts for the year ended 31 December 2020. | Management | | For | | For | | |
| 2. | To approve the Directors' Remuneration Report. | Management | | For | | For | | |
| 3. | To approve the Directors' Remuneration Policy. | Management | | For | �� | For | | |
| 4. | To approve the Climate Transition Action Plan. | Management | | Abstain | | Against | | |
| 5. | To re-elect Mr N Andersen as a Non-Executive Director. | Management | | For | | For | | |
| 6. | To re-elect Mrs L Cha as a Non-Executive Director. | Management | | For | | For | | |
| 7. | To re-elect Dr J Hartmann as a Non-Executive Director. | Management | | For | | For | | |
| 8. | To re-elect Mr A Jope as an Executive Director. | Management | | For | | For | | |
| 9. | To re-elect Ms A Jung as a Non-Executive Director. | Management | | For | | For | | |
| 10. | To re-elect Ms S Kilsby as a Non-Executive Director. | Management | | For | | For | | |
| 11. | To re-elect Mr S Masiyiwa as a Non-Executive Director. | Management | | For | | For | | |
| 12. | To re-elect Professor Y Moon as a Non-Executive Director. | Management | | For | | For | | |
| 13. | To re-elect Mr G Pitkethly as an Executive Director. | Management | | For | | For | | |
| 14. | To re-elect Mr J Rishton as a Non-Executive Director. | Management | | For | | For | | |
| 15. | To re-elect Mr F Sijbesma as a Non-Executive Director. | Management | | For | | For | | |
| 16. | To reappoint KPMG LLP as Auditors of the Company. | Management | | For | | For | | |
| 17. | To authorise the Directors to fix the remuneration of the Auditors. | Management | | For | | For | | |
| 18. | To authorise Political Donations and expenditure. | Management | | For | | For | | |
| 19. | To approve the SHARES Plan. | Management | | For | | For | | |
| 20. | To renew the authority to Directors to issue shares. | Management | | For | | For | | |
| 21. | To renew the authority to Directors to disapply pre- emption rights. | Management | | Abstain | | Against | | |
| 22. | To renew the authority to Directors to disapply pre- emption rights for the purposes of acquisitions or capital investments. | Management | | For | | For | | |
| 23. | To renew the authority to the Company to purchase its own shares. | Management | | For | | For | | |
| 24. | To shorten the notice period for General Meetings. | Management | | For | | For | | |
| 25. | To adopt new Articles of Association. | Management | | For | | For | | |
| 26. | To reduce the share premium account. | Management | | For | | For | | |
| STRYKER CORPORATION | | |
| Security | 863667101 | | | | Meeting Type | Annual |
| Ticker Symbol | SYK | | | | Meeting Date | 05-May-2021 | |
| ISIN | US8636671013 | | | | Agenda | 935359972 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1A) | Election of Director: Mary K. Brainerd | Management | | For | | For | | |
| 1B) | Election of Director: Giovanni Caforio, M.D. | Management | | For | | For | | |
| 1C) | Election of Director: Srikant M. Datar, Ph.D. | Management | | For | | For | | |
| 1D) | Election of Director: Allan C. Golston (Lead Independent Director) | Management | | For | | For | | |
| 1E) | Election of Director: Kevin A. Lobo (Chair of the Board and Chief Executive Officer) | Management | | For | | For | | |
| 1F) | Election of Director: Sherilyn S. McCoy | Management | | For | | For | | |
| 1G) | Election of Director: Andrew K. Silvernail | Management | | For | | For | | |
| 1H) | Election of Director: Lisa M. Skeete Tatum | Management | | For | | For | | |
| 1I) | Election of Director: Ronda E. Stryker | Management | | For | | For | | |
| 1J) | Election of Director: Rajeev Suri | Management | | For | | For | | |
| 2. | Ratification of Appointment of our Independent Registered Public Accounting Firm. | Management | | For | | For | | |
| 3. | Advisory Vote to Approve Named Executive Officer Compensation. | Management | | For | | For | | |
| 4. | Shareholder Proposal Regarding Workforce Involvement in Corporate Governance. | Shareholder | | Abstain | | Against | | |
| 5. | Shareholder Proposal Regarding Right to Call Special Meetings | Shareholder | | Against | | For | | |
| INTERNATIONAL FLAVORS & FRAGRANCES INC. | | |
| Security | 459506101 | | | | Meeting Type | Annual |
| Ticker Symbol | IFF | | | | Meeting Date | 05-May-2021 | |
| ISIN | US4595061015 | | | | Agenda | 935364721 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1a. | Election of Director for a one-year term expiring at the 2022 Annual Meeting of Shareholders: Kathryn J. Boor | Management | | For | | For | | |
| 1b. | Election of Director for a one-year term expiring at the 2022 Annual Meeting of Shareholders: Edward D. Breen | Management | | For | | For | | |
| 1c. | Election of Director for a one-year term expiring at the 2022 Annual Meeting of Shareholders: Carol Anthony Davidson | Management | | For | | For | | |
| 1d. | Election of Director for a one-year term expiring at the 2022 Annual Meeting of Shareholders: Michael L. Ducker | Management | | For | | For | | |
| 1e. | Election of Director for a one-year term expiring at the 2022 Annual Meeting of Shareholders: Roger W. Ferguson, Jr. | Management | | For | | For | | |
| 1f. | Election of Director for a one-year term expiring at the 2022 Annual Meeting of Shareholders: John F. Ferraro | Management | | For | | For | | |
| 1g. | Election of Director for a one-year term expiring at the 2022 Annual Meeting of Shareholders: Andreas Fibig | Management | | For | | For | | |
| 1h. | Election of Director for a one-year term expiring at the 2022 Annual Meeting of Shareholders: Christina Gold | Management | | For | | For | | |
| 1i. | Election of Director for a one-year term expiring at the 2022 Annual Meeting of Shareholders: Ilene Gordon | Management | | For | | For | | |
| 1j. | Election of Director for a one-year term expiring at the 2022 Annual Meeting of Shareholders: Matthias J. Heinzel | Management | | For | | For | | |
| 1k. | Election of Director for a one-year term expiring at the 2022 Annual Meeting of Shareholders: Dale F. Morrison | Management | | For | | For | | |
| 1l. | Election of Director for a one-year term expiring at the 2022 Annual Meeting of Shareholders: Kåre Schultz | Management | | For | | For | | |
| 1m. | Election of Director for a one-year term expiring at the 2022 Annual Meeting of Shareholders: Stephen Williamson | Management | | For | | For | | |
| 2. | Ratify the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the 2021 fiscal year. | Management | | For | | For | | |
| 3. | Approve, on an advisory basis, the compensation of our named executive officers in 2020. | Management | | For | | For | | |
| 4. | Approve our 2021 Stock Award and Incentive Plan. | Management | | For | | For | | |
| BOSTON SCIENTIFIC CORPORATION | | |
| Security | 101137107 | | | | Meeting Type | Annual |
| Ticker Symbol | BSX | | | | Meeting Date | 06-May-2021 | |
| ISIN | US1011371077 | | | | Agenda | 935360456 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1A. | Election of Director: Nelda J. Connors | Management | | For | | For | | |
| 1B. | Election of Director: Charles J. Dockendorff | Management | | For | | For | | |
| 1C. | Election of Director: Yoshiaki Fujimori | Management | | For | | For | | |
| 1D. | Election of Director: Donna A. James | Management | | For | | For | | |
| 1E. | Election of Director: Edward J. Ludwig | Management | | For | | For | | |
| 1F. | Election of Director: Michael F. Mahoney | Management | | For | | For | | |
| 1G. | Election of Director: David J. Roux | Management | | For | | For | | |
| 1H. | Election of Director: John E. Sununu | Management | | For | | For | | |
| 1I. | Election of Director: Ellen M. Zane | Management | | For | | For | | |
| 2. | To approve, on a non-binding, advisory basis, named executive officer compensation. | Management | | For | | For | | |
| 3. | To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the 2021 fiscal year. | Management | | For | | For | | |
| 4. | To consider and vote upon a stockholder proposal requesting a report to stockholders describing any benefits to the company related to employee participation in company governance. | Shareholder | | Abstain | | Against | | |
| TENET HEALTHCARE CORPORATION | | |
| Security | 88033G407 | | | | Meeting Type | Annual |
| Ticker Symbol | THC | | | | Meeting Date | 06-May-2021 | |
| ISIN | US88033G4073 | | | | Agenda | 935362537 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1a. | Election of Director: Ronald A. Rittenmeyer | Management | | For | | For | | |
| 1b. | Election of Director: J. Robert Kerrey | Management | | For | | For | | |
| 1c. | Election of Director: James L. Bierman | Management | | For | | For | | |
| 1d. | Election of Director: Richard W. Fisher | Management | | For | | For | | |
| 1e. | Election of Director: Meghan M. FitzGerald | Management | | For | | For | | |
| 1f. | Election of Director: Cecil D. Haney | Management | | For | | For | | |
| 1g. | Election of Director: Christopher S. Lynch | Management | | For | | For | | |
| 1h. | Election of Director: Richard J. Mark | Management | | For | | For | | |
| 1i. | Election of Director: Tammy Romo | Management | | For | | For | | |
| 1j. | Election of Director: Saumya Sutaria | Management | | For | | For | | |
| 1k. | Election of Director: Nadja Y. West | Management | | For | | For | | |
| 2. | Proposal to approve, on an advisory basis, the company's executive compensation. | Management | | For | | For | | |
| 3. | Proposal to ratify the selection of Deloitte & Touche LLP as independent registered public accountants for the year ending December 31, 2021. | Management | | For | | For | | |
| CHARLES RIVER LABORATORIES INTL., INC. | | |
| Security | 159864107 | | | | Meeting Type | Annual |
| Ticker Symbol | CRL | | | | Meeting Date | 06-May-2021 | |
| ISIN | US1598641074 | | | | Agenda | 935370483 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1A. | Election of Director: James C. Foster | Management | | For | | For | | |
| 1B. | Election of Director: Nancy C. Andrews | Management | | For | | For | | |
| 1C. | Election of Director: Robert Bertolini | Management | | For | | For | | |
| 1D. | Election of Director: Deborah T. Kochevar | Management | | For | | For | | |
| 1E. | Election of Director: George Llado, Sr. | Management | | For | | For | | |
| 1F. | Election of Director: Martin W. MacKay | Management | | For | | For | | |
| 1G. | Election of Director: George E. Massaro | Management | | For | | For | | |
| 1H. | Election of Director: George M. Milne, Jr. | Management | | For | | For | | |
| 1I. | Election of Director: C. Richard Reese | Management | | For | | For | | |
| 1J. | Election of Director: Richard F. Wallman | Management | | For | | For | | |
| 1K. | Election of Director: Virginia M. Wilson | Management | | For | | For | | |
| 2. | Say on Pay. | Management | | For | | For | | |
| 3. | Ratification of Auditors. | Management | | For | | For | | |
| COLGATE-PALMOLIVE COMPANY | | |
| Security | 194162103 | | | | Meeting Type | Annual |
| Ticker Symbol | CL | | | | Meeting Date | 07-May-2021 | |
| ISIN | US1941621039 | | | | Agenda | 935355392 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1a. | Election of Director: John P. Bilbrey | Management | | For | | For | | |
| 1b. | Election of Director: John T. Cahill | Management | | For | | For | | |
| 1c. | Election of Director: Lisa M. Edwards | Management | | For | | For | | |
| 1d. | Election of Director: C. Martin Harris | Management | | For | | For | | |
| 1e. | Election of Director: Martina Hund-Mejean | Management | | For | | For | | |
| 1f. | Election of Director: Kimberly A. Nelson | Management | | For | | For | | |
| 1g. | Election of Director: Lorrie M. Norrington | Management | | For | | For | | |
| 1h. | Election of Director: Michael B. Polk | Management | | For | | For | | |
| 1i. | Election of Director: Stephen I. Sadove | Management | | For | | For | | |
| 1j. | Election of Director: Noel R. Wallace | Management | | For | | For | | |
| 2. | Ratify selection of PricewaterhouseCoopers LLP as Colgate's independent registered public accounting firm. | Management | | For | | For | | |
| 3. | Advisory vote on executive compensation. | Management | | For | | For | | |
| 4. | Stockholder proposal on independent Board Chairman. | Shareholder | | Against | | For | | |
| 5. | Stockholder proposal to reduce the ownership threshold to call special stockholder meetings to 10%. | Shareholder | | Against | | For | | |
| ABBVIE INC. | | |
| Security | 00287Y109 | | | | Meeting Type | Annual |
| Ticker Symbol | ABBV | | | | Meeting Date | 07-May-2021 | |
| ISIN | US00287Y1091 | | | | Agenda | 935357891 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1. | DIRECTOR | Management | | | | | | |
| | | 1 | Roxanne S. Austin | | | | For | | For | | |
| | | 2 | Richard A. Gonzalez | | | | For | | For | | |
| | | 3 | Rebecca B. Roberts | | | | For | | For | | |
| | | 4 | Glenn F. Tilton | | | | For | | For | | |
| 2. | Ratification of Ernst & Young LLP as AbbVie's independent registered public accounting firm for 2021. | Management | | For | | For | | |
| 3. | Say on Pay-An advisory vote on the approval of executive compensation. | Management | | For | | For | | |
| 4. | Approval of the Amended and Restated 2013 Incentive Stock Program. | Management | | For | | For | | |
| 5. | Approval of the Amended and Restated 2013 Employee Stock Purchase Plan for non-U.S. employees. | Management | | For | | For | | |
| 6. | Approval of a management proposal regarding amendment of the certificate of incorporation to eliminate supermajority voting. | Management | | For | | For | | |
| 7. | Stockholder Proposal - to Issue an Annual Report on Lobbying. | Shareholder | | Abstain | | Against | | |
| 8. | Stockholder Proposal - to Adopt a Policy to Require Independent Chairman. | Shareholder | | Against | | For | | |
| AXOGEN INC | | |
| Security | 05463X106 | | | | Meeting Type | Annual |
| Ticker Symbol | AXGN | | | | Meeting Date | 10-May-2021 | |
| ISIN | US05463X1063 | | | | Agenda | 935365292 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1. | DIRECTOR | Management | | | | | | |
| | | 1 | Karen Zaderej | | | | For | | For | | |
| | | 2 | Gregory Freitag | | | | For | | For | | |
| | | 3 | Quentin S. Blackford | | | | For | | For | | |
| | | 4 | Dr. Mark Gold | | | | For | | For | | |
| | | 5 | Alan M. Levine | | | | For | | For | | |
| | | 6 | Guido Neels | | | | For | | For | | |
| | | 7 | Paul Thomas | | | | For | | For | | |
| | | 8 | Amy Wendell | | | | For | | For | | |
| 2. | To ratify the selection of Deloitte & Touche LLP as our independent registered public accounting firm for the year ending December 31, 2021. | Management | | For | | For | | |
| 3. | To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers as disclosed in the Company's Proxy Statement | Management | | For | | For | | |
| 4. | To approve the Axogen, Inc. Amended and Restated 2019 Long-Term Incentive Plan. | Management | | Against | | Against | | |
| WATERS CORPORATION | | |
| Security | 941848103 | | | | Meeting Type | Annual |
| Ticker Symbol | WAT | | | | Meeting Date | 11-May-2021 | |
| ISIN | US9418481035 | | | | Agenda | 935361888 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1.1 | Election of Director to serve for a term of one year: Udit Batra | Management | | For | | For | | |
| 1.2 | Election of Director to serve for a term of one year: Linda Baddour | Management | | For | | For | | |
| 1.3 | Election of Director to serve for a term of one year: Michael J. Berendt | Management | | For | | For | | |
| 1.4 | Election of Director to serve for a term of one year: Edward Conard | Management | | For | | For | | |
| 1.5 | Election of Director to serve for a term of one year: Gary E. Hendrickson | Management | | For | | For | | |
| 1.6 | Election of Director to serve for a term of one year: Pearl S. Huang | Management | | For | | For | | |
| 1.7 | Election of Director to serve for a term of one year: Christopher A. Kuebler | Management | | For | | For | | |
| 1.8 | Election of Director to serve for a term of one year: Flemming Ornskov | Management | | For | | For | | |
| 1.9 | Election of Director to serve for a term of one year: Thomas P. Salice | Management | | For | | For | | |
| 2. | To ratify the selection of PricewaterhouseCoopers LLP as the Company's Independent Registered Public Accounting Firm for the fiscal year ending December 31, 2021. | Management | | For | | For | | |
| 3. | To approve, by non-binding vote, named executive officer compensation. | Management | | For | | For | | |
| ICU MEDICAL, INC. | | |
| Security | 44930G107 | | | | Meeting Type | Annual |
| Ticker Symbol | ICUI | | | | Meeting Date | 11-May-2021 | |
| ISIN | US44930G1076 | | | | Agenda | 935383276 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1. | DIRECTOR | Management | | | | | | |
| | | 1 | Vivek Jain | | | | For | | For | | |
| | | 2 | George A. Lopez, M.D. | | | | For | | For | | |
| | | 3 | Robert S. Swinney, M.D. | | | | For | | For | | |
| | | 4 | David C. Greenberg | | | | For | | For | | |
| | | 5 | Elisha W. Finney | | | | For | | For | | |
| | | 6 | David F. Hoffmeister | | | | For | | For | | |
| | | 7 | Donald M. Abbey | | | | For | | For | | |
| 2. | To ratify the selection of Deloitte & Touche LLP as auditors for the Company for the year ending December 31, 2021. | Management | | For | | For | | |
| 3. | To approve named executive officer compensation on an advisory basis. | Management | | For | | For | | |
| ALEXION PHARMACEUTICALS, INC. | | |
| Security | 015351109 | | | | Meeting Type | Special |
| Ticker Symbol | ALXN | | | | Meeting Date | 11-May-2021 | |
| ISIN | US0153511094 | | | | Agenda | 935410124 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1. | To adopt the Agreement and Plan of Merger, dated as of December 12, 2020 (as it may be amended from time to time, the "merger agreement") by and among Alexion, AstraZeneca PLC ("AstraZeneca"), Delta Omega Sub Holdings Inc., a wholly owned subsidiary of AstraZeneca ("Bidco"), Delta Omega Sub Holdings Inc. 1, a direct, wholly owned subsidiary of Bidco and Delta Omega Sub Holdings LLC 2, a direct, wholly owned subsidiary of Bidco (the "merger proposal"). | Management | | For | | For | | |
| 2. | To approve, on a non-binding, advisory basis, the compensation that may be paid or become payable to Alexion's named executive officers that is based on or otherwise relates to the transactions contemplated by the merger agreement. | Management | | For | | For | | |
| 3. | To approve the adjournment of the Alexion special meeting, if necessary or appropriate, to solicit additional proxies if there are not sufficient votes at the time of the Alexion special meeting to approve the merger proposal or to ensure that any supplement or amendment to this proxy statement/ prospectus is timely provided to Alexion stockholders. | Management | | For | | For | | |
| IDORSIA LTD | | |
| Security | H3879B109 | | | | Meeting Type | Annual General Meeting |
| Ticker Symbol | | | | | Meeting Date | 12-May-2021 | |
| ISIN | CH0363463438 | | | | Agenda | 713900466 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| CMMT | PLEASE NOTE THAT BENEFICIAL OWNER DETAILS ARE REQUIRED FOR THIS MEETING. IF-NO BENEFICIAL OWNER DETAILS ARE PROVIDED, YOUR INSTRUCTION MAY BE REJECTED.-THANK YOU. | Non-Voting | | | | | | |
| CMMT | PLEASE NOTE THAT THIS IS AN AMENDMENT TO MEETING ID 550039 DUE TO SPLITTING-OF RESOLUTION 5.4. ALL VOTES RECEIVED ON THE PREVIOUS MEETING WILL BE-DISREGARDED IF VOTE DEADLINE EXTENSIONS ARE GRANTED. THEREFORE PLEASE-REINSTRUCT ON THIS MEETING NOTICE ON THE NEW JOB. IF HOWEVER VOTE DEADLINE-EXTENSIONS ARE NOT GRANTED IN THE MARKET, THIS MEETING WILL BE CLOSED AND-YOUR VOTE INTENTIONS ON THE ORIGINAL MEETING WILL BE APPLICABLE. PLEASE-ENSURE VOTING IS SUBMITTED PRIOR TO CUTOFF ON THE ORIGINAL MEETING, AND AS-SOON AS POSSIBLE ON THIS NEW AMENDED MEETING. THANK YOU | Non-Voting | | | | | | |
| CMMT | PART 2 OF THIS MEETING IS FOR VOTING ON AGENDA AND MEETING ATTENDANCE-REQUESTS ONLY. PLEASE ENSURE THAT YOU HAVE FIRST VOTED IN FAVOUR OF THE-REGISTRATION OF SHARES IN PART 1 OF THE MEETING. IT IS A MARKET REQUIREMENT-FOR MEETINGS OF THIS TYPE THAT THE SHARES ARE REGISTERED AND MOVED TO A-REGISTERED LOCATION AT THE CSD, AND SPECIFIC POLICIES AT THE INDIVIDUAL-SUB- CUSTODIANS MAY VARY. UPON RECEIPT OF THE VOTE INSTRUCTION, IT IS POSSIBLE-THAT A MARKER MAY BE PLACED ON YOUR SHARES TO ALLOW FOR RECONCILIATION AND-RE- REGISTRATION FOLLOWING A TRADE. THEREFORE WHILST THIS DOES NOT PREVENT THE-TRADING OF SHARES, ANY THAT ARE REGISTERED MUST BE FIRST DEREGISTERED IF-REQUIRED FOR SETTLEMENT. DEREGISTRATION CAN AFFECT THE VOTING RIGHTS OF THOSE-SHARES. IF YOU HAVE CONCERNS REGARDING YOUR ACCOUNTS, PLEASE CONTACT YOUR-CLIENT REPRESENTATIVE | Non-Voting | | | | | | |
| 1.1 | ANNUAL REPORT 2020, CONSOLIDATED FINANCIAL STATEMENTS 2020, STATUTORY FINANCIAL STATEMENTS 2020 AND COMPENSATION REPORT 2020: APPROVAL OF ANNUAL REPORT 2020, CONSOLIDATED FINANCIAL STATEMENTS 2020, AND STATUTORY FINANCIAL STATEMENTS 2020 | Management | | No Action | | | | |
| 1.2 | ANNUAL REPORT 2020, CONSOLIDATED FINANCIAL STATEMENTS 2020, STATUTORY FINANCIAL STATEMENTS 2020 AND COMPENSATION REPORT 2020: CONSULTATIVE VOTE ON THE COMPENSATION REPORT 2020 | Management | | No Action | | | | |
| 2 | APPROPRIATION OF AVAILABLE EARNINGS | Management | | No Action | | | | |
| 3 | DISCHARGE OF THE BOARD OF DIRECTORS AND OF THE EXECUTIVE COMMITTEE | Management | | No Action | | | | |
| 4 | INCREASE AND EXTENSION OF THE EXISTING AUTHORISED SHARE CAPITAL | Management | | No Action | | | | |
| 5.1.1 | RE-ELECTION OF MEMBER OF THE BOARD OF DIRECTORS: MATHIEU SIMON | Management | | No Action | | | | |
| 5.1.2 | RE-ELECTION OF MEMBER OF THE BOARD OF DIRECTORS: JOERN ALDAG | Management | | No Action | | | | |
| 5.1.3 | RE-ELECTION OF MEMBER OF THE BOARD OF DIRECTORS: JEAN-PAUL CLOZEL | Management | | No Action | | | | |
| 5.1.4 | RE-ELECTION OF MEMBER OF THE BOARD OF DIRECTORS: FELIX R. EHRAT | Management | | No Action | | | | |
| 5.1.5 | RE-ELECTION OF MEMBER OF THE BOARD OF DIRECTORS: SANDY MAHATME | Management | | No Action | | | | |
| 5.2.1 | ELECTION OF NEW DIRECTOR: PETER KELLOGG | Management | | No Action | | | | |
| 5.2.2 | ELECTION OF NEW DIRECTOR: SRISHTI GUPTA | Management | | No Action | | | | |
| 5.3 | RE-ELECTION OF THE CHAIR OF THE BOARD OF DIRECTORS: MATHIEU SIMON | Management | | No Action | | | | |
| 5.4.1 | ELECTION OF THE NOMINATING, GOVERNANCE AND COMPENSATION COMMITTEE: MATHIEU SIMON | Management | | No Action | | | | |
| 5.4.2 | ELECTION OF THE NOMINATING, GOVERNANCE AND COMPENSATION COMMITTEE: JOERN ALDAG | Management | | No Action | | | | |
| 5.4.3 | ELECTION OF THE NOMINATING, GOVERNANCE AND COMPENSATION COMMITTEE: FELIX R. EHRAT | Management | | No Action | | | | |
| 5.4.4 | ELECTION OF THE NOMINATING, GOVERNANCE AND COMPENSATION COMMITTEE: SRISHTI GUPTA | Management | | No Action | | | | |
| 6.1 | APPROVAL OF BOARD COMPENSATION AND EXECUTIVE COMMITTEE COMPENSATION: APPROVAL OF BOARD COMPENSATION (NON- EXECUTIVE DIRECTORS) FOR THE 2021-2022 TERM OF OFFICE | Management | | No Action | | | | |
| 6.2 | APPROVAL OF BOARD COMPENSATION AND EXECUTIVE COMMITTEE COMPENSATION: APPROVAL OF EXECUTIVE COMMITTEE COMPENSATION 2022 | Management | | No Action | | | | |
| 7 | ELECTION OF THE INDEPENDENT PROXY: BACHMANNPARTNER SACHWALTER UND TREUHAND AG | Management | | No Action | | | | |
| 8 | ELECTION OF THE STATUTORY AUDITORS: ERNST AND YOUNG AG, BASEL | Management | | No Action | | | | |
| PERRIGO COMPANY PLC | | |
| Security | G97822103 | | | | Meeting Type | Annual |
| Ticker Symbol | PRGO | | | | Meeting Date | 12-May-2021 | |
| ISIN | IE00BGH1M568 | | | | Agenda | 935361927 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1A. | Election of Director: Bradley A. Alford | Management | | For | | For | | |
| 1B. | Election of Director: Orlando D. Ashford | Management | | For | | For | | |
| 1C. | Election of Director: Rolf A. Classon | Management | | For | | For | | |
| 1D. | Election of Director: Katherine C. Doyle | Management | | For | | For | | |
| 1E. | Election of Director: Adriana Karaboutis | Management | | For | | For | | |
| 1F. | Election of Director: Murray S. Kessler | Management | | For | | For | | |
| 1G. | Election of Director: Jeffrey B. Kindler | Management | | For | | For | | |
| 1H. | Election of Director: Erica L. Mann | Management | | For | | For | | |
| 1I. | Election of Director: Donal O'Connor | Management | | For | | For | | |
| 1J. | Election of Director: Geoffrey M. Parker | Management | | For | | For | | |
| 1K. | Election of Director: Theodore R. Samuels | Management | | For | | For | | |
| 2. | Ratify the appointment of Ernst & Young LLP as our independent auditor for the period ending December 31, 2021 and authorize the Board of Directors, acting through the Audit Committee, to fix the remuneration of the auditor. | Management | | For | | For | | |
| 3. | Advisory vote on the Company's executive compensation. | Management | | For | | For | | |
| 4. | Renew the Board's authority to issue shares under Irish law. | Management | | For | | For | | |
| 5. | Renew the Board's authority to opt-out of statutory pre- emption rights under Irish law. | Management | | Against | | Against | | |
| GILEAD SCIENCES, INC. | | |
| Security | 375558103 | | | | Meeting Type | Annual |
| Ticker Symbol | GILD | | | | Meeting Date | 12-May-2021 | |
| ISIN | US3755581036 | | | | Agenda | 935366561 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1A. | Election of Director to serve for the next year: Jacqueline K. Barton, Ph.D. | Management | | For | | For | | |
| 1B. | Election of Director to serve for the next year: Jeffrey A. Bluestone, Ph.D. | Management | | For | | For | | |
| 1C. | Election of Director to serve for the next year: Sandra J. Horning, M.D. | Management | | For | | For | | |
| 1D. | Election of Director to serve for the next year: Kelly A. Kramer | Management | | For | | For | | |
| 1E. | Election of Director to serve for the next year: Kevin E. Lofton | Management | | For | | For | | |
| 1F. | Election of Director to serve for the next year: Harish Manwani | Management | | For | | For | | |
| 1G. | Election of Director to serve for the next year: Daniel P. O'Day | Management | | For | | For | | |
| 1H. | Election of Director to serve for the next year: Javier J. Rodriguez | Management | | For | | For | | |
| 1I. | Election of Director to serve for the next year: Anthony Welters | Management | | For | | For | | |
| 2. | To ratify the selection of Ernst & Young LLP by the Audit Committee of the Board of Directors as the independent registered public accounting firm of Gilead for the fiscal year ending December 31, 2021. | Management | | For | | For | | |
| 3. | To approve, on an advisory basis, the compensation of our Named Executive Officers as presented in the Proxy Statement. | Management | | For | | For | | |
| 4. | To vote on a stockholder proposal, if properly presented at the meeting, requesting that the Board adopt a policy that the Chairperson of the Board of Directors be an independent director. | Shareholder | | Against | | For | | |
| LABORATORY CORP. OF AMERICA HOLDINGS | | |
| Security | 50540R409 | | | | Meeting Type | Annual |
| Ticker Symbol | LH | | | | Meeting Date | 12-May-2021 | |
| ISIN | US50540R4092 | | | | Agenda | 935373059 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1A. | Election of Director: Kerrii B. Anderson | Management | | For | | For | | |
| 1B. | Election of Director: Jean-Luc Bélingard | Management | | For | | For | | |
| 1C. | Election of Director: Jeffrey A. Davis | Management | | For | | For | | |
| 1D. | Election of Director: D. Gary Gilliland, M.D., Ph.D. | Management | | For | | For | | |
| 1E. | Election of Director: Garheng Kong, M.D., Ph.D. | Management | | For | | For | | |
| 1F. | Election of Director: Peter M. Neupert | Management | | For | | For | | |
| 1G. | Election of Director: Richelle P. Parham | Management | | For | | For | | |
| 1H. | Election of Director: Adam H. Schechter | Management | | For | | For | | |
| 1I. | Election of Director: Kathryn E. Wengel | Management | | For | | For | | |
| 1J. | Election of Director: R. Sanders Williams, M.D. | Management | | For | | For | | |
| 2. | To approve, by non-binding vote, executive compensation. | Management | | For | | For | | |
| 3. | Ratification of the appointment of Deloitte and Touche LLP as Laboratory Corporation of America Holdings' independent registered public accounting firm for the year ending December 31, 2021. | Management | | For | | For | | |
| 4. | Shareholder proposal seeking an amendment to our proxy access by-law to remove the aggregation limit. | Shareholder | | Abstain | | Against | | |
| MIRATI THERAPEUTICS, INC. | | |
| Security | 60468T105 | | | | Meeting Type | Annual |
| Ticker Symbol | MRTX | | | | Meeting Date | 12-May-2021 | |
| ISIN | US60468T1051 | | | | Agenda | 935404157 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1. | DIRECTOR | Management | | | | | | |
| | | 1 | Charles M. Baum | | | | For | | For | | |
| | | 2 | Bruce L.A. Carter | | | | For | | For | | |
| | | 3 | Julie M. Cherrington | | | | For | | For | | |
| | | 4 | Aaron I. Davis | | | | For | | For | | |
| | | 5 | Henry J. Fuchs | | | | For | | For | | |
| | | 6 | Michael Grey | | | | For | | For | | |
| | | 7 | Faheem Hasnain | | | | For | | For | | |
| | | 8 | Craig Johnson | | | | For | | For | | |
| | | 9 | Maya Martinez-Davis | | | | For | | For | | |
| | | 10 | Shalini Sharp | | | | For | | For | | |
| 2. | To approve, on an advisory basis, the compensation paid to our named executive officers as disclosed in the Proxy Statement. | Management | | For | | For | | |
| 3. | To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2021. | Management | | For | | For | | |
| 4. | To approve our Amended and Restated 2013 Equity Incentive Plan to, among other things, increase the aggregate number of shares of common stock authorized for issuance under such plan by 2,500,000 shares. | Management | | Against | | Against | | |
| CVS HEALTH CORPORATION | | |
| Security | 126650100 | | | | Meeting Type | Annual |
| Ticker Symbol | CVS | | | | Meeting Date | 13-May-2021 | |
| ISIN | US1266501006 | | | | Agenda | 935366927 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1A. | Election of Director: Fernando Aguirre | Management | | For | | For | | |
| 1B. | Election of Director: C. David Brown II | Management | | For | | For | | |
| 1C. | Election of Director: Alecia A. DeCoudreaux | Management | | For | | For | | |
| 1D. | Election of Director: Nancy-Ann M. DeParle | Management | | For | | For | | |
| 1E. | Election of Director: David W. Dorman | Management | | For | | For | | |
| 1F. | Election of Director: Roger N. Farah | Management | | For | | For | | |
| 1G. | Election of Director: Anne M. Finucane | Management | | For | | For | | |
| 1H. | Election of Director: Edward J. Ludwig | Management | | For | | For | | |
| 1I. | Election of Director: Karen S. Lynch | Management | | For | | For | | |
| 1J. | Election of Director: Jean-Pierre Millon | Management | | For | | For | | |
| 1K. | Election of Director: Mary L. Schapiro | Management | | For | | For | | |
| 1L. | Election of Director: William C. Weldon | Management | | For | | For | | |
| 1M. | Election of Director: Tony L. White | Management | | For | | For | | |
| 2. | Ratification of the appointment of our independent registered public accounting firm for 2021. | Management | | For | | For | | |
| 3. | Say on Pay, a proposal to approve, on an advisory basis, the Company's executive compensation. | Management | | For | | For | | |
| 4. | Stockholder proposal for reducing the threshold for our stockholder right to act by written consent. | Shareholder | | Against | | For | | |
| 5. | Stockholder proposal regarding our independent Board Chair. | Shareholder | | Against | | For | | |
| HENRY SCHEIN, INC. | | |
| Security | 806407102 | | | | Meeting Type | Annual |
| Ticker Symbol | HSIC | | | | Meeting Date | 13-May-2021 | |
| ISIN | US8064071025 | | | | Agenda | 935367044 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1A. | Election of Director: Mohamad Ali | Management | | For | | For | | |
| 1B. | Election of Director: Barry J. Alperin | Management | | For | | For | | |
| 1C. | Election of Director: Gerald A. Benjamin | Management | | For | | For | | |
| 1D. | Election of Director: Stanley M. Bergman | Management | | For | | For | | |
| 1E. | Election of Director: James P. Breslawski | Management | | For | | For | | |
| 1F. | Election of Director: Deborah Derby | Management | | For | | For | | |
| 1G. | Election of Director: Joseph L. Herring | Management | | For | | For | | |
| 1H. | Election of Director: Kurt P. Kuehn | Management | | For | | For | | |
| 1I. | Election of Director: Philip A. Laskawy | Management | | For | | For | | |
| 1J. | Election of Director: Anne H. Margulies | Management | | For | | For | | |
| 1K. | Election of Director: Mark E. Mlotek | Management | | For | | For | | |
| 1L. | Election of Director: Steven Paladino | Management | | For | | For | | |
| 1M. | Election of Director: Carol Raphael | Management | | For | | For | | |
| 1N. | Election of Director: E. Dianne Rekow, DDS, Ph.D. | Management | | For | | For | | |
| 1O. | Election of Director: Bradley T. Sheares, Ph.D. | Management | | For | | For | | |
| 1P. | Election of Director: Reed V. Tuckson, M.D., FACP | Management | | For | | For | | |
| 2. | Proposal to approve, by non-binding vote, the 2020 compensation paid to the Company's Named Executive Officers. | Management | | For | | For | | |
| 3. | Proposal to ratify the selection of BDO USA, LLP as the Company's independent registered public accounting firm for the fiscal year ending December 25, 2021. | Management | | For | | For | | |
| RYMAN HOSPITALITY PROPERTIES, INC. | | |
| Security | 78377T107 | | | | Meeting Type | Annual |
| Ticker Symbol | RHP | | | | Meeting Date | 13-May-2021 | |
| ISIN | US78377T1079 | | | | Agenda | 935389812 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1A. | Election of Director: Rachna Bhasin | Management | | For | | For | | |
| 1B. | Election of Director: Alvin Bowles Jr. | Management | | For | | For | | |
| 1C. | Election of Director: Christian Brickman | Management | | For | | For | | |
| 1D. | Election of Director: Fazal Merchant | Management | | For | | For | | |
| 1E. | Election of Director: Patrick Moore | Management | | For | | For | | |
| 1F. | Election of Director: Christine Pantoya | Management | | For | | For | | |
| 1G. | Election of Director: Robert Prather, Jr. | Management | | For | | For | | |
| 1H. | Election of Director: Colin Reed | Management | | For | | For | | |
| 2. | To approve, on an advisory basis, the Company's executive compensation. | Management | | For | | For | | |
| 3. | To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for fiscal year 2021. | Management | | For | | For | | |
| AVANTOR, INC. | | |
| Security | 05352A100 | | | | Meeting Type | Annual |
| Ticker Symbol | AVTR | | | | Meeting Date | 13-May-2021 | |
| ISIN | US05352A1007 | | | | Agenda | 935400628 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1a. | Election of Director: Matthew Holt | Management | | For | | For | | |
| 1b. | Election of Director: Christi Shaw | Management | | For | | For | | |
| 1c. | Election of Director: Michael Severino | Management | | For | | For | | |
| 1d. | Election of Director: Gregory Summe | Management | | For | | For | | |
| 2a. | Amendment to the Certificate of Incorporation to permit stockholders of record representing at least 20% of the relevant voting power continuously for one year to call a special meeting of stockholders. | Management | | For | | For | | |
| 2b. | Amendment to the Certificate of Incorporation to remove supermajority voting standards for stockholder approval of future amendments to the Certificate of Incorporation and Bylaws. | Management | | For | | For | | |
| 3. | Ratification of the Appointment of Deloitte & Touche LLP as the Company's independent registered accounting firm for 2021. | Management | | For | | For | | |
| 4. | Approve, on an Advisory Basis, Named Executive Officer Compensation. | Management | | For | | For | | |
| ZIMMER BIOMET HOLDINGS, INC. | | |
| Security | 98956P102 | | | | Meeting Type | Annual |
| Ticker Symbol | ZBH | | | | Meeting Date | 14-May-2021 | |
| ISIN | US98956P1021 | | | | Agenda | 935362892 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1A. | Election of Director: Christopher B. Begley | Management | | For | | For | | |
| 1B. | Election of Director: Betsy J. Bernard | Management | | For | | For | | |
| 1C. | Election of Director: Michael J. Farrell | Management | | For | | For | | |
| 1D. | Election of Director: Robert A. Hagemann | Management | | For | | For | | |
| 1E. | Election of Director: Bryan C. Hanson | Management | | For | | For | | |
| 1F. | Election of Director: Arthur J. Higgins | Management | | For | | For | | |
| 1G. | Election of Director: Maria Teresa Hilado | Management | | For | | For | | |
| 1H. | Election of Director: Syed Jafry | Management | | For | | For | | |
| 1I. | Election of Director: Sreelakshmi Kolli | Management | | For | | For | | |
| 1J. | Election of Director: Michael W. Michelson | Management | | For | | For | | |
| 2. | Ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for 2021. | Management | | For | | For | | |
| 3. | Approve, on a non-binding advisory basis, named executive officer compensation ("Say on Pay"). | Management | | For | | For | | |
| 4. | Approve the amended 2009 Stock Incentive Plan. | Management | | For | | For | | |
| 5. | Approve the amended Stock Plan for Non-Employee Directors. | Management | | For | | For | | |
| 6. | Approve the amended Deferred Compensation Plan for Non-Employee Directors. | Management | | For | | For | | |
| 7. | Approve amendments to our Restated Certificate of Incorporation to permit shareholders to call a special meeting. | Management | | For | | For | | |
| MEDPACE HOLDINGS, INC. | | |
| Security | 58506Q109 | | | | Meeting Type | Annual |
| Ticker Symbol | MEDP | | | | Meeting Date | 14-May-2021 | |
| ISIN | US58506Q1094 | | | | Agenda | 935363820 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1. | DIRECTOR | Management | | | | | | |
| | | 1 | Fred B. Davenport, Jr. | | | | For | | For | | |
| | | 2 | C. P. McCarthy III | | | | For | | For | | |
| 2. | To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2021. | Management | | For | | For | | |
| 3. | To approve, on an advisory basis, the compensation of our named executive officers as disclosed in the proxy statement for the 2021 Annual Meeting. | Management | | For | | For | | |
| PERSONALIS, INC. | | |
| Security | 71535D106 | | | | Meeting Type | Annual |
| Ticker Symbol | PSNL | | | | Meeting Date | 14-May-2021 | |
| ISIN | US71535D1063 | | | | Agenda | 935366597 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1.1 | Election of Class II Director: John West | Management | | For | | For | | |
| 1.2 | Election of Class II Director: Alan Colowick, M.D. | Management | | For | | For | | |
| 2. | Ratification of the selection by the Audit Committee of the Board of Directors of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the year ending December 31, 2021. | Management | | For | | For | | |
| BERKELEY LIGHTS INC. | | |
| Security | 084310101 | | | | Meeting Type | Annual |
| Ticker Symbol | BLI | | | | Meeting Date | 14-May-2021 | |
| ISIN | US0843101017 | | | | Agenda | 935366977 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1. | DIRECTOR | Management | | | | | | |
| | | 1 | Gregory Lucier | | | | For | | For | | |
| | | 2 | Elizabeth Nelson | | | | For | | For | | |
| 2. | Ratification of the appointment of KPMG LLP as the Company's independent registered public accounting firm for our fiscal year ending December 31, 2021. | Management | | For | | For | | |
| SEAGEN INC. | | |
| Security | 81181C104 | | | | Meeting Type | Annual |
| Ticker Symbol | SGEN | | | | Meeting Date | 14-May-2021 | |
| ISIN | US81181C1045 | | | | Agenda | 935369668 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1A. | Election of Class II Director for term expiring in 2024: Felix J. Baker, Ph.D. | Management | | For | | For | | |
| 1B. | Election of Class II Director for term expiring in 2024: Clay B. Siegall, Ph.D | Management | | For | | For | | |
| 1C. | Election of Class II Director for term expiring in 2024: Nancy A. Simonian, M.D. | Management | | For | | For | | |
| 2. | Approve, on an advisory basis, the compensation of Seagen's named executive officers as disclosed in the accompanying proxy statement. | Management | | For | | For | | |
| 3. | Ratify the appointment of PricewaterhouseCoopers LLP as Seagen's independent registered public accounting firm for the fiscal year ending December 31, 2021. | Management | | For | | For | | |
| TELADOC HEALTH, INC. | | |
| Security | 87918A105 | | | | Meeting Type | Annual |
| Ticker Symbol | TDOC | | | | Meeting Date | 17-May-2021 | |
| ISIN | US87918A1051 | | | | Agenda | 935377437 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1A. | Election of Director for a term of one year: Christopher Bischoff | Management | | For | | For | | |
| 1B. | Election of Director for a term of one year: Karen L. Daniel | Management | | For | | For | | |
| 1C. | Election of Director for a term of one year: Sandra L. Fenwick | Management | | For | | For | | |
| 1D. | Election of Director for a term of one year: William H. Frist, MD | Management | | For | | For | | |
| 1E. | Election of Director for a term of one year: Jason Gorevic | Management | | For | | For | | |
| 1F. | Election of Director for a term of one year: Catherine A. Jacobson | Management | | For | | For | | |
| 1G. | Election of Director for a term of one year: Thomas G. McKinley | Management | | For | | For | | |
| 1H. | Election of Director for a term of one year: Kenneth H. Paulus | Management | | For | | For | | |
| 1I. | Election of Director for a term of one year: David Shedlarz | Management | | For | | For | | |
| 1J. | Election of Director for a term of one year: Mark Douglas Smith, MD | Management | | For | | For | | |
| 1K. | Election of Director for a term of one year: David B. Snow, Jr. | Management | | For | | For | | |
| 2. | Approve, on an advisory basis, the compensation of Teladoc Health's named executive officers. | Management | | For | | For | | |
| 3. | Ratify the appointment of Ernst & Young LLP as Teladoc Health's independent registered public accounting firm for the fiscal year ending December 31, 2021. | Management | | For | | For | | |
| AMGEN INC. | | |
| Security | 031162100 | | | | Meeting Type | Annual |
| Ticker Symbol | AMGN | | | | Meeting Date | 18-May-2021 | |
| ISIN | US0311621009 | | | | Agenda | 935375382 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1A. | Election of Director for a term of office expiring at the 2022 annual meeting: Dr. Wanda M. Austin | Management | | For | | For | | |
| 1B. | Election of Director for a term of office expiring at the 2022 annual meeting: Mr. Robert A. Bradway | Management | | For | | For | | |
| 1C. | Election of Director for a term of office expiring at the 2022 annual meeting: Dr. Brian J. Druker | Management | | For | | For | | |
| 1D. | Election of Director for a term of office expiring at the 2022 annual meeting: Mr. Robert A. Eckert | Management | | For | | For | | |
| 1E. | Election of Director for a term of office expiring at the 2022 annual meeting: Mr. Greg C. Garland | Management | | For | | For | | |
| 1F. | Election of Director for a term of office expiring at the 2022 annual meeting: Mr. Charles M. Holley, Jr. | Management | | For | | For | | |
| 1G. | Election of Director for a term of office expiring at the 2022 annual meeting: Dr. Tyler Jacks | Management | | For | | For | | |
| 1H. | Election of Director for a term of office expiring at the 2022 annual meeting: Ms. Ellen J. Kullman | Management | | For | | For | | |
| 1I. | Election of Director for a term of office expiring at the 2022 annual meeting: Ms. Amy E. Miles | Management | | For | | For | | |
| 1J. | Election of Director for a term of office expiring at the 2022 annual meeting: Dr. Ronald D. Sugar | Management | | For | | For | | |
| 1K. | Election of Director for a term of office expiring at the 2022 annual meeting: Dr. R. Sanders Williams | Management | | For | | For | | |
| 2. | Advisory vote to approve our executive compensation. | Management | | For | | For | | |
| 3. | To ratify the selection of Ernst & Young LLP as our independent registered public accountants for the fiscal year ending December 31, 2021. | Management | | For | | For | | |
| NUVASIVE, INC. | | |
| Security | 670704105 | | | | Meeting Type | Annual |
| Ticker Symbol | NUVA | | | | Meeting Date | 18-May-2021 | |
| ISIN | US6707041058 | | | | Agenda | 935377704 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1.1 | Election of Class II Director: Vickie L. Capps | Management | | For | | For | | |
| 1.2 | Election of Class II Director: John A. DeFord, Ph.D | Management | | For | | For | | |
| 1.3 | Election of Class II Director: R. Scott Huennekens | Management | | For | | For | | |
| 1.4 | Election of Class II Director: Siddhartha C. Kadia, Ph.D. | Management | | For | | For | | |
| 2. | Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2021. | Management | | For | | For | | |
| 3. | Approval of a non-binding advisory resolution regarding the compensation of the Company's named executive officers for the fiscal year ended December 31, 2020. | Management | | For | | For | | |
| INFUSYSTEM HOLDINGS, INC. | | |
| Security | 45685K102 | | | | Meeting Type | Annual |
| Ticker Symbol | INFU | | | | Meeting Date | 18-May-2021 | |
| ISIN | US45685K1025 | | | | Agenda | 935390752 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1. | DIRECTOR | Management | | | | | | |
| | | 1 | Richard DiIorio | | | | For | | For | | |
| | | 2 | Paul Gendron | | | | For | | For | | |
| | | 3 | Carrie Lachance | | | | For | | For | | |
| | | 4 | Gregg Lehman | | | | For | | For | | |
| | | 5 | Darrell Montgomery | | | | For | | For | | |
| | | 6 | Christopher Sansone | | | | For | | For | | |
| | | 7 | Scott Shuda | | | | For | | For | | |
| 2. | Approval, on an advisory basis, of the Company's executive compensation. | Management | | For | | For | | |
| 3. | Approval of the 2021 Equity Incentive Plan. | Management | | Against | | Against | | |
| 4. | Ratification of the appointment of BDO USA, LLP as the registered independent public accounting firm for the fiscal year ending December 31, 2021. | Management | | For | | For | | |
| QUIDEL CORPORATION | | |
| Security | 74838J101 | | | | Meeting Type | Annual |
| Ticker Symbol | QDEL | | | | Meeting Date | 18-May-2021 | |
| ISIN | US74838J1016 | | | | Agenda | 935412750 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1. | DIRECTOR | Management | | | | | | |
| | | 1 | Douglas C. Bryant | | | | For | | For | | |
| | | 2 | Kenneth F. Buechler | | | | For | | For | | |
| | | 3 | Edward L. Michael | | | | For | | For | | |
| | | 4 | Kathy P. Ordoñez | | | | For | | For | | |
| | | 5 | Mary Lake Polan | | | | For | | For | | |
| | | 6 | Ann D. Rhoads | | | | For | | For | | |
| | | 7 | Charles P. Slacik | | | | For | | For | | |
| | | 8 | Matthew W. Strobeck | | | | For | | For | | |
| | | 9 | Kenneth J. Widder | | | | For | | For | | |
| | | 10 | Joseph D. Wilkins Jr. | | | | For | | For | | |
| 2. | To ratify the selection of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2021. | Management | | For | | For | | |
| 3. | Advisory approval of the compensation of the Company's named executive officers. | Management | | For | | For | | |
| MONDELĒZ INTERNATIONAL, INC. | | |
| Security | 609207105 | | | | Meeting Type | Annual |
| Ticker Symbol | MDLZ | | | | Meeting Date | 19-May-2021 | |
| ISIN | US6092071058 | | | | Agenda | 935357360 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1A. | Election of Director: Lewis W.K. Booth | Management | | For | | For | | |
| 1B. | Election of Director: Charles E. Bunch | Management | | For | | For | | |
| 1C. | Election of Director: Lois D. Juliber | Management | | For | | For | | |
| 1D. | Election of Director: Peter W. May | Management | | For | | For | | |
| 1E. | Election of Director: Jorge S. Mesquita | Management | | For | | For | | |
| 1F. | Election of Director: Jane H. Nielsen | Management | | For | | For | | |
| 1G. | Election of Director: Fredric G. Reynolds | Management | | For | | For | | |
| 1H. | Election of Director: Christiana S. Shi | Management | | For | | For | | |
| 1I. | Election of Director: Patrick T. Siewert | Management | | For | | For | | |
| 1J. | Election of Director: Michael A. Todman | Management | | For | | For | | |
| 1K. | Election of Director: Jean-François M. L. van Boxmeer | Management | | For | | For | | |
| 1L. | Election of Director: Dirk Van de Put | Management | | For | | For | | |
| 2. | Advisory Vote to Approve Executive Compensation. | Management | | For | | For | | |
| 3. | Ratification of PricewaterhouseCoopers LLP as Independent Registered Public Accountants for Fiscal Year Ending December 31, 2021. | Management | | For | | For | | |
| 4. | Consider Employee Pay in Setting Chief Executive Officer Pay. | Shareholder | | Abstain | | Against | | |
| OPTION CARE HEALTH, INC. | | |
| Security | 68404L201 | | | | Meeting Type | Annual |
| Ticker Symbol | OPCH | | | | Meeting Date | 19-May-2021 | |
| ISIN | US68404L2016 | | | | Agenda | 935367157 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1. | DIRECTOR | Management | | | | | | |
| | | 1 | John J. Arlotta | | | | For | | For | | |
| | | 2 | Elizabeth Q. Betten | | | | For | | For | | |
| | | 3 | David W. Golding | | | | For | | For | | |
| | | 4 | Harry M.J. Kraemer, Jr. | | | | For | | For | | |
| | | 5 | Alan Nielsen | | | | For | | For | | |
| | | 6 | R. Carter Pate | | | | For | | For | | |
| | | 7 | John C. Rademacher | | | | For | | For | | |
| | | 8 | Nitin Sahney | | | | For | | For | | |
| | | 9 | Timothy Sullivan | | | | For | | For | | |
| | | 10 | Mark Vainisi | | | | For | | For | | |
| 2. | To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the year ending December 31, 2021. | Management | | For | | For | | |
| 3. | To approve, on a non-binding advisory basis, our executive compensation. | Management | | For | | For | | |
| 4. | To approve an amendment to the Option Care Health, Inc. 2018 Equity Incentive Plan for the reservation of an additional 5,000,000 shares of Common Stock for future issuance under such plan. | Management | | For | | For | | |
| THERMO FISHER SCIENTIFIC INC. | | |
| Security | 883556102 | | | | Meeting Type | Annual |
| Ticker Symbol | TMO | | | | Meeting Date | 19-May-2021 | |
| ISIN | US8835561023 | | | | Agenda | 935375736 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1A. | Election of Director: Marc N. Casper | Management | | For | | For | | |
| 1B. | Election of Director: Nelson J. Chai | Management | | For | | For | | |
| 1C. | Election of Director: C. Martin Harris | Management | | For | | For | | |
| 1D. | Election of Director: Tyler Jacks | Management | | For | | For | | |
| 1E. | Election of Director: R. Alexandra Keith | Management | | For | | For | | |
| 1F. | Election of Director: Thomas J. Lynch | Management | | For | | For | | |
| 1G. | Election of Director: Jim P. Manzi | Management | | For | | For | | |
| 1H. | Election of Director: James C. Mullen | Management | | For | | For | | |
| 1I. | Election of Director: Lars R. Sørensen | Management | | For | | For | | |
| 1J. | Election of Director: Debora L. Spar | Management | | For | | For | | |
| 1K. | Election of Director: Scott M. Sperling | Management | | For | | For | | |
| 1L. | Election of Director: Dion J. Weisler | Management | | For | | For | | |
| 2. | An advisory vote to approve named executive officer compensation. | Management | | For | | For | | |
| 3. | Ratification of the Audit Committee's selection of PricewaterhouseCoopers LLP as the Company's independent auditors for 2021. | Management | | For | | For | | |
| 4. | A shareholder Proposal regarding special Shareholder Meetings. | Shareholder | | Against | | For | | |
| VERTEX PHARMACEUTICALS INCORPORATED | | |
| Security | 92532F100 | | | | Meeting Type | Annual |
| Ticker Symbol | VRTX | | | | Meeting Date | 19-May-2021 | |
| ISIN | US92532F1003 | | | | Agenda | 935383959 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1A. | Election of Director: Sangeeta Bhatia | Management | | For | | For | | |
| 1B. | Election of Director: Lloyd Carney | Management | | For | | For | | |
| 1C. | Election of Director: Alan Garber | Management | | For | | For | | |
| 1D. | Election of Director: Terrence Kearney | Management | | For | | For | | |
| 1E. | Election of Director: Reshma Kewalramani | Management | | For | | For | | |
| 1F. | Election of Director: Yuchun Lee | Management | | For | | For | | |
| 1G. | Election of Director: Jeffrey Leiden | Management | | For | | For | | |
| 1H. | Election of Director: Margaret McGlynn | Management | | For | | For | | |
| 1I. | Election of Director: Diana McKenzie | Management | | For | | For | | |
| 1J. | Election of Director: Bruce Sachs | Management | | For | | For | | |
| 2. | Ratification of Ernst & Young LLP as independent Registered Public Accounting firm for the year ending December 31, 2021. | Management | | For | | For | | |
| 3. | Advisory vote to approve named executive officer compensation. | Management | | For | | For | | |
| 4. | Shareholder proposal, if properly presented at the meeting, regarding a report on lobbying activities. | Shareholder | | Abstain | | Against | | |
| 5. | Shareholder proposal, if properly presented at the meeting, regarding a report on political spending. | Shareholder | | Abstain | | Against | | |
| INTEGER HOLDINGS CORPORATION | | |
| Security | 45826H109 | | | | Meeting Type | Annual |
| Ticker Symbol | ITGR | | | | Meeting Date | 19-May-2021 | |
| ISIN | US45826H1095 | | | | Agenda | 935384139 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1. | DIRECTOR | Management | | | | | | |
| | | 1 | Sheila Antrum | | | | For | | For | | |
| | | 2 | Pamela G. Bailey | | | | For | | For | | |
| | | 3 | Cheryl C. Capps | | | | For | | For | | |
| | | 4 | Joseph W. Dziedzic | | | | For | | For | | |
| | | 5 | James F. Hinrichs | | | | For | | For | | |
| | | 6 | Jean Hobby | | | | For | | For | | |
| | | 7 | Tyrone Jeffers | | | | For | | For | | |
| | | 8 | M. Craig Maxwell | | | | For | | For | | |
| | | 9 | Filippo Passerini | | | | For | | For | | |
| | | 10 | Bill R. Sanford | | | | For | | For | | |
| | | 11 | Donald J. Spence | | | | For | | For | | |
| | | 12 | William B. Summers, Jr. | | | | For | | For | | |
| 2. | To ratify the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for Integer Holdings Corporation for fiscal year 2021. | Management | | For | | For | | |
| 3. | To approve, on an advisory basis, the compensation of our named executive officers. | Management | | For | | For | | |
| 4. | To approve the adoption of the Integer Holdings Corporation 2021 Omnibus Incentive Plan. | Management | | For | | For | | |
| ZOETIS INC. | | |
| Security | 98978V103 | | | | Meeting Type | Annual |
| Ticker Symbol | ZTS | | | | Meeting Date | 20-May-2021 | |
| ISIN | US98978V1035 | | | | Agenda | 935383252 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1A. | Election of Director: Sanjay Khosla | Management | | For | | For | | |
| 1B. | Election of Director: Antoinette R. Leatherberry | Management | | For | | For | | |
| 1C. | Election of Director: Willie M. Reed | Management | | For | | For | | |
| 1D. | Election of Director: Linda Rhodes | Management | | For | | For | | |
| 2. | Advisory vote to approve our executive compensation (Say on Pay). | Management | | For | | For | | |
| 3. | Ratification of appointment of KPMG LLP as our independent registered public accounting firm for 2021. | Management | | For | | For | | |
| 4. | Shareholder proposal regarding simple majority vote. | Shareholder | | Against | | For | | |
| COLLEGIUM PHARMACEUTICAL, INC. | | |
| Security | 19459J104 | | | | Meeting Type | Annual |
| Ticker Symbol | COLL | | | | Meeting Date | 20-May-2021 | |
| ISIN | US19459J1043 | | | | Agenda | 935386450 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1a. | Election of Director: Rita Balice-Gordon, Ph.D. | Management | | For | | For | | |
| 1b. | Election of Director: Garen Bohlin | Management | | For | | For | | |
| 1c. | Election of Director: Gwen Melincoff | Management | | For | | For | | |
| 1d. | Election of Director: Theodore Schroeder | Management | | For | | For | | |
| 2. | Approval of, on an advisory basis, the compensation of the Company's named executive officers. | Management | | For | | For | | |
| 3. | Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2021. | Management | | For | | For | | |
| MERCK & CO., INC. | | |
| Security | 58933Y105 | | | | Meeting Type | Annual |
| Ticker Symbol | MRK | | | | Meeting Date | 25-May-2021 | |
| ISIN | US58933Y1055 | | | | Agenda | 935381044 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1A. | Election of Director: Leslie A. Brun | Management | | For | | For | | |
| 1B. | Election of Director: Mary Ellen Coe | Management | | For | | For | | |
| 1C. | Election of Director: Pamela J. Craig | Management | | For | | For | | |
| 1D. | Election of Director: Kenneth C. Frazier | Management | | For | | For | | |
| 1E. | Election of Director: Thomas H. Glocer | Management | | For | | For | | |
| 1F. | Election of Director: Risa J. Lavizzo-Mourey | Management | | For | | For | | |
| 1G. | Election of Director: Stephen L. Mayo | Management | | For | | For | | |
| 1H. | Election of Director: Paul B. Rothman | Management | | For | | For | | |
| 1I. | Election of Director: Patricia F. Russo | Management | | For | | For | | |
| 1J. | Election of Director: Christine E. Seidman | Management | | For | | For | | |
| 1K. | Election of Director: Inge G. Thulin | Management | | For | | For | | |
| 1L. | Election of Director: Kathy J. Warden | Management | | For | | For | | |
| 1M. | Election of Director: Peter C. Wendell | Management | | For | | For | | |
| 2. | Non-binding advisory vote to approve the compensation of our named executive officers. | Management | | For | | For | | |
| 3. | Ratification of the appointment of the Company's independent registered public accounting firm for 2021. | Management | | For | | For | | |
| 4. | Shareholder proposal concerning a shareholder right to act by written consent. | Shareholder | | Against | | For | | |
| 5. | Shareholder proposal regarding access to COVID-19 products. | Shareholder | | Abstain | | Against | | |
| BIOMARIN PHARMACEUTICAL INC. | | |
| Security | 09061G101 | | | | Meeting Type | Annual |
| Ticker Symbol | BMRN | | | | Meeting Date | 25-May-2021 | |
| ISIN | US09061G1013 | | | | Agenda | 935385357 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1. | DIRECTOR | Management | | | | | | |
| | | 1 | Jean-Jacques Bienaimé | | | | For | | For | | |
| | | 2 | Elizabeth M. Anderson | | | | For | | For | | |
| | | 3 | Willard Dere | | | | For | | For | | |
| | | 4 | Michael Grey | | | | For | | For | | |
| | | 5 | Elaine J. Heron | | | | For | | For | | |
| | | 6 | Maykin Ho | | | | For | | For | | |
| | | 7 | Robert J. Hombach | | | | For | | For | | |
| | | 8 | V. Bryan Lawlis | | | | For | | For | | |
| | | 9 | Richard A. Meier | | | | For | | For | | |
| | | 10 | David E.I. Pyott | | | | For | | For | | |
| | | 11 | Dennis J. Slamon | | | | For | | For | | |
| 2. | To ratify the selection of KPMG LLP as the independent registered public accounting firm for BioMarin for the fiscal year ending December 31, 2021. | Management | | For | | For | | |
| 3. | To approve, on an advisory basis, the compensation of the Company's Named Executive Officers as disclosed in the Proxy Statement. | Management | | For | | For | | |
| 4. | To approve an amendment to the 2017 Equity Incentive Plan, as amended. | Management | | Against | | Against | | |
| FLUIDIGM CORPORATION | | |
| Security | 34385P108 | | | | Meeting Type | Annual |
| Ticker Symbol | FLDM | | | | Meeting Date | 25-May-2021 | |
| ISIN | US34385P1084 | | | | Agenda | 935399039 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1. | DIRECTOR | Management | | | | | | |
| | | 1 | Gerhard F. Burbach | | | | For | | For | | |
| | | 2 | Carlos Paya M.D PhD | | | | For | | For | | |
| | | 3 | Ana K.S M.D, Ph.D, MSPH | | | | For | | For | | |
| 2. | To approve our executive compensation program for the year ended December 31, 2020, on an advisory (non- binding) basis. | Management | | For | | For | | |
| 3. | To approve the amendment of our 2011 Equity Incentive Plan to increase the number of shares reserved thereunder and to make certain other changes. | Management | | Against | | Against | | |
| 4. | To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the year ending December 31, 2021. | Management | | For | | For | | |
| SPROUTS FARMERS MARKET, INC. | | |
| Security | 85208M102 | | | | Meeting Type | Annual |
| Ticker Symbol | SFM | | | | Meeting Date | 26-May-2021 | |
| ISIN | US85208M1027 | | | | Agenda | 935380422 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1. | DIRECTOR | Management | | | | | | |
| | | 1 | Joseph Fortunato | | | | For | | For | | |
| | | 2 | Lawrence P. Molloy | | | | For | | For | | |
| | | 3 | Joseph D. O'Leary | | | | For | | For | | |
| 2. | To vote on a non-binding advisory resolution to approve the compensation paid to our named executive officers for fiscal 2020 ("say-on-pay"). | Management | | For | | For | | |
| 3. | To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending January 2, 2022. | Management | | For | | For | | |
| INCYTE CORPORATION | | |
| Security | 45337C102 | | | | Meeting Type | Annual |
| Ticker Symbol | INCY | | | | Meeting Date | 26-May-2021 | |
| ISIN | US45337C1027 | | | | Agenda | 935380864 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1.1 | Election of Director: Julian C. Baker | Management | | For | | For | | |
| 1.2 | Election of Director: Jean-Jacques Bienaimé | Management | | For | | For | | |
| 1.3 | Election of Director: Paul J. Clancy | Management | | For | | For | | |
| 1.4 | Election of Director: Wendy L. Dixon | Management | | For | | For | | |
| 1.5 | Election of Director: Jacqualyn A. Fouse | Management | | For | | For | | |
| 1.6 | Election of Director: Edmund P. Harrigan | Management | | For | | For | | |
| 1.7 | Election of Director: Katherine A. High | Management | | For | | For | | |
| 1.8 | Election of Director: Hervé Hoppenot | Management | | For | | For | | |
| 2. | Approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers. | Management | | For | | For | | |
| 3. | Approve amendments to the Company's Amended and Restated 2010 Stock Incentive Plan. | Management | | Against | | Against | | |
| 4. | Ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for 2021. | Management | | For | | For | | |
| ANTHEM, INC. | | |
| Security | 036752103 | | | | Meeting Type | Annual |
| Ticker Symbol | ANTM | | | | Meeting Date | 26-May-2021 | |
| ISIN | US0367521038 | | | | Agenda | 935387488 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1.1 | Election of Director: Lewis Hay, III | Management | | For | | For | | |
| 1.2 | Election of Director: Antonio F. Neri | Management | | For | | For | | |
| 1.3 | Election of Director: Ramiro G. Peru | Management | | For | | For | | |
| 2. | Advisory vote to approve the compensation of our named executive officers. | Management | | For | | For | | |
| 3. | To ratify the appointment of Ernst & Young LLP as the independent registered public accounting firm for 2021. | Management | | For | | For | | |
| DENTSPLY SIRONA INC. | | |
| Security | 24906P109 | | | | Meeting Type | Annual |
| Ticker Symbol | XRAY | | | | Meeting Date | 26-May-2021 | |
| ISIN | US24906P1093 | | | | Agenda | 935390219 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1A. | Election of Director: Eric K. Brandt | Management | | For | | For | | |
| 1B. | Election of Director: Donald M. Casey Jr. | Management | | For | | For | | |
| 1C. | Election of Director: Willie A. Deese | Management | | For | | For | | |
| 1D. | Election of Director: Betsy D. Holden | Management | | For | | For | | |
| 1E. | Election of Director: Clyde R. Hosein | Management | | For | | For | | |
| 1F. | Election of Director: Arthur D. Kowaloff | Management | | For | | For | | |
| 1G. | Election of Director: Harry M. Kraemer Jr. | Management | | For | | For | | |
| 1H. | Election of Director: Gregory T. Lucier | Management | | For | | For | | |
| 1I. | Election of Director: Leslie F. Varon | Management | | For | | For | | |
| 1J. | Election of Director: Janet S. Vergis | Management | | For | | For | | |
| 2. | Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accountants for 2021. | Management | | For | | For | | |
| 3. | Approval, by non-binding vote, of the Company's executive compensation. | Management | | For | | For | | |
| STERICYCLE, INC. | | |
| Security | 858912108 | | | | Meeting Type | Annual |
| Ticker Symbol | SRCL | | | | Meeting Date | 26-May-2021 | |
| ISIN | US8589121081 | | | | Agenda | 935394813 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1A. | Election of Director: Robert S. Murley | Management | | For | | For | | |
| 1B. | Election of Director: Cindy J. Miller | Management | | For | | For | | |
| 1C. | Election of Director: Brian P. Anderson | Management | | For | | For | | |
| 1D. | Election of Director: Lynn D. Bleil | Management | | For | | For | | |
| 1E. | Election of Director: Thomas F. Chen | Management | | For | | For | | |
| 1F. | Election of Director: J. Joel Hackney, Jr. | Management | | For | | For | | |
| 1G. | Election of Director: Veronica M. Hagen | Management | | For | | For | | |
| 1H. | Election of Director: Stephen C. Hooley | Management | | For | | For | | |
| 1I. | Election of Director: James J. Martell | Management | | For | | For | | |
| 1J. | Election of Director: Kay G. Priestly | Management | | For | | For | | |
| 1K. | Election of Director: James L. Welch | Management | | For | | For | | |
| 1L. | Election of Director: Mike S. Zafirovski | Management | | For | | For | | |
| 2. | Advisory vote to approve executive compensation. | Management | | For | | For | | |
| 3. | Approval of the Stericycle, Inc. 2021 Long-Term Incentive Plan. | Management | | Against | | Against | | |
| 4. | Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for 2021. | Management | | For | | For | | |
| 5. | Stockholder proposal entitled Improve our Excess Baggage Special Shareholder Meeting "Right". | Shareholder | | Against | | For | | |
| 6. | Stockholder proposal with respect to amendment of our compensation clawback policy. | Shareholder | | Against | | For | | |
| ILLUMINA, INC. | | |
| Security | 452327109 | | | | Meeting Type | Annual |
| Ticker Symbol | ILMN | | | | Meeting Date | 26-May-2021 | |
| ISIN | US4523271090 | | | | Agenda | 935395485 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1A. | Election of Director: Caroline D. Dorsa | Management | | For | | For | | |
| 1B. | Election of Director: Robert S. Epstein, M.D. | Management | | For | | For | | |
| 1C. | Election of Director: Scott Gottlieb, M.D. | Management | | For | | For | | |
| 1D. | Election of Director: Gary S. Guthart | Management | | For | | For | | |
| 1E. | Election of Director: Philip W. Schiller | Management | | For | | For | | |
| 1F. | Election of Director: John W. Thompson | Management | | For | | For | | |
| 2. | To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending January 2, 2022. | Management | | For | | For | | |
| 3. | To approve, on an advisory basis, the compensation of the named executive officers as disclosed in the Proxy Statement. | Management | | For | | For | | |
| FLOWERS FOODS, INC. | | |
| Security | 343498101 | | | | Meeting Type | Annual |
| Ticker Symbol | FLO | | | | Meeting Date | 27-May-2021 | |
| ISIN | US3434981011 | | | | Agenda | 935383719 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1A. | Election of Director to serve for a term of one year: George E. Deese | Management | | For | | For | | |
| 1B. | Election of Director to serve for a term of one year: Edward J. Casey, Jr. | Management | | For | | For | | |
| 1C. | Election of Director to serve for a term of one year: Thomas C. Chubb, III | Management | | For | | For | | |
| 1D. | Election of Director to serve for a term of one year: Rhonda Gass | Management | | For | | For | | |
| 1E. | Election of Director to serve for a term of one year: Benjamin H. Griswold, IV | Management | | For | | For | | |
| 1F. | Election of Director to serve for a term of one year: Margaret G. Lewis | Management | | For | | For | | |
| 1G. | Election of Director to serve for a term of one year: W. Jameson McFadden | Management | | For | | For | | |
| 1H. | Election of Director to serve for a term of one year: A. Ryals McMullian | Management | | For | | For | | |
| 1I. | Election of Director to serve for a term of one year: James T. Spear | Management | | For | | For | | |
| 1J. | Election of Director to serve for a term of one year: Melvin T. Stith, Ph.D. | Management | | For | | For | | |
| 1K. | Election of Director to serve for a term of one year: Terry S. Thomas | Management | | For | | For | | |
| 1L. | Election of Director to serve for a term of one year: C. Martin Wood III | Management | | For | | For | | |
| 2. | To approve by advisory vote the compensation of the company's named executive officers. | Management | | For | | For | | |
| 3. | To ratify the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for Flowers Foods, Inc. for the fiscal year ending January 1, 2022. | Management | | For | | For | | |
| 4. | A shareholder proposal regarding political contribution disclosure, if properly presented at the annual meeting. | Shareholder | | Abstain | | Against | | |
| NEOGENOMICS, INC. | | |
| Security | 64049M209 | | | | Meeting Type | Annual |
| Ticker Symbol | NEO | | | | Meeting Date | 27-May-2021 | |
| ISIN | US64049M2098 | | | | Agenda | 935389759 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1A. | Election of Director for a one (1) year term: Douglas M. VanOort | Management | | For | | For | | |
| 1B. | Election of Director for a one (1) year term: Mark W. Mallon | Management | | For | | For | | |
| 1C. | Election of Director for a one (1) year term: Lynn A. Tetrault | Management | | For | | For | | |
| 1D. | Election of Director for a one (1) year term: Bruce K. Crowther | Management | | For | | For | | |
| 1E. | Election of Director for a one (1) year term: Dr. Alison L. Hannah | Management | | For | | For | | |
| 1F. | Election of Director for a one (1) year term: Kevin C. Johnson | Management | | For | | For | | |
| 1G. | Election of Director for a one (1) year term: Stephen M. Kanovsky | Management | | For | | For | | |
| 1H. | Election of Director for a one (1) year term: Michael A. Kelly | Management | | For | | For | | |
| 1I. | Election of Director for a one (1) year term: Rachel A. Stahler | Management | | For | | For | | |
| 2. | Advisory Vote on the Compensation Paid to our Named Executive Officers. | Management | | For | | For | | |
| 3. | Second Amendment of the Amended and Restated Equity Incentive Plan. | Management | | For | | For | | |
| 4. | Ratification of Appointment of Independent Registered Public Accounting Firm. | Management | | For | | For | | |
| NEURONETICS, INC. | | |
| Security | 64131A105 | | | | Meeting Type | Annual |
| Ticker Symbol | STIM | | | | Meeting Date | 27-May-2021 | |
| ISIN | US64131A1051 | | | | Agenda | 935390043 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1. | DIRECTOR | Management | | | | | | |
| | | 1 | John Bakewell | | | | For | | For | | |
| | | 2 | Robert Cascella | | | | For | | For | | |
| | | 3 | Sheryl Conley | | | | For | | For | | |
| | | 4 | Wilfred Jaeger | | | | For | | For | | |
| | | 5 | Glenn Muir | | | | For | | For | | |
| | | 6 | Bruce Shook | | | | For | | For | | |
| | | 7 | Keith J. Sullivan | | | | For | | For | | |
| 2. | Ratification of the selection of KPMG LLP as our independent registered public accounting firm. | Management | | For | | For | | |
| INTERCEPT PHARMACEUTICALS, INC. | | |
| Security | 45845P108 | | | | Meeting Type | Annual |
| Ticker Symbol | ICPT | | | | Meeting Date | 27-May-2021 | |
| ISIN | US45845P1084 | | | | Agenda | 935424642 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1A. | Election of Director to serve until the 2022 Annual Meeting: Paolo Fundarò | Management | | For | | For | | |
| 1B. | Election of Director to serve until the 2022 Annual Meeting: Jerome Durso | Management | | For | | For | | |
| 1C. | Election of Director to serve until the 2022 Annual Meeting: Srinivas Akkaraju, M.D., Ph.D. | Management | | For | | For | | |
| 1D. | Election of Director to serve until the 2022 Annual Meeting: Luca Benatti, Ph.D. | Management | | For | | For | | |
| 1E. | Election of Director to serve until the 2022 Annual Meeting: Daniel Bradbury | Management | | For | | For | | |
| 1F. | Election of Director to serve until the 2022 Annual Meeting: Keith Gottesdiener, M.D. | Management | | For | | For | | |
| 1G. | Election of Director to serve until the 2022 Annual Meeting: Nancy Miller-Rich | Management | | For | | For | | |
| 1H. | Election of Director to serve until the 2022 Annual Meeting: Mark Pruzanski, M.D. | Management | | For | | For | | |
| 1I. | Election of Director to serve until the 2022 Annual Meeting: Dagmar Rosa-Bjorkeson | Management | | For | | For | | |
| 1J. | Election of Director to serve until the 2022 Annual Meeting: Gino Santini | Management | | For | | For | | |
| 1K. | Election of Director to serve until the 2022 Annual Meeting: Glenn Sblendorio | Management | | For | | For | | |
| 2. | FOR the approval of a one-time stock option exchange program for non-executive employees. | Management | | Against | | Against | | |
| 3. | FOR the approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers. | Management | | For | | For | | |
| 4. | Voting on a non-binding, advisory basis, that the stockholder advisory vote on the compensation of the Company's named executive officers should occur every ONE YEAR. | Management | | 1 Year | | For | | |
| 5. | FOR the ratification of the appointment of KPMG LLP as the Company's independent registered public accounting firm for the year ending December 31, 2021. | Management | | For | | For | | |
| CHINA MENGNIU DAIRY CO LTD | | |
| Security | G21096105 | | | | Meeting Type | Annual General Meeting |
| Ticker Symbol | | | | | Meeting Date | 02-Jun-2021 | |
| ISIN | KYG210961051 | | | | Agenda | 713988369 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| CMMT | PLEASE NOTE THAT THE COMPANY NOTICE AND PROXY FORM ARE AVAILABLE BY CLICKING-ON THE URL LINKS:- https://www1.hkexnews.hk/listedco/listconews/sehk/2021/ 0426/2021042600716.pdf-AND- https://www1.hkexnews.hk/listedco/listconews/sehk/2021/ 0426/2021042600664.pdf | Non-Voting | | | | | | |
| CMMT | PLEASE NOTE THAT SHAREHOLDERS ARE ALLOWED TO VOTE 'IN FAVOR' OR 'AGAINST' FOR- ALL RESOLUTIONS, ABSTAIN IS NOT A VOTING OPTION ON THIS MEETING | Non-Voting | | | | | | |
| 1 | TO REVIEW AND CONSIDER THE AUDITED FINANCIAL STATEMENTS AND THE REPORTS OF THE DIRECTORS AND THE INDEPENDENT AUDITORS FOR THE YEAR ENDED 31 DECEMBER 2020 | Management | | For | | For | | |
| 2 | TO APPROVE THE PROPOSED FINAL DIVIDEND OF RMB0.268 PER SHARE FOR THE YEAR ENDED 31 DECEMBER 2020 | Management | | For | | For | | |
| 3.A | TO RE-ELECT MR. NIU GENSHENG AS DIRECTOR AND AUTHORISE THE BOARD OF DIRECTORS OF THE COMPANY TO FIX HIS REMUNERATION | Management | | Against | | Against | | |
| 3.B | TO RE-ELECT MR. YAU KA CHI AS DIRECTOR AND AUTHORISE THE BOARD OF DIRECTORS OF THE COMPANY TO FIX HIS REMUNERATION | Management | | For | | For | | |
| 3.C | TO RE-ELECT MR. SIMON DOMINIC STEVENS AS DIRECTOR AND AUTHORISE THE BOARD OF DIRECTORS OF THE COMPANY TO FIX HIS REMUNERATION | Management | | Against | | Against | | |
| 4 | TO RE-APPOINT ERNST & YOUNG AS THE AUDITORS OF THE COMPANY AND AUTHORISE THE BOARD OF DIRECTORS TO FIX THEIR REMUNERATION FOR THE YEAR ENDING 31 DECEMBER 2021 | Management | | For | | For | | |
| 5 | ORDINARY RESOLUTION NO. 5 SET OUT IN THE NOTICE OF AGM (TO GIVE A GENERAL MANDATE TO THE DIRECTORS TO REPURCHASE SHARES IN THE COMPANY NOT EXCEEDING 10% OF THE ISSUED SHARE CAPITAL OF THE COMPANY) | Management | | For | | For | | |
| 6 | ORDINARY RESOLUTION NO. 6 SET OUT IN THE NOTICE OF AGM (TO GIVE A GENERAL MANDATE TO THE DIRECTORS TO ALLOT, ISSUE AND DEAL WITH ADDITIONAL SHARES NOT EXCEEDING 10% OF THE ISSUED SHARE CAPITAL OF THE COMPANY) | Management | | Against | | Against | | |
| TURNING POINT THERAPEUTICS, INC. | | |
| Security | 90041T108 | | | | Meeting Type | Annual |
| Ticker Symbol | TPTX | | | | Meeting Date | 02-Jun-2021 | |
| ISIN | US90041T1088 | | | | Agenda | 935397530 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1. | DIRECTOR | Management | | | | | | |
| | | 1 | Simeon J. George, M.D | | | | For | | For | | |
| | | 2 | Carol Gallagher Pharm.D | | | | For | | For | | |
| 2. | Advisory approval of the compensation of our named executive officers, as disclosed in the Proxy Statement in accordance with SEC rules. | Management | | For | | For | | |
| 3. | Advisory indication of the preferred frequency of stockholder advisory votes on the compensation of our named executive officers. | Management | | 1 Year | | For | | |
| 4. | To ratify the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2021. | Management | | For | | For | | |
| FATE THERAPEUTICS, INC. | | |
| Security | 31189P102 | | | | Meeting Type | Annual |
| Ticker Symbol | FATE | | | | Meeting Date | 02-Jun-2021 | |
| ISIN | US31189P1021 | | | | Agenda | 935398710 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1. | DIRECTOR | Management | | | | | | |
| | | 1 | R. Hershberg, M.D, Ph.D | | | | For | | For | | |
| | | 2 | Michael Lee | | | | For | | For | | |
| | | 3 | W.H. Rastetter, Ph.D. | | | | For | | For | | |
| 2. | To approve the ratification of Ernst & Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2021. | Management | | For | | For | | |
| 3. | To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers as disclosed in the proxy statement. | Management | | For | | For | | |
| 4. | To approve the amendment and restatement of the Company's Amended and Restated Certificate of Incorporation to increase the amount of authorized common stock from 150,000,000 shares to 250,000,000 shares. | Management | | For | | For | | |
| BIOGEN INC. | | |
| Security | 09062X103 | | | | Meeting Type | Annual |
| Ticker Symbol | BIIB | | | | Meeting Date | 02-Jun-2021 | |
| ISIN | US09062X1037 | | | | Agenda | 935409032 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1A. | Election of Director to serve for a one-year term extending until the 2022 annual meeting: Alexander J. Denner | Management | | For | | For | | |
| 1B. | Election of Director to serve for a one-year term extending until the 2022 annual meeting: Caroline D. Dorsa | Management | | For | | For | | |
| 1C. | Election of Director to serve for a one-year term extending until the 2022 annual meeting: Maria C. Freire | Management | | For | | For | | |
| 1D. | Election of Director to serve for a one-year term extending until the 2022 annual meeting: William A. Hawkins | Management | | For | | For | | |
| 1E. | Election of Director to serve for a one-year term extending until the 2022 annual meeting: William D. Jones | Management | | For | | For | | |
| 1F. | Election of Director to serve for a one-year term extending until the 2022 annual meeting: Nancy L. Leaming | Management | | For | | For | | |
| 1G. | Election of Director to serve for a one-year term extending until the 2022 annual meeting: Jesus B. Mantas | Management | | For | | For | | |
| 1H. | Election of Director to serve for a one-year term extending until the 2022 annual meeting: Richard C. Mulligan | Management | | For | | For | | |
| 1I. | Election of Director to serve for a one-year term extending until the 2022 annual meeting: Stelios Papadopoulos | Management | | For | | For | | |
| 1J. | Election of Director to serve for a one-year term extending until the 2022 annual meeting: Brian S. Posner | Management | | For | | For | | |
| 1K. | Election of Director to serve for a one-year term extending until the 2022 annual meeting: Eric K. Rowinsky | Management | | For | | For | | |
| 1L. | Election of Director to serve for a one-year term extending until the 2022 annual meeting: Stephen A. Sherwin | Management | | For | | For | | |
| 1M. | Election of Director to serve for a one-year term extending until the 2022 annual meeting: Michel Vounatsos | Management | | For | | For | | |
| 2. | To ratify the selection of PricewaterhouseCoopers LLP as Biogen Inc.'s independent registered public accounting firm for the fiscal year ending December 31, 2021. | Management | | For | | For | | |
| 3. | Say on Pay - To approve an advisory vote on executive compensation. | Management | | For | | For | | |
| 4. | To approve an amendment to Biogen's Amended and Restated Certificate of Incorporation, as amended, to add a federal forum selection provision. | Management | | For | | For | | |
| 5. | Stockholder proposal requesting a report on Biogen's lobbying activities. | Shareholder | | Abstain | | Against | | |
| 6. | Stockholder proposal requesting a report on Biogen's gender pay gap. | Shareholder | | Abstain | | Against | | |
| BLUEPRINT MEDICINES CORPORATION | | |
| Security | 09627Y109 | | | | Meeting Type | Annual |
| Ticker Symbol | BPMC | | | | Meeting Date | 02-Jun-2021 | |
| ISIN | US09627Y1091 | | | | Agenda | 935409397 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1. | DIRECTOR | Management | | | | | | |
| | | 1 | George D. Demetri | | | | For | | For | | |
| | | 2 | Lynn Seely | | | | For | | For | | |
| 2. | To approve an advisory vote on named executive officer compensation. | Management | | For | | For | | |
| 3. | Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2021. | Management | | For | | For | | |
| ACLARIS THERAPEUTICS, INC. | | |
| Security | 00461U105 | | | | Meeting Type | Annual |
| Ticker Symbol | ACRS | | | | Meeting Date | 03-Jun-2021 | |
| ISIN | US00461U1051 | | | | Agenda | 935402999 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1. | DIRECTOR | Management | | | | | | |
| | | 1 | Christopher Molineaux | | | | For | | For | | |
| | | 2 | Bryan Reasons | | | | For | | For | | |
| | | 3 | Vincent Milano | | | | For | | For | | |
| 2. | To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in the proxy statement accompanying this proxy card. | Management | | For | | For | | |
| 3. | To indicate, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of our named executive officers. | Management | | 1 Year | | For | | |
| 4. | To ratify the selection by the Audit Committee of the Board of Directors of PricewaterhouseCoopers LLP as the independent registered public accounting firm of Aclaris Therapeutics, Inc. for its fiscal year ending December 31, 2021. | Management | | For | | For | | |
| VOYAGER THERAPEUTICS, INC. | | |
| Security | 92915B106 | | | | Meeting Type | Annual |
| Ticker Symbol | VYGR | | | | Meeting Date | 03-Jun-2021 | |
| ISIN | US92915B1061 | | | | Agenda | 935405274 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1. | DIRECTOR | Management | | | | | | |
| | | 1 | Michael Higgins | | | | For | | For | | |
| | | 2 | Nancy Vitale | | | | For | | For | | |
| 2. | To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers. | Management | | For | | For | | |
| 3. | To approve, on a non-binding advisory basis, the frequency of future advisory votes on the compensation of the Company's named executive officers. | Management | | 1 Year | | For | | |
| 4. | To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2021. | Management | | For | | For | | |
| SAREPTA THERAPEUTICS INC. | | |
| Security | 803607100 | | | | Meeting Type | Annual |
| Ticker Symbol | SRPT | | | | Meeting Date | 03-Jun-2021 | |
| ISIN | US8036071004 | | | | Agenda | 935409450 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1.1 | Election of Class II Director to hold office until the 2023 Annual meeting: Richard J. Barry | Management | | For | | For | | |
| 1.2 | Election of Class II Director to hold office until the 2023 Annual meeting: M. Kathleen Behrens, Ph.D. | Management | | For | | For | | |
| 1.3 | Election of Class II Director to hold office until the 2023 Annual meeting: Claude Nicaise, M.D. | Management | | For | | For | | |
| 2. | To hold an advisory vote to approve, on a non-binding basis, named executive officer compensation. | Management | | For | | For | | |
| 3. | To ratify the selection of KPMG LLP as the Company's independent registered public accounting firm for the current year ending December 31, 2021. | Management | | For | | For | | |
| SMILEDIRECTCLUB, INC. | | |
| Security | 83192H106 | | | | Meeting Type | Annual |
| Ticker Symbol | SDC | | | | Meeting Date | 03-Jun-2021 | |
| ISIN | US83192H1068 | | | | Agenda | 935411811 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1. | DIRECTOR | Management | | | | | | |
| | | 1 | Alexander Fenkell | | | | For | | For | | |
| | | 2 | Dr. William H. Frist | | | | For | | For | | |
| | | 3 | Richard F. Wallman | | | | For | | For | | |
| 2. | Ratification of Ernst & Young LLP as the company's independent registered accounting firm for the fiscal year ending December 31, 2021. | Management | | For | | For | | |
| GLOBUS MEDICAL, INC. | | |
| Security | 379577208 | | | | Meeting Type | Annual |
| Ticker Symbol | GMED | | | | Meeting Date | 03-Jun-2021 | |
| ISIN | US3795772082 | | | | Agenda | 935413156 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1a. | Election of Director: David D. Davidar | Management | | For | | For | | |
| 1b. | Election of Director: James R. Tobin | Management | | For | | For | | |
| 1c. | Election of Director: Stephen T. Zarrilli | Management | | For | | For | | |
| 2. | The approval of the 2021 Equity Incentive Plan. | Management | | Against | | Against | | |
| 3. | To ratify the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the year ending December 31, 2021. | Management | | For | | For | | |
| 4. | To approve, in an advisory vote, the compensation of the Company's named executive officers (the Say-on-Pay Vote). | Management | | For | | For | | |
| TINGYI (CAYMAN ISLANDS) HOLDING CORP | | |
| Security | G8878S103 | | | | Meeting Type | Annual General Meeting |
| Ticker Symbol | | | | | Meeting Date | 07-Jun-2021 | |
| ISIN | KYG8878S1030 | | | | Agenda | 713931930 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| CMMT | PLEASE NOTE THAT THE COMPANY NOTICE AND PROXY FORM ARE AVAILABLE BY CLICKING-ON THE URL LINKS:- https://www1.hkexnews.hk/listedco/listconews/sehk/2021/ 0416/2021041600229.pdf-AND- https://www1.hkexnews.hk/listedco/listconews/sehk/2021/ 0416/2021041600215.pdf | Non-Voting | | | | | | |
| CMMT | PLEASE NOTE THAT SHAREHOLDERS ARE ALLOWED TO VOTE 'IN FAVOR' OR 'AGAINST' FOR- ALL RESOLUTIONS, ABSTAIN IS NOT A VOTING OPTION ON THIS MEETING | Non-Voting | | | | | | |
| 1 | TO RECEIVE AND CONSIDER THE AUDITED ACCOUNTS AND THE REPORTS OF THE DIRECTORS AND AUDITORS FOR THE YEAR ENDED 31 DECEMBER 2020 | Management | | For | | For | | |
| 2 | TO APPROVE THE PAYMENT OF A FINAL DIVIDEND FOR THE YEAR ENDED 31 DECEMBER 2020 | Management | | For | | For | | |
| 3 | TO APPROVE THE PAYMENT OF A SPECIAL DIVIDEND FOR THE YEAR ENDED 31 DECEMBER 2020 | Management | | For | | For | | |
| 4 | TO RE-ELECT MR. WEI HONG-CHEN AS AN EXECUTIVE DIRECTOR AND TO AUTHORIZE THE DIRECTORS TO FIX HIS REMUNERATION | Management | | For | | For | | |
| 5 | TO RE-ELECT MR. KOJI SHINOHARA AS AN EXECUTIVE DIRECTOR AND TO AUTHORIZE THE DIRECTORS TO FIX HIS REMUNERATION | Management | | For | | For | | |
| 6 | TO RE-ELECT MR. LEE TIONG-HOCK AS AN INDEPENDENT NON-EXECUTIVE DIRECTOR AND TO AUTHORIZE THE DIRECTORS TO FIX HIS REMUNERATION | Management | | Against | | Against | | |
| 7 | TO RE-APPOINT AUDITORS OF THE COMPANY AND AUTHORISE THE DIRECTORS TO FIX THEIR REMUNERATION: MAZARS CPA LIMITED | Management | | For | | For | | |
| 8 | TO CONSIDER AND APPROVE THE GENERAL MANDATE TO ISSUE SHARES | Management | | Against | | Against | | |
| 9 | TO CONSIDER AND APPROVE THE GENERAL MANDATE TO BUY BACK SHARES OF THE COMPANY | Management | | For | | For | | |
| 10 | TO CONSIDER AND APPROVE THAT THE TOTAL NUMBER OF SHARES WHICH ARE BOUGHT BACK BY THE COMPANY SHALL BE ADDED TO THE TOTAL NUMBER OF SHARES WHICH MAY BE ALLOTED PURSUANT TO THE GENERAL MANDATE FOR ISSUE OF SHARES | Management | | Against | | Against | | |
| CMMT | 20 APR 2021: PLEASE NOTE THAT THIS IS A REVISION DUE TO MODIFICATION OF THE-TEXT OF RESOLUTION 7. IF YOU HAVE ALREADY SENT IN YOUR VOTES, PLEASE DO NOT-VOTE AGAIN UNLESS YOU DECIDE TO AMEND YOUR ORIGINAL INSTRUCTIONS. THANK YOU | Non-Voting | | | | | | |
| INVITAE CORPORATION | | |
| Security | 46185L103 | | | | Meeting Type | Annual |
| Ticker Symbol | NVTA | | | | Meeting Date | 07-Jun-2021 | |
| ISIN | US46185L1035 | | | | Agenda | 935412736 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1A. | Election of Class II Director: Kimber D. Lockhart | Management | | For | | For | | |
| 1B. | Election of Class II Director: Chitra Nayak | Management | | For | | For | | |
| 2. | Approval of, on a non-binding advisory basis, the compensation paid by us to our named executive officers. | Management | | For | | For | | |
| 3. | Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2021. | Management | | For | | For | | |
| 4. | Stockholder proposal concerning proxy access. | Shareholder | | Abstain | | Against | | |
| 5. | Stockholder proposal concerning majority voting in uncontested director elections. | Shareholder | | Against | | For | | |
| UNITEDHEALTH GROUP INCORPORATED | | |
| Security | 91324P102 | | | | Meeting Type | Annual |
| Ticker Symbol | UNH | | | | Meeting Date | 07-Jun-2021 | |
| ISIN | US91324P1021 | | | | Agenda | 935414879 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1A. | Election of Director: Richard T. Burke | Management | | For | | For | | |
| 1B. | Election of Director: Timothy P. Flynn | Management | | For | | For | | |
| 1C. | Election of Director: Stephen J. Hemsley | Management | | For | | For | | |
| 1D. | Election of Director: Michele J. Hooper | Management | | For | | For | | |
| 1E. | Election of Director: F. William McNabb III | Management | | For | | For | | |
| 1F. | Election of Director: Valerie C. Montgomery Rice, M.D. | Management | | For | | For | | |
| 1G. | Election of Director: John H. Noseworthy, M.D. | Management | | For | | For | | |
| 1H. | Election of Director: Gail R. Wilensky, Ph.D. | Management | | For | | For | | |
| 1I. | Election of Director: Andrew Witty | Management | | For | | For | | |
| 2. | Advisory approval of the Company's executive compensation. | Management | | For | | For | | |
| 3. | Ratification of the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for the Company for the year ending December 31, 2021. | Management | | For | | For | | |
| 4. | Approval of an amendment to the UnitedHealth Group 1993 Employee Stock Purchase Plan. | Management | | For | | For | | |
| 5. | If properly presented at the 2021 Annual Meeting of Shareholders, the shareholder proposal set forth in the proxy statement requesting a reduction of the share ownership threshold for calling a special meeting of shareholders. | Shareholder | | Against | | For | | |
| AURINIA PHARMACEUTICALS INC. | | |
| Security | 05156V102 | | | | Meeting Type | Annual and Special Meeting |
| Ticker Symbol | AUPH | | | | Meeting Date | 07-Jun-2021 | |
| ISIN | CA05156V1022 | | | | Agenda | 935437120 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1 | To fix the number of directors to be elected at eight (8). | Management | | For | | For | | |
| 2 | DIRECTOR | Management | | | | | | |
| | | 1 | George Milne | | | | For | | For | | |
| | | 2 | Peter Greenleaf | | | | For | | For | | |
| | | 3 | David R.W. Jayne | | | | For | | For | | |
| | | 4 | Joseph P. Hagan | | | | For | | For | | |
| | | 5 | Daniel Billen | | | | For | | For | | |
| | | 6 | R. Hector MacKay-Dunn | | | | For | | For | | |
| | | 7 | Jill Leversage | | | | For | | For | | |
| | | 8 | Timothy P. Walbert | | | | For | | For | | |
| 3 | Appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm until the close of the 2022 annual general meeting of shareholders or until a successor is appointed. To withhold your vote, mark the against box. | Management | | For | | For | | |
| 4 | To approve, on a non-binding advisory basis, a "say on pay" resolution regarding the Company's executive compensation set forth in the Company's Proxy Statement/Circular. | Management | | For | | For | | |
| 5 | To approve, on a non-binding advisory basis, the frequency of future advisory votes on "say on pay" as occurring every 1, 2 or 3 years. | Management | | 1 Year | | For | | |
| 6 | To approve the Company's Amended and Restated Equity Incentive Plan as adopted by the Board as set forth in the Company's Proxy Statement/Circular. | Management | | Against | | Against | | |
| 7 | To approve the 2021 Employee Share Purchase Plan as set forth in the Company's Proxy Statement/Circular. | Management | | For | | For | | |
| 8 | To confirm the Company's Amended and Restated By- law No. 2 to increase the quorum for shareholder meetings to 33 1/3% as adopted by the Board as set forth in the Company's Proxy Statement/Circular. | Management | | For | | For | | |
| TRILLIUM THERAPEUTICS INC. | | |
| Security | 89620X506 | | | | Meeting Type | Annual and Special Meeting |
| Ticker Symbol | TRIL | | | | Meeting Date | 08-Jun-2021 | |
| ISIN | CA89620X5064 | | | | Agenda | 935436091 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1 | DIRECTOR | Management | | | | | | |
| | | 1 | Luke Beshar | | | | For | | For | | |
| | | 2 | Michael Kamarck | | | | For | | For | | |
| | | 3 | Paul Walker | | | | For | | For | | |
| | | 4 | Paolo Pucci | | | | For | | For | | |
| | | 5 | Jan Skvarka | | | | For | | For | | |
| | | 6 | Helen Tayton-Martin | | | | For | | For | | |
| | | 7 | Scott Myers | | | | For | | For | | |
| 2 | To reappoint Ernst & Young, LLP, Chartered Professional Accountants, Licensed Public Accountants, as auditors of the Corporation for the ensuing year and to authorize the directors to fix the remuneration to be paid to the auditors. | Management | | For | | For | | |
| 3 | To consider and if deemed appropriate, act upon an advisory vote on the compensation of the Corporation's named executive officers, the full text of the resolution is set forth in the management information circular and proxy statement (the "Circular") prepared in connection with the Meeting. | Management | | For | | For | | |
| 4 | To consider and if deemed appropriate, act upon an advisory vote on the frequency of future advisory votes on the compensation of the Corporation's named executed officers, the full text of the resolution is set forth in the Circular. | Management | | 1 Year | | For | | |
| GERRESHEIMER AG | | |
| Security | D2852S109 | | | | Meeting Type | Annual General Meeting |
| Ticker Symbol | | | | | Meeting Date | 09-Jun-2021 | |
| ISIN | DE000A0LD6E6 | | | | Agenda | 714013808 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| CMMT | PLEASE NOTE THAT SHAREHOLDER DETAILS ARE REQUIRED TO VOTE AT THIS MEETING. IF-NO SHAREHOLDER DETAILS ARE PROVIDED, YOUR INSTRUCTION MAY CARRY A HEIGHTENED-RISK OF BEING REJECTED. THANK YOU | Non-Voting | | | | | | |
| CMMT | FROM 10TH FEBRUARY, BROADRIDGE WILL CODE ALL AGENDAS FOR GERMAN MEETINGS IN-ENGLISH ONLY. IF YOU WISH TO SEE THE AGENDA IN GERMAN, THIS WILL BE MADE-AVAILABLE AS A LINK UNDER THE MATERIAL URL DROPDOWN AT THE TOP OF THE BALLOT.-THE GERMAN AGENDAS FOR ANY EXISTING OR PAST MEETINGS WILL REMAIN IN PLACE.-FOR FURTHER INFORMATION, PLEASE CONTACT YOUR CLIENT SERVICE REPRESENTATIVE. | Non-Voting | | | | | | |
| CMMT | ACCORDING TO GERMAN LAW, IN CASE OF SPECIFIC CONFLICTS OF INTEREST IN- CONNECTION WITH SPECIFIC ITEMS OF THE AGENDA FOR THE GENERAL MEETING YOU ARE- NOT ENTITLED TO EXERCISE YOUR VOTING RIGHTS. FURTHER, YOUR VOTING RIGHT MIGHT-BE EXCLUDED WHEN YOUR SHARE IN VOTING RIGHTS HAS REACHED CERTAIN THRESHOLDS-AND YOU HAVE NOT COMPLIED WITH ANY OF YOUR MANDATORY VOTING RIGHTS-NOTIFICATIONS PURSUANT TO THE GERMAN SECURITIES TRADING ACT (WPHG). FOR-QUESTIONS IN THIS REGARD PLEASE CONTACT YOUR CLIENT SERVICE REPRESENTATIVE-FOR CLARIFICATION. IF YOU DO NOT HAVE ANY INDICATION REGARDING SUCH CONFLICT-OF INTEREST, OR ANOTHER EXCLUSION FROM VOTING, PLEASE SUBMIT YOUR VOTE AS- USUAL. | Non-Voting | | | | | | |
| CMMT | INFORMATION ON COUNTER PROPOSALS CAN BE FOUND DIRECTLY ON THE ISSUER'S-WEBSITE (PLEASE REFER TO THE MATERIAL URL SECTION OF THE APPLICATION). IF YOU-WISH TO ACT ON THESE ITEMS, YOU WILL NEED TO REQUEST A MEETING ATTEND AND-VOTE YOUR SHARES DIRECTLY AT THE COMPANY'S MEETING. COUNTER PROPOSALS CANNOT-BE REFLECTED ON THE BALLOT ON PROXYEDGE. | Non-Voting | | | | | | |
| 1 | RECEIVE FINANCIAL STATEMENTS AND STATUTORY REPORTS FOR SHORT FISCAL YEAR 2020 | Non-Voting | | | | | | |
| 2 | APPROVE ALLOCATION OF INCOME AND DIVIDENDS OF EUR 1.25 PER SHARE | Management | | No Action | | | | |
| 3 | APPROVE DISCHARGE OF MANAGEMENT BOARD FOR FISCAL YEAR 2020 | Management | | No Action | | | | |
| 4 | APPROVE DISCHARGE OF SUPERVISORY BOARD FOR FISCAL YEAR 2020 | Management | | No Action | | | | |
| 5 | RATIFY DELOITTE GMBH AS AUDITORS FOR FISCAL YEAR 2021 | Management | | No Action | | | | |
| 6 | APPROVE REMUNERATION POLICY | Management | | No Action | | | | |
| 7 | APPROVE REMUNERATION OF SUPERVISORY BOARD | Management | | No Action | | | | |
| 8 | APPROVE CREATION OF EUR 6.3 MILLION POOL OF CAPITAL WITH PARTIAL EXCLUSION OF PREEMPTIVE RIGHTS | Management | | No Action | | | | |
| 9 | APPROVE CREATION OF EUR 3.1 MILLION POOL OF AUTHORIZED CAPITAL II WITH PARTIAL EXCLUSION OF PREEMPTIVE RIGHTS | Management | | No Action | | | | |
| PARATEK PHARMACEUTICALS, INC. | | |
| Security | 699374302 | | | | Meeting Type | Annual |
| Ticker Symbol | PRTK | | | | Meeting Date | 09-Jun-2021 | |
| ISIN | US6993743029 | | | | Agenda | 935410516 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1. | DIRECTOR | Management | | | | | | |
| | | 1 | Rolf K. Hoffmann | | | | For | | For | | |
| | | 2 | Kristine Peterson | | | | For | | For | | |
| | | 3 | Jeffrey Stein, Ph.D. | | | | For | | For | | |
| 2. | To approve an amendment to our Amended and Restated Certificate of Incorporation, as amended, to increase the number of authorized shares of our common stock from 100,000,000 shares to 200,000,000 shares. | Management | | For | | For | | |
| 3. | To ratify the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2021. | Management | | For | | For | | |
| LEGEND BIOTECH CORPORATION | | |
| Security | 52490G102 | | | | Meeting Type | Annual |
| Ticker Symbol | LEGN | | | | Meeting Date | 09-Jun-2021 | |
| ISIN | US52490G1022 | | | | Agenda | 935437651 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1. | To receive the audited consolidated financial statements of the Company for the fiscal year ended December 31, 2020. | Management | | For | | For | | |
| 2. | To ratify the re-appointment of Ernst & Young Hua Ming LLP as independent auditor of the Company (the "Independent Auditor") for the fiscal year ending December 31, 2021. | Management | | For | | For | | |
| 3. | To re-elect Ms. Ye Wang, whose term of office will expire pursuant to article 88(b) of the Company's memorandum of association, to serve as a Class I director of the Company for a full term of three (3) years. | Management | | Abstain | | Against | | |
| 4. | To re-elect Dr. Darren Xiaohui Ji, whose term of office will expire pursuant to article 88(b) of the Company's memorandum of association, to serve as a Class I director of the Company for a full term of three (3) years. | Management | | For | | For | | |
| 5. | To authorize each of the directors and officers of the Company to take any and every action that might be necessary to effect the foregoing resolutions as such director or officer, in his or her absolute discretion, thinks fit. | Management | | For | | For | | |
| SAGE THERAPEUTICS, INC. | | |
| Security | 78667J108 | | | | Meeting Type | Annual |
| Ticker Symbol | SAGE | | | | Meeting Date | 10-Jun-2021 | |
| ISIN | US78667J1088 | | | | Agenda | 935404549 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1. | DIRECTOR | Management | | | | | | |
| | | 1 | Elizabeth Barrett | | | | For | | For | | |
| | | 2 | Geno Germano | | | | For | | For | | |
| | | 3 | Steven Paul, M.D. | | | | For | | For | | |
| 2. | To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2021. | Management | | For | | For | | |
| 3. | To hold a non-binding advisory vote to approve the compensation paid to our named executive officers. | Management | | For | | For | | |
| AMICUS THERAPEUTICS, INC. | | |
| Security | 03152W109 | | | | Meeting Type | Annual |
| Ticker Symbol | FOLD | | | | Meeting Date | 10-Jun-2021 | |
| ISIN | US03152W1099 | | | | Agenda | 935410679 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1. | DIRECTOR | Management | | | | | | |
| | | 1 | Craig A. Wheeler | | | | For | | For | | |
| | | 2 | Burke W. Whitman | | | | For | | For | | |
| 2. | Approval of the Amended and Restated 2007 Equity Incentive Plan to add 7,000,000 shares to the equity pool. | Management | | Against | | Against | | |
| 3. | Ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2021. | Management | | For | | For | | |
| 4. | Approval, on an advisory basis, the Company's executive compensation. | Management | | For | | For | | |
| GOODRX HOLDINGS INC | | |
| Security | 38246G108 | | | | Meeting Type | Annual |
| Ticker Symbol | GDRX | | | | Meeting Date | 10-Jun-2021 | |
| ISIN | US38246G1085 | | | | Agenda | 935411760 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1. | DIRECTOR | Management | | | | | | |
| | | 1 | Douglas Hirsch | | | | For | | For | | |
| | | 2 | Jacqueline Kosecoff | | | | For | | For | | |
| | | 3 | Agnes Rey-Giraud | | | | For | | For | | |
| 2. | Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2021. | Management | | For | | For | | |
| DAVITA INC. | | |
| Security | 23918K108 | | | | Meeting Type | Annual |
| Ticker Symbol | DVA | | | | Meeting Date | 10-Jun-2021 | |
| ISIN | US23918K1088 | | | | Agenda | 935415148 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1A. | Election of Director: Pamela M. Arway | Management | | For | | For | | |
| 1B. | Election of Director: Charles G. Berg | Management | | For | | For | | |
| 1C. | Election of Director: Barbara J. Desoer | Management | | For | | For | | |
| 1D. | Election of Director: Paul J. Diaz | Management | | For | | For | | |
| 1E. | Election of Director: Shawn M. Guertin | Management | | For | | For | | |
| 1F. | Election of Director: John M. Nehra | Management | | For | | For | | |
| 1G. | Election of Director: Paula A. Price | Management | | For | | For | | |
| 1H. | Election of Director: Javier J. Rodriguez | Management | | For | | For | | |
| 1I. | Election of Director: Phyllis R. Yale | Management | | For | | For | | |
| 2. | To ratify the appointment of KPMG LLP as our independent registered public accounting firm for fiscal year 2021. | Management | | For | | For | | |
| 3. | To approve, on an advisory basis, the compensation of our named executive officers. | Management | | For | | For | | |
| 4. | Stockholder proposal regarding political contributions disclosure, if properly presented at the meeting. | Shareholder | | Abstain | | Against | | |
| REATA PHARMACEUTICALS, INC. | | |
| Security | 75615P103 | | | | Meeting Type | Annual |
| Ticker Symbol | RETA | | | | Meeting Date | 10-Jun-2021 | |
| ISIN | US75615P1030 | | | | Agenda | 935416657 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1. | DIRECTOR | Management | | | | | | |
| | | 1 | William D. McClellan Jr | | | | For | | For | | |
| | | 2 | William E. Rose | | | | For | | For | | |
| 2. | To approve, on an advisory basis, the compensation of our named executive officers. | Management | | For | | For | | |
| 3. | To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2021. | Management | | For | | For | | |
| EVOLENT HEALTH, INC. | | |
| Security | 30050B101 | | | | Meeting Type | Annual |
| Ticker Symbol | EVH | | | | Meeting Date | 10-Jun-2021 | |
| ISIN | US30050B1017 | | | | Agenda | 935420834 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1. | Proposal to approve amendments to the Company's Restated Certificate of Incorporation to declassify the Board. | Management | | For | | For | | |
| 2. | Proposal to approve amendments to the Company's Restated Certificate of Incorporation to eliminate supermajority voting requirements. | Management | | For | | For | | |
| 3A. | Election of Class III Director: Craig Barbarosh | Management | | For | | For | | |
| 3B. | Election of Class III Director: Kim Keck | Management | | For | | For | | |
| 3C. | Election of Class III Director: Cheryl Scott | Management | | For | | For | | |
| 3D. | Election of Class III Director: Frank Williams | Management | | For | | For | | |
| 4. | Proposal to ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2021. | Management | | For | | For | | |
| 5. | Proposal to approve the compensation of our named executive officers for 2020 on an advisory basis. | Management | | For | | For | | |
| 6. | Proposal to approve the Amended and Restated 2015 Omnibus Incentive Compensation Plan. | Management | | Against | | Against | | |
| ALX ONCOLOGY HOLDINGS INC | | |
| Security | 00166B105 | | | | Meeting Type | Annual |
| Ticker Symbol | ALXO | | | | Meeting Date | 10-Jun-2021 | |
| ISIN | US00166B1052 | | | | Agenda | 935433083 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1. | DIRECTOR | Management | | | | | | |
| | | 1 | Corey Goodman, Ph.D. | | | | For | | For | | |
| | | 2 | Jason Lettmann | | | | For | | For | | |
| | | 3 | Sophia Randolph MD PhD | | | | For | | For | | |
| 2. | Ratification of the appointment of KPMG LLP as the independent registered public accounting firm for our fiscal year ending December 31, 2021. | Management | | For | | For | | |
| REGENERON PHARMACEUTICALS, INC. | | |
| Security | 75886F107 | | | | Meeting Type | Annual |
| Ticker Symbol | REGN | | | | Meeting Date | 11-Jun-2021 | |
| ISIN | US75886F1075 | | | | Agenda | 935414627 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1A. | Election of Director: N. Anthony Coles, M.D. | Management | | For | | For | | |
| 1B. | Election of Director: Arthur F. Ryan | Management | | For | | For | | |
| 1C. | Election of Director: George L. Sing | Management | | For | | For | | |
| 1D. | Election of Director: Marc Tessier-Lavigne, Ph.D. | Management | | For | | For | | |
| 2. | Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2021. | Management | | For | | For | | |
| IOVANCE BIOTHERAPEUTICS, INC. | | |
| Security | 462260100 | | | | Meeting Type | Annual |
| Ticker Symbol | IOVA | | | | Meeting Date | 11-Jun-2021 | |
| ISIN | US4622601007 | | | | Agenda | 935419324 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1. | DIRECTOR | Management | | | | | | |
| | | 1 | Iain Dukes, D. Phil | | | | For | | For | | |
| | | 2 | Maria Fardis, Ph.D, MBA | | | | Withheld | | Against | | |
| | | 3 | Athena Countouriotis MD | | | | For | | For | | |
| | | 4 | Ryan Maynard | | | | For | | For | | |
| | | 5 | Merrill A. McPeak | | | | For | | For | | |
| | | 6 | Wayne P. Rothbaum | | | | For | | For | | |
| | | 7 | Michael Weiser MD Ph.D | | | | For | | For | | |
| 2. | To approve, by non-binding advisory vote, the compensation of our named executive officers. | Management | | For | | For | | |
| 3. | To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2021. | Management | | For | | For | | |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | | |
| Security | 881624209 | | | | Meeting Type | Annual |
| Ticker Symbol | TEVA | | | | Meeting Date | 14-Jun-2021 | |
| ISIN | US8816242098 | | | | Agenda | 935414110 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1A. | Election of Director: Rosemary A. Crane | Management | | For | | For | | |
| 1B. | Election of Director: Abbas Hussain | Management | | For | | For | | |
| 1C. | Election of Director: Gerald M. Lieberman | Management | | For | | For | | |
| 1D. | Election of Director: Prof. Ronit Satchi-Fainaro | Management | | For | | For | | |
| 2. | To approve, on a non-binding advisory basis, the compensation for Teva's named executive officers. | Management | | For | | For | | |
| 3. | To appoint Kesselman & Kesselman, a member of PricewaterhouseCoopers International Ltd., as Teva's independent registered public accounting firm until Teva's 2022 annual meeting of shareholders. | Management | | For | | For | | |
| CUTERA, INC. | | |
| Security | 232109108 | | | | Meeting Type | Annual |
| Ticker Symbol | CUTR | | | | Meeting Date | 15-Jun-2021 | |
| ISIN | US2321091082 | | | | Agenda | 935414778 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1. | DIRECTOR | Management | | | | | | |
| | | 1 | Gregory A. Barrett | | | | For | | For | | |
| | | 2 | David H. Mowry | | | | For | | For | | |
| | | 3 | Timothy J. O'Shea | | | | For | | For | | |
| | | 4 | J. Daniel Plants | | | | For | | For | | |
| | | 5 | Joseph E. Whitters | | | | For | | For | | |
| | | 6 | Katherine S. Zanotti | | | | For | | For | | |
| 2. | Ratify the selection of BDO USA, LLP as the independent registered public accounting firm of the Company (the "Independent Registered Public Accounting Firm") for the fiscal year ending December 31, 2021. | Management | | For | | For | | |
| 3. | Hold a non-binding advisory vote on the compensation of Named Executive Officers. | Management | | For | | For | | |
| 4. | Approval of the amendment and restatement of our 2019 Equity Incentive Plan to increase the total number of shares available for issuance under the 2019 Equity Incentive Plan by 600,000 shares of common stock. | Management | | For | | For | | |
| 5. | Elect Sheila A. Hopkins to serve a one-year term that expires at the 2022 Annual Meeting of Stockholders and until her successor has been duly elected and qualified. | Management | | For | | For | | |
| BLUEBIRD BIO, INC. | | |
| Security | 09609G100 | | | | Meeting Type | Annual |
| Ticker Symbol | BLUE | | | | Meeting Date | 15-Jun-2021 | |
| ISIN | US09609G1004 | | | | Agenda | 935422636 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1A. | Election of Class II Director: John O. Agwunobi, M.D. | Management | | For | | For | | |
| 1B. | Election of Class II Director: Daniel S. Lynch | Management | | For | | For | | |
| 1C. | Election of Class II Director: William R. Sellers, M.D. | Management | | For | | For | | |
| 2. | To approve, in a non-binding advisory vote, the compensation paid to the Company's named executive officers. | Management | | For | | For | | |
| 3. | To recommend the frequency of future advisory votes on executive compensation. | Management | | 1 Year | | For | | |
| 4. | To approve an amendment to the 2013 Employee Stock Purchase Plan. | Management | | For | | For | | |
| 5. | To ratify the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2021. | Management | | For | | For | | |
| CAREDX, INC. | | |
| Security | 14167L103 | | | | Meeting Type | Annual |
| Ticker Symbol | CDNA | | | | Meeting Date | 15-Jun-2021 | |
| ISIN | US14167L1035 | | | | Agenda | 935424325 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1. | DIRECTOR | Management | | | | | | |
| | | 1 | G. W. Bickerstaff, III | | | | For | | For | | |
| | | 2 | Grace E. Colón, Ph.D. | | | | For | | For | | |
| | | 3 | Ralph Snyderman, M.D. | | | | For | | For | | |
| 2. | Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2021. | Management | | For | | For | | |
| 3. | Approval, on an advisory basis, of the compensation of our named executive officers. | Management | | For | | For | | |
| 4. | Approval of amendments to the Company's Certificate of Incorporation and Bylaws to eliminate certain supermajority voting requirements. | Management | | For | | For | | |
| NUANCE COMMUNICATIONS, INC. | | |
| Security | 67020Y100 | | | | Meeting Type | Special |
| Ticker Symbol | NUAN | | | | Meeting Date | 15-Jun-2021 | |
| ISIN | US67020Y1001 | | | | Agenda | 935445406 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1. | To adopt the Agreement and Plan of Merger, dated as of April 11, 2021, by and among Microsoft Corporation, Big Sky Merger Sub Inc. ("Sub") and Nuance Communications, Inc. (the "Company"), pursuant to which Sub will merge with and into the Company (the "Merger"). | Management | | For | | For | | |
| 2. | To approve, by means of a non-binding, advisory vote, compensation that will or may become payable to the Company's named executive officers in connection with the Merger. | Management | | For | | For | | |
| ANIKA THERAPEUTICS, INC. | | |
| Security | 035255108 | | | | Meeting Type | Annual |
| Ticker Symbol | ANIK | | | | Meeting Date | 16-Jun-2021 | |
| ISIN | US0352551081 | | | | Agenda | 935419007 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1A. | Election of Director: Stephen O. Richard | Management | | For | | For | | |
| 1B. | Election of Director: Jeffery S. Thompson | Management | | For | | For | | |
| 2. | Approval of the amendment to the Anika Therapeutics, Inc. 2017 Omnibus Incentive Plan. | Management | | Against | | Against | | |
| 3. | Approval of the Anika Therapeutics, Inc. 2021 Employee Stock Purchase Plan. | Management | | For | | For | | |
| 4. | Ratification of Deloitte & Touche LLP as the Company's independent registered public accounting firm. | Management | | For | | For | | |
| 5. | Advisory vote on the compensation of the Company's named executive officers. | Management | | For | | For | | |
| GUARDANT HEALTH, INC. | | |
| Security | 40131M109 | | | | Meeting Type | Annual |
| Ticker Symbol | GH | | | | Meeting Date | 16-Jun-2021 | |
| ISIN | US40131M1099 | | | | Agenda | 935420810 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1A. | Election of Class III Director: Helmy Eltoukhy, Ph.D. | Management | | For | | For | | |
| 1B. | Election of Class III Director: AmirAli Talasaz, Ph.D. | Management | | For | | For | | |
| 1C. | Election of Class III Director: Bahija Jallal, Ph.D. | Management | | For | | For | | |
| 2. | Ratification of the appointment of Ernst & Young LLP as Guardant Health, Inc.'s independent registered public accounting firm for the year ending December 31, 2021. | Management | | For | | For | | |
| 3. | Advisory vote to approve named executive officer compensation. | Management | | For | | For | | |
| NANOSTRING TECHNOLOGIES, INC. | | |
| Security | 63009R109 | | | | Meeting Type | Annual |
| Ticker Symbol | NSTG | | | | Meeting Date | 16-Jun-2021 | |
| ISIN | US63009R1095 | | | | Agenda | 935421216 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1A. | Election of Director: Elisha W. Finney | Management | | For | | For | | |
| 1B. | Election of Director: Gregory Norden | Management | | For | | For | | |
| 1C. | Election of Director: Janet George | Management | | For | | For | | |
| 1D. | Election of Director: Charles P. Waite | Management | | For | | For | | |
| 2. | To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2021. | Management | | For | | For | | |
| 3. | To approve, on an advisory basis, the compensation of our named executive officers. | Management | | For | | For | | |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | | |
| Security | 69404D108 | | | | Meeting Type | Annual |
| Ticker Symbol | PACB | | | | Meeting Date | 16-Jun-2021 | |
| ISIN | US69404D1081 | | | | Agenda | 935421533 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1.1 | Election of Class II Director: Randy Livingston | Management | | For | | For | | |
| 1.2 | Election of Class II Director: Marshall Mohr | Management | | For | | For | | |
| 1.3 | Election of Class II Director: Hannah Valantine, MD | Management | | For | | For | | |
| 2. | Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2021. | Management | | For | | For | | |
| TG THERAPEUTICS, INC. | | |
| Security | 88322Q108 | | | | Meeting Type | Annual |
| Ticker Symbol | TGTX | | | | Meeting Date | 16-Jun-2021 | |
| ISIN | US88322Q1085 | | | | Agenda | 935428739 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1. | DIRECTOR | Management | | | | | | |
| | | 1 | Laurence Charney | | | | For | | For | | |
| | | 2 | Yann Echelard | | | | Withheld | | Against | | |
| | | 3 | William J. Kennedy | | | | For | | For | | |
| | | 4 | Kenneth Hoberman | | | | For | | For | | |
| | | 5 | Daniel Hume | | | | Withheld | | Against | | |
| | | 6 | Sagar Lonial, MD | | | | Withheld | | Against | | |
| | | 7 | Michael S. Weiss | | | | For | | For | | |
| 2. | To approve an amendment to our Certificate of Incorporation to increase the number of authorized shares of common stock from 150,000,000 to 175,000,000. | Management | | For | | For | | |
| 3. | To ratify the appointment of KPMG, LLP as our independent registered public accounting firm for the year ending December 31, 2021. | Management | | For | | For | | |
| JDE PEET'S B.V. | | |
| Security | N44664105 | | | | Meeting Type | Annual General Meeting |
| Ticker Symbol | | | | | Meeting Date | 17-Jun-2021 | |
| ISIN | NL0014332678 | | | | Agenda | 714056074 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| CMMT | PLEASE NOTE THAT BENEFICIAL OWNER DETAILS IS REQUIRED FOR THIS MEETING. IF NO- BENEFICIAL OWNER DETAILS IS PROVIDED, YOUR INSTRUCTION MAY BE REJECTED. THANK-YOU. | Non-Voting | | | | | | |
| CMMT | PLEASE NOTE THAT SHAREHOLDER DETAILS ARE REQUIRED TO VOTE AT THIS MEETING. IF-NO SHAREHOLDER DETAILS ARE PROVIDED, YOUR INSTRUCTION MAY CARRY A HEIGHTENED-RISK OF BEING REJECTED. THANK YOU | Non-Voting | | | | | | |
| 1. | OPENING | Non-Voting | | | | | | |
| 2.a. | REPORT OF THE BOARD FOR THE FINANCIAL YEAR 2020 | Non-Voting | | | | | | |
| 2.b. | ADVISORY VOTE ON THE 2020 REMUNERATION REPORT | Management | | No Action | | | | |
| 2.c. | PROPOSAL TO ADOPT THE 2020 FINANCIAL STATEMENTS | Management | | No Action | | | | |
| 3.a. | EXPLANATION OF THE POLICY ON ADDITIONS TO RESERVES AND DIVIDEND | Non-Voting | | | | | | |
| 3.b. | DIVIDEND DISTRIBUTION: PROPOSAL TO ADOPT THE DIVIDEND PROPOSAL FOR 2020 | Management | | No Action | | | | |
| 4.a. | DISCHARGE OF THE MEMBERS OF THE BOARD: PROPOSAL TO DISCHARGE THE EXECUTIVE MEMBERS OF THE BOARD IN RESPECT OF THEIR DUTIES DURING 2020 | Management | | No Action | | | | |
| 4.b. | DISCHARGE OF THE MEMBERS OF THE BOARD: PROPOSAL TO DISCHARGE THE NON-EXECUTIVE MEMBERS OF THE BOARD IN RESPECT OF THEIR DUTIES DURING 2020 | Management | | No Action | | | | |
| 5. | PROPOSAL TO RE-APPOINT DELOITTE ACCOUNTANTS B.V. AS EXTERNAL AUDITOR OF JDE PEET'S FOR THE FINANCIAL YEARS 2021 AND 2022 | Management | | No Action | | | | |
| 6.a. | AUTHORISATIONS OF THE BOARD: PROPOSAL TO AUTHORISE THE BOARD TO ACQUIRE UP TO 10% ORDINARY SHARES IN JDE PEET'S | Management | | No Action | | | | |
| 6.b. | AUTHORISATIONS OF THE BOARD: PROPOSAL TO DESIGNATE THE BOARD TO ISSUE UP TO 10% ORDINARY SHARES AND TO RESTRICT OR EXCLUDE PRE-EMPTIVE RIGHTS | Management | | No Action | | | | |
| 6.c. | AUTHORISATIONS OF THE BOARD: PROPOSAL TO DESIGNATE THE BOARD TO ISSUE UP TO 40% ORDINARY SHARES IN CONNECTION WITH A RIGHTS ISSUE | Management | | No Action | | | | |
| 7. | ANY OTHER BUSINESS | Non-Voting | | | | | | |
| 8. | VOTING RESULTS | Non-Voting | | | | | | |
| 9. | CLOSING OF THE MEETING | Non-Voting | | | | | | |
| CMMT | 21 MAY 2021: PLEASE NOTE THAT THIS IS A REVISION DUE TO DUE CHANGE IN-NUMBERING FOR ALL RESOLUTIONS AND ADDITIONAL OF COMMENT. IF YOU HAVE ALREADY-SENT IN YOUR VOTES, PLEASE DO NOT VOTE AGAIN UNLESS YOU DECIDE TO AMEND YOUR-ORIGINAL INSTRUCTIONS. THANK YOU | Non-Voting | | | | | | |
| CMMT | 21 MAY 2021: INTERMEDIARY CLIENTS ONLY - PLEASE NOTE THAT IF YOU ARE-CLASSIFIED AS AN INTERMEDIARY CLIENT UNDER THE SHAREHOLDER RIGHTS DIRECTIVE-II, YOU SHOULD BE PROVIDING THE UNDERLYING SHAREHOLDER INFORMATION AT THE-VOTE INSTRUCTION LEVEL. IF YOU ARE UNSURE ON HOW TO PROVIDE THIS LEVEL OF- DATA TO BROADRIDGE OUTSIDE OF PROXYEDGE, PLEASE SPEAK TO YOUR DEDICATED-CLIENT SERVICE REPRESENTATIVE FOR ASSISTANCE | Non-Voting | | | | | | |
| GLOBAL BLOOD THERAPEUTICS, INC. | | |
| Security | 37890U108 | | | | Meeting Type | Annual |
| Ticker Symbol | GBT | | | | Meeting Date | 17-Jun-2021 | |
| ISIN | US37890U1088 | | | | Agenda | 935418550 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1. | DIRECTOR | Management | | | | | | |
| | | 1 | Scott W. Morrison | | | | For | | For | | |
| | | 2 | Deval L. Patrick | | | | For | | For | | |
| | | 3 | Mark L. Perry | | | | For | | For | | |
| 2. | Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers as disclosed in the proxy statement. | Management | | For | | For | | |
| 3. | Ratification of the appointment of KPMG LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2021. | Management | | For | | For | | |
| SILK ROAD MEDICAL INC | | |
| Security | 82710M100 | | | | Meeting Type | Annual |
| Ticker Symbol | SILK | | | | Meeting Date | 17-Jun-2021 | |
| ISIN | US82710M1009 | | | | Agenda | 935419982 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1. | DIRECTOR | Management | | | | | | |
| | | 1 | Kevin J. Ballinger | | | | For | | For | | |
| | | 2 | Tony M. Chou, M.D. | | | | For | | For | | |
| 2. | To adopt and approve amendment to our Certificate of Incorporation to phase out the classified structure of our board of directors. | Management | | For | | For | | |
| 3. | To approve Named Executive Officer Compensation on an advisory basis. | Management | | For | | For | | |
| 4. | The frequency of advisory votes on Named Executive Officer Compensation on an advisory basis. | Management | | 1 Year | | For | | |
| 5. | To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2021. | Management | | For | | For | | |
| NOVAVAX, INC. | | |
| Security | 670002401 | | | | Meeting Type | Annual |
| Ticker Symbol | NVAX | | | | Meeting Date | 17-Jun-2021 | |
| ISIN | US6700024010 | | | | Agenda | 935426761 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1A. | Election of Class II Director to serve for a three-year term expiring at the 2024 Annual Meeting: Richard H. Douglas, Ph.D. | Management | | For | | For | | |
| 1B. | Election of Class II Director to serve for a three-year term expiring at the 2024 Annual Meeting: Margaret G. McGlynn, R. Ph. | Management | | For | | For | | |
| 1C. | Election of Class II Director to serve for a three-year term expiring at the 2024 Annual Meeting: David M. Mott | Management | | For | | For | | |
| 2. | The approval, on an advisory basis, of the compensation paid to our Named Executive Officers. | Management | | For | | For | | |
| 3. | Amendment and restatement of the Amended and Restated Novavax, Inc. 2015 Stock Plan to increase the number of shares of Common Stock available for issuance thereunder by 1,500,000 shares. | Management | | Against | | Against | | |
| 4. | Ratification of certain April 2020 equity awards. | Management | | Abstain | | Against | | |
| 5. | Ratification of certain June 2020 equity awards. | Management | | Abstain | | Against | | |
| 6. | Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2021. | Management | | For | | For | | |
| IRHYTHM TECHNOLOGIES, INC. | | |
| Security | 450056106 | | | | Meeting Type | Annual |
| Ticker Symbol | IRTC | | | | Meeting Date | 18-Jun-2021 | |
| ISIN | US4500561067 | | | | Agenda | 935449834 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1. | DIRECTOR | Management | | | | | | |
| | | 1 | C. Noel Bairey Merz M.D | | | | For | | For | | |
| | | 2 | Mark J. Rubash | | | | For | | For | | |
| | | 3 | Renee Budig | | | | For | | For | | |
| 2. | To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2021. | Management | | For | | For | | |
| 3. | Advisory vote to approve Named Executive Officer Compensation. | Management | | For | | For | | |
| ORTHOFIX MEDICAL INC. | | |
| Security | 68752M108 | | | | Meeting Type | Annual |
| Ticker Symbol | OFIX | | | | Meeting Date | 21-Jun-2021 | |
| ISIN | US68752M1080 | | | | Agenda | 935424286 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1.1 | Election of Director: Catherine M. Burzik | Management | | For | | For | | |
| 1.2 | Election of Director: Jason M. Hannon | Management | | For | | For | | |
| 1.3 | Election of Director: James F. Hinrichs | Management | | For | | For | | |
| 1.4 | Election of Director: Alexis V. Lukianov | Management | | For | | For | | |
| 1.5 | Election of Director: Lilly Marks | Management | | For | | For | | |
| 1.6 | Election of Director: Michael E. Paolucci | Management | | For | | For | | |
| 1.7 | Election of Director: Jon C. Serbousek | Management | | For | | For | | |
| 1.8 | Election of Director: John E. Sicard | Management | | For | | For | | |
| 2. | Advisory vote on compensation of named executive officers. | Management | | For | | For | | |
| 3. | Approval of Amendment No. 2 to the Amended and Restated 2012 Long-Term Incentive Plan. | Management | | Against | | Against | | |
| 4. | Approval of Amendment No. 2 to the Second Amended and Restated Stock Purchase Plan. | Management | | For | | For | | |
| 5. | Ratification of the selection of Ernst & Young LLP as the Company's Independent Registered Public Accounting Firm for the fiscal year ending December 31, 2021. | Management | | For | | For | | |
| LUMINEX CORPORATION | | |
| Security | 55027E102 | | | | Meeting Type | Special |
| Ticker Symbol | LMNX | | | | Meeting Date | 21-Jun-2021 | |
| ISIN | US55027E1029 | | | | Agenda | 935446193 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1. | To adopt the Agreement and Plan of Merger, dated as of April 11, 2021, as it may be amended, supplemented or modified from time to time, by and among Luminex Corporation, DiaSorin S.p.A., and Diagonal Subsidiary Inc. and approve the Merger. | Management | | For | | For | | |
| 2. | To adjourn the Special Meeting, if necessary and for a minimum period of time reasonable under the circumstances, to ensure that any necessary supplement or amendment to the proxy statement is provided to the stockholders of Luminex Corporation a reasonable amount of time in advance of the Special Meeting, or to solicit additional proxies if there are insufficient votes at the time of the Special Meeting to approve the proposal to adopt the Merger Agreement and approve the Merger. | Management | | For | | For | | |
| 3. | To approve, by non-binding, advisory vote, the compensation that will or may be paid or become payable to Luminex Corporation's named executive officers that is based on or otherwise relates to the Merger. | Management | | For | | For | | |
| KIKKOMAN CORPORATION | | |
| Security | J32620106 | | | | Meeting Type | Annual General Meeting |
| Ticker Symbol | | | | | Meeting Date | 22-Jun-2021 | |
| ISIN | JP3240400006 | | | | Agenda | 714226443 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| | Please reference meeting materials. | Non-Voting | | | | | | |
| 1 | Approve Appropriation of Surplus | Management | | For | | For | | |
| 2.1 | Appoint a Director Mogi, Yuzaburo | Management | | Against | | Against | | |
| 2.2 | Appoint a Director Horikiri, Noriaki | Management | | For | | For | | |
| 2.3 | Appoint a Director Yamazaki, Koichi | Management | | For | | For | | |
| 2.4 | Appoint a Director Nakano, Shozaburo | Management | | For | | For | | |
| 2.5 | Appoint a Director Shimada, Masanao | Management | | For | | For | | |
| 2.6 | Appoint a Director Mogi, Osamu | Management | | For | | For | | |
| 2.7 | Appoint a Director Matsuyama, Asahi | Management | | For | | For | | |
| 2.8 | Appoint a Director Kamiyama, Takao | Management | | For | | For | | |
| 2.9 | Appoint a Director Fukui, Toshihiko | Management | | For | | For | | |
| 2.10 | Appoint a Director Ozaki, Mamoru | Management | | For | | For | | |
| 2.11 | Appoint a Director Inokuchi, Takeo | Management | | For | | For | | |
| 2.12 | Appoint a Director Iino, Masako | Management | | For | | For | | |
| 3.1 | Appoint a Corporate Auditor Fukasawa, Haruhiko | Management | | Against | | Against | | |
| 3.2 | Appoint a Corporate Auditor Kogo, Motohiko | Management | | For | | For | | |
| 4 | Appoint a Substitute Corporate Auditor Endo, Kazuyoshi | Management | | For | | For | | |
| ACADIA PHARMACEUTICALS INC. | | |
| Security | 004225108 | | | | Meeting Type | Annual |
| Ticker Symbol | ACAD | | | | Meeting Date | 22-Jun-2021 | |
| ISIN | US0042251084 | | | | Agenda | 935440052 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1. | DIRECTOR | Management | | | | | | |
| | | 1 | Stephen Biggar, MD Ph.D | | | | For | | For | | |
| | | 2 | Julian C. Baker | | | | For | | For | | |
| | | 3 | Daniel B. Soland | | | | For | | For | | |
| 2. | To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in the proxy statement for the annual meeting. | Management | | For | | For | | |
| 3. | To ratify the selection of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2021. | Management | | For | | For | | |
| BIONTECH SE | | |
| Security | 09075V102 | | | | Meeting Type | Annual |
| Ticker Symbol | BNTX | | | | Meeting Date | 22-Jun-2021 | |
| ISIN | US09075V1026 | | | | Agenda | 935445672 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 2 | Approval of the actions of the Management Board. | Management | | For | | For | | |
| 3 | Approval of the actions of the Supervisory Board. | Management | | For | | For | | |
| 4 | Appointment of the auditor for the financial year 2021. | Management | | For | | For | | |
| 5 | Resolution on the revocation of the existing authorized capital and the creation of a new authorized capital (Authorized Capital 2021) against contributions in cash and/or in kind with the possibility of excluding subscription rights and corresponding amendments to the Articles of Association. | Management | | Abstain | | Against | | |
| 6 | Amendment of the authorization to issue stock options. | Management | | For | | For | | |
| 7 | Resolution on the partial revocation and amendment of the current authorization to issue stock options (Stock Option Program 2017/2019) and on the partial revocation of Conditional Capital ESOP 2017/2019; Resolution on the authorization to issue stock options (Stock Option Program 2021) and on the implementation of a new Conditional Capital 2021 and corresponding amendments of the Articles of Association. | Management | | For | | For | | |
| 8 | Amendment to the existing authorization to acquire treasury shares and their use, also excluding subscription rights. | Management | | Abstain | | Against | | |
| 9 | Extending the authorization to acquire treasury shares and to use them, also excluding subscription rights. | Management | | Abstain | | Against | | |
| 10 | Resolution on the approval of the system for the compensation of the members of the Management Board. | Management | | For | | For | | |
| 11 | Resolution on the compensation and on the compensation system for the members of the Supervisory Board and an amendment of Sec. 9 para. 6 of the Articles of Association. | Management | | For | | For | | |
| 12 | Resolution on the revocation of the resolution of the Company's Annual General Meeting of June 26, 2020 (agenda item 8 lit. d)) on the consent to the conclusion of the domination and profit and loss transfer agreement between the Company as controlling company and JPT Peptide Technologies GmbH as dependent company. | Management | | For | | For | | |
| 13A | Approval of the conclusion of the domination and profit and loss transfer agreement between the Company as controlling company and JPT Peptide Technologies GmbH as dependent company. | Management | | For | | For | | |
| 13B | Approval of the conclusion of the domination and profit and loss transfer agreement between the Company as controlling company and BioNTech Manufacturing Marburg GmbH as dependent company. | Management | | For | | For | | |
| 13C | Approval of the conclusion of the domination and profit and loss transfer agreement between the Company as controlling company and reSano GmbH as dependent company. | Management | | For | | For | | |
| YAKULT HONSHA CO.,LTD. | | |
| Security | J95468120 | | | | Meeting Type | Annual General Meeting |
| Ticker Symbol | | | | | Meeting Date | 23-Jun-2021 | |
| ISIN | JP3931600005 | | | | Agenda | 714250026 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| | Please reference meeting materials. | Non-Voting | | | | | | |
| 1.1 | Appoint a Director Narita, Hiroshi | Management | | For | | For | | |
| 1.2 | Appoint a Director Wakabayashi, Hiroshi | Management | | For | | For | | |
| 1.3 | Appoint a Director Ishikawa, Fumiyasu | Management | | For | | For | | |
| 1.4 | Appoint a Director Ito, Masanori | Management | | For | | For | | |
| 1.5 | Appoint a Director Doi, Akifumi | Management | | For | | For | | |
| 1.6 | Appoint a Director Hayashida, Tetsuya | Management | | For | | For | | |
| 1.7 | Appoint a Director Hirano, Susumu | Management | | For | | For | | |
| 1.8 | Appoint a Director Imada, Masao | Management | | For | | For | | |
| 1.9 | Appoint a Director Yasuda, Ryuji | Management | | For | | For | | |
| 1.10 | Appoint a Director Fukuoka, Masayuki | Management | | For | | For | | |
| 1.11 | Appoint a Director Maeda, Norihito | Management | | For | | For | | |
| 1.12 | Appoint a Director Tobe, Naoko | Management | | For | | For | | |
| 1.13 | Appoint a Director Hirano, Koichi | Management | | For | | For | | |
| 1.14 | Appoint a Director Shimbo, Katsuyoshi | Management | | For | | For | | |
| 1.15 | Appoint a Director Nagasawa, Yumiko | Management | | For | | For | | |
| CLOVIS ONCOLOGY, INC. | | |
| Security | 189464100 | | | | Meeting Type | Annual |
| Ticker Symbol | CLVS | | | | Meeting Date | 23-Jun-2021 | |
| ISIN | US1894641000 | | | | Agenda | 935410794 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1. | DIRECTOR | Management | | | | | | |
| | | 1 | Patrick J. Mahaffy | | | | For | | For | | |
| | | 2 | Robert W. Azelby | | | | For | | For | | |
| | | 3 | Thorlef Spickschen | | | | For | | For | | |
| 2. | Approval of an amendment to our Amended and Restated Certificate of Incorporation to increase the number of authorized shares of common stock from 200,000,000 to 250,000,000. | Management | | For | | For | | |
| 3. | Approval of an amendment and restatement of our 2020 Stock Incentive Plan to increase the number of shares available for issuance under the plan. | Management | | Against | | Against | | |
| 4. | Approval of the Clovis Oncology, Inc. 2021 Employee Stock Purchase Plan. | Management | | For | | For | | |
| 5. | Approval of an advisory proposal on compensation of the Company's named executive officers, as disclosed in the attached proxy statement. | Management | | For | | For | | |
| 6. | Ratification of the appointment of Ernst & Young LLP as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2021. | Management | | For | | For | | |
| OPKO HEALTH, INC. | | |
| Security | 68375N103 | | | | Meeting Type | Annual |
| Ticker Symbol | OPK | | | | Meeting Date | 24-Jun-2021 | |
| ISIN | US68375N1037 | | | | Agenda | 935428397 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1. | DIRECTOR | Management | | | | | | |
| | | 1 | Phillip Frost, M.D. | | | | For | | For | | |
| | | 2 | Jane H. Hsiao, PhD, MBA | | | | For | | For | | |
| | | 3 | Steven D. Rubin | | | | For | | For | | |
| | | 4 | Jon R. Cohen, M.D. | | | | For | | For | | |
| | | 5 | Robert S. Fishel, M.D. | | | | For | | For | | |
| | | 6 | Richard M. Krasno, Ph.D | | | | For | | For | | |
| | | 7 | Prem A. Lachman, M.D. | | | | For | | For | | |
| | | 8 | Richard A. Lerner, M.D. | | | | For | | For | | |
| | | 9 | Roger J. Medel, M.D. | | | | For | | For | | |
| | | 10 | John A. Paganelli | | | | For | | For | | |
| | | 11 | Richard C Pfenniger, Jr | | | | For | | For | | |
| | | 12 | A. Lin-Tsing Yu, MD PhD | | | | For | | For | | |
| 2. | A non-binding advisory vote to approve the compensation paid to named executive officers of the Company ("Say on Pay"). | Management | | For | | For | | |
| 3. | To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2021. | Management | | For | | For | | |
| THE KROGER CO. | | |
| Security | 501044101 | | | | Meeting Type | Annual |
| Ticker Symbol | KR | | | | Meeting Date | 24-Jun-2021 | |
| ISIN | US5010441013 | | | | Agenda | 935432889 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1A. | Election of Director: Nora A. Aufreiter | Management | | For | | For | | |
| 1B. | Election of Director: Kevin M. Brown | Management | | For | | For | | |
| 1C. | Election of Director: Anne Gates | Management | | For | | For | | |
| 1D. | Election of Director: Karen M. Hoguet | Management | | For | | For | | |
| 1E. | Election of Director: W. Rodney McMullen | Management | | For | | For | | |
| 1F. | Election of Director: Clyde R. Moore | Management | | For | | For | | |
| 1G. | Election of Director: Ronald L. Sargent | Management | | For | | For | | |
| 1H. | Election of Director: J. Amanda Sourry Knox | Management | | For | | For | | |
| 1I. | Election of Director: Mark S. Sutton | Management | | For | | For | | |
| 1J. | Election of Director: Ashok Vemuri | Management | | For | | For | | |
| 2. | Approval, on an advisory basis, of Kroger's executive compensation. | Management | | For | | For | | |
| 3. | Ratification of PricewaterhouseCoopers LLP, as auditors. | Management | | For | | For | | |
| 4. | A shareholder proposal, if properly presented, to issue a report assessing the environmental impacts of using unrecyclable packaging for private label brands. | Shareholder | | Abstain | | Against | | |
| ODONATE THERAPEUTICS, INC. | | |
| Security | 676079106 | | | | Meeting Type | Annual |
| Ticker Symbol | ODT | | | | Meeting Date | 24-Jun-2021 | |
| ISIN | US6760791060 | | | | Agenda | 935457413 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1.1 | Election of Director: Kevin Tang | Management | | For | | For | | |
| 1.2 | Election of Director: Aaron Davis | Management | | For | | For | | |
| 1.3 | Election of Director: Craig Johnson | Management | | For | | For | | |
| 1.4 | Election of Director: Laura Johnson | Management | | For | | For | | |
| 1.5 | Election of Director: Robert Rosen | Management | | For | | For | | |
| 2. | Ratification of the selection of Baker Tilly US, LLP as the Company's independent registered public accounting firm for the year ending December 31, 2021. | Management | | For | | For | | |
| 3. | Advisory approval of the Company's executive compensation. | Management | | For | | For | | |
| MORINAGA MILK INDUSTRY CO.,LTD. | | |
| Security | J46410114 | | | | Meeting Type | Annual General Meeting |
| Ticker Symbol | | | | | Meeting Date | 29-Jun-2021 | |
| ISIN | JP3926800008 | | | | Agenda | 714243285 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| | Please reference meeting materials. | Non-Voting | | | | | | |
| 1 | Approve Appropriation of Surplus | Management | | For | | For | | |
| 2.1 | Appoint a Director Miyahara, Michio | Management | | For | | For | | |
| 2.2 | Appoint a Director Onuki, Yoichi | Management | | For | | For | | |
| 2.3 | Appoint a Director Okawa, Teiichiro | Management | | For | | For | | |
| 2.4 | Appoint a Director Minato, Tsuyoshi | Management | | For | | For | | |
| 2.5 | Appoint a Director Yanagida, Yasuhiko | Management | | For | | For | | |
| 2.6 | Appoint a Director Hyodo, Hitoshi | Management | | For | | For | | |
| 2.7 | Appoint a Director Kawakami, Shoji | Management | | For | | For | | |
| 2.8 | Appoint a Director Yoneda, Takatomo | Management | | For | | For | | |
| 2.9 | Appoint a Director Tominaga, Yukari | Management | | For | | For | | |
| 3 | Appoint a Substitute Corporate Auditor Suzuki, Michio | Management | | For | | For | | |
| MEIJI HOLDINGS CO.,LTD. | | |
| Security | J41729104 | | | | Meeting Type | Annual General Meeting |
| Ticker Symbol | | | | | Meeting Date | 29-Jun-2021 | |
| ISIN | JP3918000005 | | | | Agenda | 714250038 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| | Please reference meeting materials. | Non-Voting | | | | | | |
| 1.1 | Appoint a Director Kawamura, Kazuo | Management | | For | | For | | |
| 1.2 | Appoint a Director Kobayashi, Daikichiro | Management | | For | | For | | |
| 1.3 | Appoint a Director Matsuda, Katsunari | Management | | For | | For | | |
| 1.4 | Appoint a Director Shiozaki, Koichiro | Management | | For | | For | | |
| 1.5 | Appoint a Director Furuta, Jun | Management | | For | | For | | |
| 1.6 | Appoint a Director Matsumura, Mariko | Management | | For | | For | | |
| 1.7 | Appoint a Director Kawata, Masaya | Management | | Against | | Against | | |
| 1.8 | Appoint a Director Kuboyama, Michiko | Management | | For | | For | | |
| 2.1 | Appoint a Corporate Auditor Chida, Hiroaki | Management | | For | | For | | |
| 2.2 | Appoint a Corporate Auditor Ono, Takayoshi | Management | | Against | | Against | | |
| 2.3 | Appoint a Corporate Auditor Watanabe, Hajime | Management | | For | | For | | |
| 2.4 | Appoint a Corporate Auditor Ando, Makoto | Management | | For | | For | | |
| 3 | Appoint a Substitute Corporate Auditor Imamura, Makoto | Management | | For | | For | | |
| PETIQ, INC. | | |
| Security | 71639T106 | | | | Meeting Type | Annual |
| Ticker Symbol | PETQ | | | | Meeting Date | 29-Jun-2021 | |
| ISIN | US71639T1060 | | | | Agenda | 935437295 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1A. | Election of class I director to serve until the third annual meeting: Ronald Kennedy | Management | | For | | For | | |
| 1B. | Election of class I director to serve until the third annual meeting: Sheryl Oloughlin | Management | | For | | For | | |
| 2. | To ratify the selection of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2021. | Management | | For | | For | | |
| 3. | To approve, on an advisory, non-binding basis, the compensation of our named executive officers. | Management | | For | | For | | |
| 4. | To approve the amendment and restatement of our Amended and Restated 2017 Omnibus Incentive Plan. | Management | | Against | | Against | | |
| 5. | To approve on an advisory, non-binding basis, the frequency of stockholder advisory approval on the compensation of our named executive officers. | Management | | 1 Year | | For | | |
| TAKEDA PHARMACEUTICAL CO LTD | | |
| Security | 874060205 | | | | Meeting Type | Annual |
| Ticker Symbol | TAK | | | | Meeting Date | 29-Jun-2021 | |
| ISIN | US8740602052 | | | | Agenda | 935457437 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1 | Appropriation of Surplus | Management | | For | | | | |
| 2 | Partial Amendment to the Articles of Incorporation | Management | | For | | | | |
| 3A | Election of Director who is not Audit and Supervisory Committee Member: Christophe Weber | Management | | For | | | | |
| 3B | Election of Director who is not Audit and Supervisory Committee Member: Masato Iwasaki | Management | | For | | | | |
| 3C | Election of Director who is not Audit and Supervisory Committee Member: Andrew Plump | Management | | For | | | | |
| 3D | Election of Director who is not Audit and Supervisory Committee Member: Costa Saroukos | Management | | For | | | | |
| 3E | Election of Director who is not Audit and Supervisory Committee Member: Masahiro Sakane | Management | | For | | | | |
| 3F | Election of Director who is not Audit and Supervisory Committee Member: Oliver Bohuon | Management | | For | | | | |
| 3G | Election of Director who is not Audit and Supervisory Committee Member: Jean-Luc Butel | Management | | For | | | | |
| 3H | Election of Director who is not Audit and Supervisory Committee Member: Ian Clark | Management | | Against | | | | |
| 3I | Election of Director who is not Audit and Supervisory Committee Member: Yoshiaki Fujimori | Management | | For | | | | |
| 3J | Election of Director who is not Audit and Supervisory Committee Member: Steven Gillis | Management | | For | | | | |
| 3K | Election of Director who is not Audit and Supervisory Committee Member: Shiro Kuniya | Management | | For | | | | |
| 3L | Election of Director who is not Audit and Supervisory Committee Member: Toshiyuki Shiga | Management | | For | | | | |
| 4.1 | Election of Director who is an Audit and Supervisory Committee Member: Masami Iijima | Management | | For | | | | |
| 5 | Payment of Bonuses to Directors who are not Audit and Supervisory Committee Members | Management | | For | | | | |
| NOMAD FOODS LIMITED | | |
| Security | G6564A105 | | | | Meeting Type | Annual |
| Ticker Symbol | NOMD | | | | Meeting Date | 30-Jun-2021 | |
| ISIN | VGG6564A1057 | | | | Agenda | 935433704 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1A. | Election of Director: Sir Martin Ellis Franklin, KGCN | Management | | For | | For | | |
| 1B. | Election of Director: Noam Gottesman | Management | | For | | For | | |
| 1C. | Election of Director: Ian G.H. Ashken | Management | | For | | For | | |
| 1D. | Election of Director: Stéfan Descheemaeker | Management | | For | | For | | |
| 1E. | Election of Director: Golnar Khosrowshahi | Management | | For | | For | | |
| 1F. | Election of Director: James E. Lillie | Management | | For | | For | | |
| 1G. | Election of Director: Stuart M. MacFarlane | Management | | For | | For | | |
| 1H. | Election of Director: Lord Myners of Truro CBE | Management | | For | | For | | |
| 1I. | Election of Director: Victoria Parry | Management | | For | | For | | |
| 1J. | Election of Director: Melanie Stack | Management | | For | | For | | |
| 1K. | Election of Director: Samy Zekhout | Management | | For | | For | | |
| 2. | Ratification of the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for 2021. | Management | | For | | For | | |
| EXACT SCIENCES CORPORATION | | |
| Security | 30063P105 | | | | Meeting Type | Annual |
| Ticker Symbol | EXAS | | | | Meeting Date | 30-Jun-2021 | |
| ISIN | US30063P1057 | | | | Agenda | 935434960 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1. | DIRECTOR | Management | | | | | | |
| | | 1 | Paul Clancy | | | | For | | For | | |
| | | 2 | Pierre Jacquet | | | | For | | For | | |
| | | 3 | Daniel Levangie | | | | For | | For | | |
| 2. | To ratify the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for 2021. | Management | | For | | For | | |
| 3. | To approve, on an advisory basis, the compensation of the Company's named executive officers. | Management | | For | | For | | |
| EHEALTH, INC. | | |
| Security | 28238P109 | | | | Meeting Type | Annual |
| Ticker Symbol | EHTH | | | | Meeting Date | 30-Jun-2021 | |
| ISIN | US28238P1093 | | | | Agenda | 935441446 - Management |
| | | | | | | | | | | | | | |
| Item | Proposal | Proposed by | | Vote | For/Against Management | | |
| 1. | DIRECTOR | Management | | | | | | |
| | | 1 | James E. Murray | | | | For | | For | | |
| | | 2 | Cesar M. Soriano | | | | For | | For | | |
| | | 3 | Dale B. Wolf | | | | For | | For | | |
| 2. | Company Proposal: To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the Company's fiscal year ending December 31, 2021. | Management | | For | | For | | |
| 3. | Company Proposal: To vote to approve, on an advisory basis, the compensation of the Company's named executive officers. | Management | | For | | For | | |
Pursuant to the requirements of the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
*Print the name and title of each signing officer under his or her signature.